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Swati S. Nigudkar
Doctor of Philosophy
University of Missouri - St. Louis
Prof. Alexei V. Demchenko, Chairperson

It has been recognized that carbohydrates are involved in all phases of life beginning with
the embryonic development and cell growth. However, it is the involvement of
carbohydrates in the progression of various deadly diseases that gave these natural
compounds significant roles in diagnostics and as pharmaceuticals. Although
carbohydrates are highly desirable to the biological and medical communities, these
molecules are still very challenging targets for chemists. Functionalization,
derivatization, controlling anomeric stereoselectivity, purification, and characterization
are all existing experimental hurdles towards producing synthetic carbohydrates in large
quantities and high purity. Advances in chemistry and biochemistry have certainly
facilitated the synthesis and purification of carbohydrates. However, the development of
practical and general methods for chemical glycosylation and expeditious oligosaccharide
synthesis remain an important and challenging area of research.
This topic has also become the basis for this doctoral dissertation wherein the focus was
primarily placed on the development of new leaving groups for chemical glycosylation
and designing novel methods and technologies for efficient oligosaccharide synthesis.
ii

One outcome of this study is the development of two new classes of building blocks for
chemical glycosylation, O-benzoxazolyl (OBox) and 3,3-difluoro-3H-indol-2-yl (OFox)
imidates. Based on our observation that the OFox leaving group has the same structure
before its introduction and after its departure, 3,3-difluoroxindole (HOFox) aglycone, we
developed a new regenerative concept for chemical glycosylation. This method allows for
performing glycosylation reactions in a conceptually novel way using catalytic amounts
of reagents and activators. Further application of the regenerative concept to the HPLCassisted synthesis on polymer support, an automated technology being developed in our
laboratory, was complementary for refining all chemical aspects of both methods.
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Chapter 1

Stereocontrolled 1,2-cis glycosylation as the
driving force of progress in synthetic
carbohydrate chemistry

1.1. Introduction
Carbohydrates, as polysaccharides or glycoconjugates, represent the largest class of naturally
occurring compounds and are often found as essential components of many bioactive molecules
in nature.1-4 Carbohydrates were initially viewed as energy-storage materials, structural
components, and primary metabolites. Now it is known that carbohydrates mediate many
fundamental biological processes such as immune defense, fertilization, metastasis, signal
transduction, cell growth and cell-cell adhesion. In the past few years, we have been learning that
carbohydrates play crucial roles in pathogenesis of diabetes, bacterial and viral infections,
inflammation, development and growth of cancers, and many other diseases.5-9 Clearly,
uncovering the contributions of carbohydrates to cell biology would greatly facilitate advances in
the field of glycobiology and medicine.10-13
For the most part, medicinally important carbohydrates exist as complex oligomers or as
conjugates with other biomolecules including natural products,4,14,15 lipids,2,16-20 peptides,21-23
proteins,3,24-26 etc.27-31 The carbohydrate part itself exists in various sizes and shapes ranging
from monomeric sugars and simple linear chains to highly branched glycoforms. Major obstacles
in studying the natural carbohydrates are the difficulties in isolating, characterizing, and
synthesizing these molecules due to their low abundance and heterogeneity in nature. While
scientists have been able to successfully isolate and characterize certain classes of natural
carbohydrates, the availability of pure isolates is still low. As a consequence, the systematic
study of these molecules often relies on synthetic chemistry to provide pure compounds in
significant quantities.
Among a variety of glycosidic bonds in nature, it is the O-glycosidic bonds that are of major
interest and challenge to chemists due to their high abundance and difficulty in synthesis. There

2

are two major types of O-glycosides, which are, depending on nomenclature, most commonly
defined as - and -, or 1,2-cis and 1,2-trans glycosides. The 1,2-cis glycosyl residues, glycosides for D-glucose, D-galactose or -glycosides for D-mannose, L-rhamnose, as well as
their 1,2-trans counterparts (β-glycosides for D-glucose, β-glycosides for D-mannose) are both
important and abundant classes of linkages and are found as components in a variety of natural
compounds. Some other common types of glycosides, for instance 2-deoxyglycosides and
sialosides, lack the neighboring substituent. These compounds can neither be defined as 1,2-cis
nor 1,2-trans glycosides, hence, these are commonly referred to as α and β glycosides.
Representative examples of common glycosides are shown in Figure 1.1.
Figure 1.1. Common monosaccharide residues found in the mammalian and bacterial
glycome.

3

Many oligosaccharides containing 1,2-cis O-glycosidic linkages are of high importance due to
their biological roles and therapeutic potential. Some representative naturally occurring
oligosaccharides containing 1,2-cis linkages are shown in Figure 1.2.
Figure 1.2. Naturally occurring oligosaccharides containing 1,2-cis linkages
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For example, immunomodulatory pentasaccharide FPS-1 from Aconitum carmichaeli is
composed of the α-(16) linked glucosyl backbone with some α-(13)-glucosyl branching.32
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Fungus Pseudallescheria boydii consists of the glycogen-like α-(14)-linked glucan backbone
with occasional α-(16)-glucosyl branches.33,34 Zwitterionic polysaccharide A1 found on the
capsule of the bacterium Bacteroides fragilis has a 1,2-cis-linked glycosaminoglycan motif.35
Many pneumococcal polysaccharides possess 1,2-cis glycosidic linkages, for instance
polysaccharide from Streptococcus pneumonia serotype 6B36-39 that is included in all current
pneumococcal vaccines,40-44 has α-glucose and α-galactose residues. The trisaccharide repeating
unit isolated from Staphylococcus aureus type 545 possesses uncommon ManNAcA and
FucNAc, both 1,2-cis-glycosidically linked. High mannose-type N-linked glycans46,47 that
mediate the pathogenesis of cancers,27 AIDS,48 Alzheimer’s disease,49 idiopathic normal pressure
hydrocephalus,49 classical galactosemia,50 etc. bear an important β-mannose bond.

All

glycosphingolipids of the globoside family have an α-linked galactose residue. Amongst these,
Globo-H, which is a current target for breast and prostate cancer vaccine development,51,52 has an
α-fucose residue as well.

1.2. Outline of chemical glycosylation: mechanism, general principles and special cases
Over the last two decades, synthetic carbohydrate chemistry has witnessed a dramatic
improvement in the methods available. Glycosylation is arguably the most important albeit
challenging reaction in the field of carbohydrate chemistry. Most commonly, it involves the
reaction between a glycosyl donor and glycosyl acceptor, in presence of an activator or promoter,
to form a glycosidic bond. Upon activation, the promoter-assisted departure of the leaving group
results in the formation of a glycosyl cation, which then gets stabilized via an oxacarbenium ion
intermediate (Scheme 1.1a). The nucleophile, glycosyl acceptor, can then attack (form the
glycosidic bond) either from the top or the bottom face of the flattened ring. This would give rise

5

to either 1,2-cis or 1,2-trans glycosides with respect to the neighboring substituent at C-2, and
uncontrolled reactions may lead to the mixture of both.
Scheme 1.1. General outline of glycosylation and the key intermediates involved

The formation of 1,2-trans linkages can be accomplished using the participatory effect of the
neighboring 2-acyl substituent. In this case, the oxacarbenium ion can be further stabilized via a
bicyclic acyloxonium intermediate, which becomes the key intermediate en route to
glycosylation products (Scheme 1.1b). Since the bottom face of the ring can be blocked now, the
nucleophilic attack of the glycosyl acceptor would be directed from the opposite, top face,
6

providing access to 1,2-trans linkage with a high stereoselectivity. Occasionally, substantial
amounts of 1,2-cis-linked products are also formed. In these cases, glycosylation assumingly
proceeds via oxacarbenium ion, resulting in the formation of 1,2-trans and 1,2-cis glycosides,
respectively, or most-commonly mixtures thereof. An orthoester formation is another possible
process (Scheme 1.1b).
While the stereoselective synthesis of 1,2-trans linkages can be reliably achieved with the use
of the neighboring group assistance,53-55 the formation of 1,2-cis linkages is typically much more
challenging. The presence of a non-participating group is required for the synthesis of 1,2-cis
glycosides, but the non-participating group alone cannot ensure the stereoselectivity. Although
the α-product is favored by the anomeric effect,56 the stereoselectivity of glycosylation can be
poor and requires other modes of stereocontrol. A variety of reaction conditions and structural
elements of the reactants has been developed to obtain excellent 1,2-cis stereoselectivity, no
comprehensive method for 1,2-cis glycosylation is yet available. The failure to control the
stereoselectivity of glycosylations leads to the formation of a mixture of anomers. Thus, the
effective formation of 1,2-cis glycosidic linkages with high stereocontrol is a major challenge. 57
In addition to the apparent complexity of the glycosidation process, there are other competing
processes that cannot be disregarded. Side reactions, such as elimination, substitution (formation
of unexpected substitution products or hydrolysis at the anomeric center), cyclization (inter- and
intramolecular orthoesterification), migration, redox, etc,58 often complicate stereocontrol and
compromise the yields of glycosylations. Several factors are known to affect stereoselectivity
and yield of glycosylation and those include temperature, solvent, type of donor used, type of
acceptor used, amount and type of promoter used, protecting groups, etc. (Figure 1.3). These
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effects and specifically designed methods to control the stereoselectivity of glycosylation will be
discussed in the subsequent sections.
Figure 1.3. Factors affecting the stereoselectivity of glycosylations
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While some sugars follow general trends, there are classes of compounds and glycosidic
linkages that require special methods. These special cases of glycosylation require careful
selection of techniques, their modification, or design of conceptually new approaches. Indirect or
total synthesis-based technologies have been developed and applied specifically to the synthesis
of these targets.
Glycosides of 2-amino-2-deoxy sugars, in particular those of the D-gluco and D-galacto
series, are widely distributed in living organisms as glycoconjugates (glycolipids,
lipopolysaccharides, glycoproteins),59 or glycosaminoglycans (heparin, heparan sulfate,
dermatan sulfate, chondroitin sulfate, hyaluronic acid),60 etc.61

Since a vast majority of

naturally-occurring 2-amino-2-deoxy sugars are N-acetylated, from the synthetic point of view, a
2-acetamido-2-deoxy substituted glycosyl donor would be desirable. For this type of glycosyl
donors however, the oxacarbenium ion rearranges rapidly into an unreactive oxazoline
intermediate. Therefore, even the synthesis of such 1,2-trans glycosides requires an additional
8

step and a careful selection of suitable protecting groups. A minimal requirement for the
synthesis of 1,2-cis glycosides would be the use of a C-2 non-participating moiety, most
commonly

azide.

2,3-Oxazolidinone

protection

introduced

by

Kerns

and

N-p-

methoxybenzylidene protection explored by Nguyen also show good promise to become
universal approaches to 1,2-cis glycosylation with 2-aminosugars (vide infra).
β-Mannosyl residues are frequently found in glycoproteins. The chemical synthesis of βmannosides cannot be achieved by relying on the anomeric effect, which would favor axial αmannosides. In addition, the formation of β-mannosides is further disfavored by the repulsive
interactions that would have occurred between the axial C-2 substituent and the nucleophile
approaching from the top face of the ring. For many years, the only direct procedure applicable
to β-mannosylation - Ag-silicate promoted glycosidation of α-halides - was assumed to follow a
bimolecular SN2 mechanism.62,63 The difficulty of the direct β-mannosylation was addressed by
developing a variety of indirect approaches such as C-2 oxidation-reduction, C-2 inversion,
anomeric alkylation, and intramolecular aglycone delivery.64-68 This was the standing in the field
before Crich and co-workers discovered that 4,6-O-benzylidene protected sulfoxide69 or
thioglycoside70 glycosyl donors provide excellent β-manno stereoselectivity. Detailed
mechanistic and spectroscopic studies by the Crich group65,71-73 showed that anomeric α-Otriflates generated in situ are reactive intermediates that can substituted with high stereocontrol at
low temperatures.
In comparison to their six-membered counterparts, furanosides are less abundant.
Nevertheless, their presence in a variety of polysaccharides from bacteria, parasites, and fungi
makes this type of glycosidic linkage an important synthetic target.74,75 The synthesis of 1,2-trans
furanosides is relatively straightforward and, similarly to that of pyranosides, can be reliably
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achieved with the use of glycosyl donors bearing a participating group at C-2. In contrast,
construction of 1,2-cis glycofuranosidic linkage is difficult, even more so than with pyranosides
due to the lack of the anomeric effect and the conformational flexibility of the five-membered
ring. In fact, both electronic and steric effects favor the formation of 1,2-trans glycofuranosides.
In the past decade, a notable improvement in 1,2-cis furanosylation was made possible with
glycosyl donors in which the ring has been locked into a single conformation. These examples
include

2,3-anhydro,76-80

3,5-O-(di-tert-butylsilylene),81,82

and

3,5-O-

tetraisopropyldisiloxanylidene83 protected bicyclic glycosyl donors. A recent example wherein
stereoselective 1,2-cis glycofuranosylation was accomplished with the assistance of H-bond
mediated aglycone delivery will be discussed below.
2-Deoxyglycosides are important constituents of many classes of antibiotics. The
development of reliable methods for stereoselective synthesis of both α- and β-2deoxyglycosides is critical for the synthesis of natural products, drugs and glycomimetics.84,85 It
should be noted that due to the lack of anchimeric assistance from the substituent at C-2, the
synthesis of both types of linkages represents a notable challenge. Direct glycosylation of 2deoxy glycosyl donors often results in the formation of anomeric mixtures, though notable recent
progress in the area has to be acknowledged.86-91
Sialic acids are nine-carbon monosaccharides involved in a wide range of biological
phenomena. Their unique structure is characterized by the presence of a carboxylic group,
deoxygenated C-3, glycerol chain at C-6 and differently functionalized C-5. The natural
equatorial glycosides and their unnatural axial counterparts are classified as α- and β-glycosides,
respectively. In spite of extensive efforts and notable progress, the chemical synthesis of
sialosides remains a significant challenge.92-95 The presence of a destabilizing electron-
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withdrawing carboxylic group and the lack of a participating auxiliary often drive sialylation
reactions toward competitive elimination reactions resulting in the formation of a 2,3-dehydro
derivative and/or in poor stereoselectivity (β-anomer). To overcome these problems, a variety of
leaving groups and activation conditions for direct sialylations have been developed. It was also
demonstrated that the N-substituent at C-5 plays an influential role in both stereoselectivity of
sialylation and the reactivity of sialyl donors.96 A particular advance in the recent years has been
made with 4,5-oxazolidinone derivatives that provide high yields and stereoselectivities in
sialylations.97-100

1.3. Effect of the glycosyl donor
Varying the nature of anomeric leaving groups in the donor has been exploited in many
different ways. Glycosylations using trichloroacetimidates101-104 and thioglycosides105 as donors
have become the most widely studied methods for chemical glycosylation. There are many
publications describing the comparison of various glycosylation methods applied for particular
targets. Our previous reviews on 1,2-cis glycosylation, thoroughly discusses all pros and cons of
using various leaving groups.106,107 However, only a few principles could be reliably outlined. It
has been unambiguously demonstrated that halides activated in the presence of a halide ion (from
e.g. Bu4NBr) often provide the highest ratios of α/β-glycosides.108-112 Since glycosylation
reactions commonly follow a unimolecular SN1 displacement mechanism, the orientation of the
leaving group at the anomeric center is of little importance. However, occasionally glycosylation
reactions proceed via an SN2-like mechanism with inversion of the anomeric configuration: βglycosyl halides formed from their α-counterparts with bromonium ion113 or from αthioglycosides in the presence of bromine,114 glycosyl thiocyanates,115,116 and anomeric
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mannosyl triflates formed in situ from sulfoxides or thioglycosides for the synthesis of

-

mannosides.69,70
Protecting groups are introduced into a molecule to temporarily mask a functional group,
thereby differentiating similar types of functional groups and exposing only the one that needs to
be reacted.117 It is well known that the stereoselectivity of glycosylation can be profoundly
influenced by protecting groups.118 Various protecting groups that may have a significant effect
on the stereoselectivity of glycosylation have been discussed below. Neighboring protecting
groups at C-2 traditionally known as participating groups for the synthesis of 1,2-trans
glycosides can now assist in the formation of either 1,2-cis or 1,2-trans glycosides. Remote
protecting groups at positions C-3, 4 and/or 6 may affect the stereoselectivity via remote
assistance by means of participation, H-bond mediated aglycone delivery, steric hindrance and/or
electron withdrawal. Also discussed in this section are protecting groups that restrict the
conformational flexibility of carbohydrates or force carbohydrate molecules to adopt unusual
conformation.

1.3.1. Neighboring protecting group at C-2
As aforementioned, neighboring acyl-type protecting group offers one of the most powerful
tools to direct stereoselectivity toward the formation of a 1,2-trans-linked product. Demchenko
and co-workers developed glycosyl donors equipped with a 2-picolinyl ether substituent that can
also participate and form 1,2-trans glycosides stereoselectively.119,120 Boons and co-workers took
a different approach for developing a participating group capable of the participation from the
opposite face of the ring giving rise to 1,2-cis linked glycosides.121 According to this approach,
the C-2 position was protected with a substituted benzyl group that contains a nucleophilic
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moiety capable of participation at the anomeric center.121 On activation of the glycosyl donor, the
resulting oxacarbenium ion is attacked by this nucleophilic moiety. This attack, in principle, can
lead to the formation of a cis- or trans-decalin-like system, Boons and co-workers showed that
the selectivity is highly dependent on the configuration of the asymmetric center of the chiral
auxiliary. To accommodate the bulky phenyl group in the pseudo-equatorial position of the
newly formed six-membered ring, auxiliary with (S)-stereochemistry would lead to a transdecalin-like intermediate. This intermediate would help to direct the nucleophilic attack of the
glycosyl acceptor from the bottom face and hence lead to a 1,2-cis-linked glycoside. Conversely
a chiral auxiliary with the opposite (R)-configuration could participate via the cis-decalin-like
intermediate, thereby producing 1,2-trans glycoside. Ethyl mandelate was chosen to test this
methodology because both the enantiomers are readily available, conditions required for its
installation are compatible with other protecting groups, and it is stable during the glycosylation,
but can be readily removed under mild reductive conditions.
Scheme 1.2. Stereoselective glycosylations with ethyl (R)- and (S)-mandelate protected
glycosyl donor 1.1
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As depicted in Scheme 1.2, when ethyl (S)-mandelate-protected donor (S)-1.1 was
glycosylated with glycosyl acceptor 1.2, disaccharide 1.3 was obtained with high α-selectivity
(α/β = 20/1). Conversely, when (R)-1.1 was used as the glycosyl donor, reversal of anomeric
selectivity was observed (α/β = 1/5). Deprotection of the acyl groups using sodium methoxide in
methanol and the benzyl groups, including the chiral auxiliary, under Birch reduction conditions
provided disaccharide 1.4.
The second generation auxiliary developed to further enhance 1,2-cis stereoselectivity was
based on (S)-phenyl-thiomethylbenzyl ether moiety at C-2 of the glycosyl donor.122,123 It was
assumed that this type of moiety would be capable of more efficient and stereoselective
participation via the formation of a chair and hence more stable trans-decalin-like intermediate.
This, in turn, would force the (S)-phenyl group into the equatorial position to avoid unfavorable
1,3-diaxial interactions that would have occurred if the bulky phenyl group was placed into the
axial position. As depicted in Scheme 1.3, 1-(S)-phenyl-2-(phenylsulfanyl)ethyl ether protected
trichloroacetimidate donor 1.7 was obtained from glucose tetraacetate 1.5 via sequential
protection, liberation of the anomeric hydroxyl and the introduction of the imidoyl leaving
group. Glycosyl donor 1.7 was then reacted with glycosyl acceptor 1.8 in the presence of
TMSOTf to afford α-glycoside 1.9 in 86% yield and with exclusive α-stereoselectivity. The
auxiliary can then be removed by acetolysis in the presence of BF3-OEt2 and acetic anhydride.
This method has been extended to the polymer-supported synthesis of the repeating unit of the
immune-modulatory polysaccharide from Aconitum carmichaeli composed of an α-(16)-linked
glucosyl backbone branched with α(13)-linked glucoside moieties.124
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Scheme 1.3. Synthesis of C-2 (S)-phenyl-thiomethylbenzyl ether-protected glycosyl
donor 1.6 and its glycosidation

More recently, to simplify this approach, Boons and co-workers adopted a different direction
towards the synthesis of 1,2-cis glycosides.125 This was certainly inspired by their earlier work
on chiral auxiliaries and inherent drawbacks related to the necessity of obtaining pure
enantiomeric substrate, and the relatively low stability of the moiety. Additional inspiration came
from work by Turnbull et al. who developed a very elegant approach using thioglycoside donors
having an integral α-directing group.126 As depicted in Scheme 1.4a, these reactions proceeded
via bicyclic intermediates and the cyclic thioglycoside 1.11 was activated via the oxidation into
sulfoxide 1.12 and S-arylation to form reactive sulfonium ions 1.13 en route to O-glycosylation.
In the Boons’ approach depicted in Scheme 1.4b,125 sulfoxide donor 1.16 was prepared from
thioglycoside 1.15 by the treatment with trimethylsilyl anhydride (TMS2O) in presence of
TMSOTf, followed by reduction with Et3SiH. The latter 1.16 was subjected to a series of
protecting group manipulations followed by oxidation with m-CPBA to give sulfoxide 1.17. The
glycosidation of donor 1.17 included the treatment with trifluoromethanesulfonic anhydride
(Tf2O), arylation with 1,3,5-trimethoxybenzene, followed by addition of the glycosyl acceptor.
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Scheme 1.4. Stereoselective glycosylation via cyclic sulfonium ions

Entry Acceptor (ROH) Product Yield, α/β ratio
1

1.21

62%, 25/1

2

1.22

89%, α-only

3

1.23

72%, α-only

As summarized in Scheme 1.4b, glycosyl acceptors 1.18-1.20 provided the corresponding
disaccharides 1.21-1.23 in high yields and stereoselectivities.125 It was observed that while the
donors bearing electron-withdrawing groups at C-3, 4, and 6 gave only the α-anomer, their 4,6diether substituted counterpart suffered from a slight loss of α-anomeric selectivity. It was
16

concluded that the highly reactive sulfonium ions partially react via oxacarbenium ion
intermediate.
Building upon their previous work, Turnbull and co-workers recently designed a new
oxathiane donor scaffold where the axial methoxy group was replaced with O-substituent
constrained in a spirocyclic ring.127 As in the previous methods, the oxathiane spiroketal donor is
then activated via S-arylation. Overall, a novel class of oxathiane glycosyl donors is easily
accessible, highly α-selective in glycosylations, and offers high stability towards common
protecting group manipulations.

1.3.3. Remote protecting groups
The effects of the remote substituents have long been considered of somewhat lesser
importance than that of the neighboring substituent at C-2. However, the idea of participating
groups at remote positions other than C-2 has been brought to the attention by many researchers.
There have been various reports, both in favor and in opposition of the idea of remote
participation, starting from long-range 6-O-acyl or carbonate group assisted synthesis of αglucosides.128-132 For derivatives of the D-galacto series a remote effect beneficial for the
formation of α-galactosides was noted when a participating moiety was present at C-4.132-135.
Similar effects (including C-3 participation) were also detected for the derivatives of the Lfuco,136-138 L-rhamno,139 D-manno,140 D-gluco63,141,142 series.
In 2009, Kim presented a dedicated study of the effect of 3- and 6-O-acetyl donors on the
stereoselectivity of mannopyranosylation.143 The comparative study showed that there was the
remote participation by 3-O and 6-O acetyl groups, but no participation by 4-O-acyl group. It
was observed that when mannopyranosyl trichloroacetimidate donors bearing electron
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withdrawing ester groups, such as acetyl (1.24) or benzoyl (1.25) at C-3 position, were coupled
with primary acceptors 1.27-1.29 in presence of TMSOTf as a promoter, the corresponding
disaccharides were obtained in excellent yields (88-94%) and high β-selectivity (α/β = 1/26-40,
entries 1-4, Table 1.1). However, when benzyl sulfoxide was used as an electron withdrawing
protecting group at C-3, the selectivity obtained with donor 1.26 was reversed and the
corresponding disaccharides were obtained with preferential α-selectivity (α/β = 1/10-16, entries
5 and 6, Table 1.1).
Table 1.1. Effect of 3-O-acyl protection on the stereoselectivity of mannosylation

Entry Donor (EWG) Acceptor (1.0 equiv.) Disaccharide yield α/β ratio
1

1.24 (Ac)

1.27

91%

1/25.9

2

1.24 (Ac)

1.28

94%

1/39.0

3

1.24 (Ac)

1.29

92%

1/40.4

4

1.25 (Bz)

1.28

88%

1/29.6

5

1.26 (SO2Bn)

1.27

95%

15.9/1

6

1.26 (SO2Bn)

1.28

93%

10.2/1

Very recently, Nifantiev et al. studied the effect of an acyl substituent at C-3 position on the
stereoselectivity obtained with conformationally flexible and conformationally restricted
glucosyl donors.144 Partially acylated N-phenyltrifluoroacetimidate and sulfoxide glycosyl
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donors showed no significant difference in stereoselectivity between the rigid or flexible 3-Oacetylated structures. Irrespectively of the protecting group at C-3, the conformationally rigid
4,6-O-benzylidene-protected glucosyl donors gave excellent α-selectivity at higher reaction
temperatures (-35 oC to rt).
Table 1.2. Effect of an acyl substituent at C-3 position on the stereoselectivity

Entry Donor

Acceptor

Yield, α/β ratio

1a

1.30

89%, 5.3/1

2a

1.30

93%, 11.2/1

3a

1.31

93%, 16.4/1

4b

1.32

59%, 6.8/1

5c

1.33

96%, 5.9/1

Conditions: a - MeOTf, CH2Cl2, AW-300, -35  -15 oC;
 0 oC;

c

- MeOTf, CH2Cl2, AW-300, 20 oC.
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b

- Tf2O, DTBMP, CH2Cl2, -78

Thus, as depicted in Table 1.2, when glycosyl donor 1.30 bearing acetyl protecting groups at
C-3 and C-6 is reacted with glycosyl acceptors 1.34 and 1.35 the corresponding disaccharides are
obtained in good yields and with high selectivities (α/β = 5.3-11.2/1, entries 1 and 2).
Suprisingly, when glycosyl donor 1.31 wherein the C-6 acetyl was replaced with C-6 benzoyl
was used, further increase in selectivity was observed (α/β = 16.4/1, entry 3). In this context,
3,6-di-O-acetyl protected sulfoxide donor 1.32 provided lower yields and stereoselectivities
(entry 4).

A similar selectivity albeit excellent yield was observed with conformationally

restricted 4,6-O-benzylidene-protected glucosyl donors 1.33 (96% yield, α/β = 5.9/1, entry 5).
It was also found that steric bulkiness or strong electron-withdrawing properties of remote
substituents, particularly those at C-6, are beneficial for 1,2-cis glucosylation and galactosylation
most likely due to shielding (sterically or electronically) the top face of the ring and therefore
favoring the nucleophilic attack from the opposite side.63,141,145-150 Ito and co-workers also
reported that the use of 4-O-pentafluoropropionyl group is beneficial for synthesis of αgalactosides.151 A study with 2-azido sugars revealed an interesting relationship between the
stereoselectivity and the effect of remote participating groups in GalN3 and GlcN3 sugars.152
Over the course of this study it was observed that for GlcN3 sugars, acetyl groups at C-3 and C-6
positions show more α-directing effect whereas 4-O-acetyl is more β-directing.153 Crich showed
that bulky 3-O-tert-butyldimethylsilyl (TBDMS) can push the axial 2-O-benzyl of mannosyl
donors towards the anomeric center, thereby hindering the nucleophilic attack from the top face,
leading to poor β-selectivities.154 Differently, naphthylpropargyl ether protection at C-2 or C-3
favors high β-manno selectivity.155
Codee and co-workers investigated the use of 2-azidomannouronate ester donor for
glycosidation, and observed high 1,2-cis selectivity.156 On gaining further insight into the
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mechanism, it was concluded that the first step involves the formation of a mixture of anomeric
triflates in which the triflate with a 1C4 chair conformation is the predominant species. This
species accommodates the anomeric triflate in the equatorial position. On decomposition of the
triflate, oxacarbenium ion intermediate preferentially adopts 3H4 half-chair conformation. In this
case, the C-5 carboxylate occupies a pseudo-axial position allowing space-stabilization of the
positive charge at the anomeric center. Accordingly, when thiophenyl donor 1.37 was activated
in the presence of diphenyl sulfoxide and triflic anhydride, anomeric triflate 1.38 was formed.
The later was then reacted with acceptor 1.39 to give disaccharide 1.40 in 85% yield and with
complete β-selectivity (Scheme 1.5.).
The presence of anomeric triflate, C-5 ester and the C-2 azide together render the anomeric
center more electron deficient. As a result, the incoming nucleophile attacks the half chair along
a pseudo-axial trajectory on the β-face of the molecule to produce 1,2-cis linkage. It was also
shown that the stereoselectivity obtained is independent of the type of donor used and does not
rely on the preactivation protocol.157 It was also reported that the stereodirecting effect of the C5-carboxylate ester is important for obtaining 1,2-cis selectivity.
Scheme 1.5. Rationalization of the high β-selectivity achieved with 2-azidomannouronate
thiophenyl donor 1.30
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A very different stereodirecting effect was discovered for remote picolinyl (Pic) and picoloyl
(Pico) substituents. As aforementioned, picolinyl at C-2 formally participated at the anomeric
center and gives 1,2-trans glycosides via six-membered ring intermediate.120 The action of the
remote picolinyl and related picoloyl substituents is totally different. Not being able to
participate at the anomeric center directly, picolinyl nitrogen forms the hydrogen bond with the
incoming glycosyl acceptor. As a result, very high facial selectivity, always anti in respect to the
picolinyl substituent is observed.158 This, rather unexpected involvement of remote picolinyl
substituents was termed as H-bond-mediated aglycone delivery (HAD). Based on the above
hypothesis, it was shown that under high dilution conditions (5 mM), 4-O-picoloyl or picolinyl
glucosyl donors (1.41-1.45) provide faster coupling times and enhanced selectivity compared to
that obtained under standard concentration (50 mM). Thus, glucosyl donors 1.41 and 1.42
provided high levels of α-selectivity, particularly with O-picolinyl protection (α/β = >25/1, entry
1, Table 1.3.). Respectively, galactosyl donor 1.43 and rhamnosyl donor 1.44 gave high βselectivity (α/β = >1/ 25, entries 3 and 4). An extension to this study, Demchenko and coworkers showed that the presence of 3-O-picoloyl group in mannosyl donor 1.45 can effectively
provide β-selectivities (α/β = 1/18.5, entry 5).159
The applicability of this approach was demonstrated for the synthesis of an oligosaccharide
containing both primary and secondary β-mannosidic linkages (Scheme 1.6a). Thus, when 3-Opicolylated mannosyl donor 1.45 was reacted with glycosyl acceptor 1.27 in the presence of
DMTST β-linked disaccharide 1.50 was obtained with α/β = 1/18.5 selectivity. The picoloyl
group at C-3 position of this disaccharide was then selectively deprotected using copper(II)
acetate. The resulting acceptor 1.51 was then coupled with mannosyl donor 1.52, to provide the
desired trisaccharide 1.53 in 76% yield and with complete β-selectivity.
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Table 1.3. Hydrogen-bond-mediated Aglycone Delivery (HAD)

Entry

Conc.

Time

1

5mM

4h

1.46 (73%)

>25/1

2

5mM

5h

1.47 (86%)

5.3/1

3

5mM

1h

1.48 (95%)

>1/25

1.49 (94%)

>1/25

1.50 (91%)

1/18.5

4

5

Donor

50 mM 15 min

5mM

2.5 h

Product (Yield) α/β Ratio

Further application of this new stereoselective glycosylation reaction has emerged in
application to the synthesis of linear and branched α-glucans.160 As depicted in Scheme 1.6b,
when 4-O-picoloylated glucosyl donor 1.41 was glycosylated with acceptor 1.54 in the presence
of DMTST, disaccharide 1.46 was obtained in 83% yield (α/β = 21/1). The picoloyl group was
then deprotected with copper(II) acetate to form the second generation glycosyl acceptor 1.55.
The process was reiterated to obtain pentasaccharide 1.46 (n = 4) with 41% yield and complete
α-selectivity.
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Scheme 1.6. HAD-assisted synthesis of β-mannan and α-glucan

Hung and co-workers developed a series of orthogonally protected D-glucoaminyl donors for
stereocontrolled α-glycosylation.161 The most advantageous protecting group pattern was
determined to be 2-azido functionality, 2-nphthylmethyl (2-NAP) group at C-4, p-bromobenzyl
(p-BrBn) at C-3, and TBDPS at C-6 positions. Azido protection was preferred since it is a small
protecting group and provides easy analysis of the sugar derivatives, 2-NAP group was used
because of its flexibility as a temporary or a permanent protecting group, and p-BrBn and
TBDPS groups were used as sterically bulky groups to prevent the attack of the acceptor from
the unwanted top face. This orthogonally protected glucosamine-derived trichloroacetimidate
donor was used for synthesis of heparin-related sequences.161
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1.3.3. Conformation restraining cyclic protecting groups
Torsional effects induced by the cyclic protecting groups may also strongly affect the
stereoselectivity at the anomeric center. The best-known example of this effect is the work by
Crich and co-workers on the synthesis of β-mannosides. Thus, it has been demonstrated that 4,6O-benzylidene-protected thioglycoside donors give superior β-manno selectivity in comparison
to that achieved with donors lacking this type of protection.65,69,71,162,163 The stereoselectivity
observed was rationalized by carrying out experiments in which the benzylidene protected
sulfoxide donor69 164,165 is pre-activated using Tf2O to form a sulfonium salt, which collapses into
the α-triflate that exists in the dynamic equilibrium with the contact ion pair. The presence of
glycosyl triflate intermediate in mannosylations was also recognized with thioglycoside,166
trichloroacetimidate,167

2-(hydroxycarbonyl)-benzyl,168

hemiacetal,169

pentenoate,170

and

phthalate171,172 donors, all protected as 4,6-benzylidene acetals. It is believed that the closely
associated triflate counterion shields the α-face and β-linked product forms preferentially. An αdeuterium kinetic isotope effect (KIE) study indicated substantial oxacarbenium ion character of
this reaction pathway ruling out a possibility of the bimolecular displacement.163 Similar
conclusions were made as a result of KIE experiments with mannosyl iodides.173 The
deactivating effect of benzyl substituent was found to be a combination or torsional strain174
restricting the conformational flexibility of the ring and enhanced electron-withdrawal.175 The
latter effect is due to locking the hydroxylmethyl group in the conformation wherein the C6-O6
bond is directed away from the O-5. This may cause additional destabilization of the
oxacarbenium intermediate that seeks for compensation from tight coordination to the counter
anion.
This study revealed that 4,6-O-benzylidene protected glycopyranosyl triflates provide high βselectivities with glycosyl donors of the mannose series, whereas high α-selectivity is obtained
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with their glucose configured counterparts.162 The reaction for synthesis of α-glucosides was
found to be independent on the anomeric stereochemistry of the donor employed. They
rationalized this finding by the fact that the α-triflate formed undergoes the equilibrium with its
more reactive β-counterpart rather than with the oxacarbenium ion intermediate. The rate and
equilibrium constant for formation of β-glucosyl triflate are such that it preferentially forms the
α-linked product.
Table 1.4. Stereodirecting effect of 4,6-O-benzylidene protected glucosyl donors
activated with PhSOTf and Tf2O
Disaccharides

Glycosyl Donors
Ph

O
O
O
BnO
1.56a BnO SPh

Ph

O
O
BnO

1.56b

O

HO
1.39

O
O
BnO
1.57a

O

O
Ph
BnO

SOPh

O
O
BnO

O

O
O
BnO
1.57b

SPh

O

SOPh

BnO

Ph

O

O

O
BnO 1.60

Ph

BnO

O
O
BnO

O
O

O
O
BnO

Glycosyl Acceptors
OH

O
O

Ph

1.61
O

O
O
O

O
1.58

Ph

1.59

OH

O
O
BnO

O

O

O
O
BnO
1.62

Entry Donor, Acceptor Coupling reagent Product Yield, α/β ratio
1

1.56a, 1.39

PhSOTf

1.60

70%, >95/5

2

1.56b, 1.39

PhSOTf

1.60

80%, >95/5

3

1.57a, 1.59

Tf2O

1.62

89%, >95/5

4

1.57b, 1.58

Tf2O

1.61

63%, >95/5

Many useful applications have evolved from the Crich methodology. For instance, the direct
syntheses of a β-(12)-mannooctaose and of a β-(14)-mannohexaose represent the power of
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this technique.176 As depicted in Scheme 1.7, the synthesis of the (12)-mannan was achieved
by means of the sulfoxide coupling protocol. Thus, 2-O-paramethoxybenzyl protected sulfoxide
donor 1.63 was reacted with cyclohexanol 1.64 in the presence of triflic anhydride and 2,4,6-tritert-butylpyrimidine (TTBP) to afford β-mannoside 1.65 (n = 1) in 77% yield. The latter was
deprotected with DDQ to give glycosyl acceptor 1.66. Reiteration of glycosylation deprotection
steps led to a series of (12)-linked mannan homologs. For instance, octasaccharide 1.65 (n = 8)
was obtained in 64% yield (β/α = 4.5/1). In this context, the (14)-linked mannan was prepared
from the thioglycoside donors activated using sulfinamide methodology.
Scheme 1.7. β-(12)-Linked mannans using sulfoxide coupling protocol

To study the influence of similar conformationally rigid protecting groups, on the selectivity
obtained, Werz and co-workers synthesized variety of mannosyl donors with a spiroannulated
cyclopropane ring at C-5 bearing one hydroxyl group.177 Though very high β-selectivity wasn’t
observed, it was shown that the spiroannulated cyclopropane motif leads to fixation of the chairlike conformation, similar to that shown for 4,6-benzylidene protected sugars.
Kerns discovered that 2,3-trans-oxazolidinone-protected glucosaminyl donor provides
excellent 1,2-cis selectivity in glycosylations (Scheme 1.8a).178,179 Although high α-selectivity
could be obtained, the oxazolidinone protected donor showed propensity to undergo side
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reactions, such as N-glycosylation or N-sulfenylation. As an extension to that, Kerns et al.180,181
and Oscarson et al.182 reported an N-acetylated version of these oxazolidinones in which the
nitrogen is protected.178,180 These donors showed switchable stereoselectivity of glycosylations
that was achieved by tuning the reaction conditions.183-185 This interesting finding stimulated
further experimental and mechanistic studies. Mechanistically it was suggested that the β-linked
product is formed initially, which rapidly anomerizes into the corresponding α-anomer. The
presence of the oxazolidinone ring is the key for this anomerization to occur, which was found to
proceed via the endocyclic C1-O5 bond cleavage.186,187 For instance, when N-acetyl-2,3oxazolidinone protected donor 1.67 was reacted with glycosyl acceptor 1.68 in presence of NIS
and AgOTf, disaccharide 1.69 was obtained in 82% yield (α-only, Scheme 1.8b.).
Scheme 1.8. Selective α-glycosylations with N-acetyl- and N-benzyl-2,3-oxazolidinoneprotected glycosyl donors 1.67 and 1.70

Manabe, Ito and their co-workers reported N-benzylated 2,3-oxazolidinone donors for 1,2-cis
glycosylation.188,189 Thus, when glycosyl donor 1.70 was glycosidated with acceptor 1.71 in
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presence of N-(phenylthio)-ε-caprolactam and triflic anhydride at rt, disaccharide 1.72 was
obtained in 52% yield with complete α-selectivity (Scheme 1.8b).
Crich et al. showed that the 2,3-O-carbonate protecting group is highly α-selective for
mannosylations and rhamnosylations.154,190 In contrast, 3,4-O-carbonate protected rhamnosyl
donors showed moderate β-selectivities owing to the electron withdrawing but non-participating
nature of this group. Crich reported synthesis of β-glucosides using 2,3-O-carbonate protected
glucosyl donor.191 It was suggested that the conformation restricting trans-fused ring favors the
formation of an α-triflate intermediate over the formation of an oxacarbenium ion. The effect of
3,4-O-carbonate protection was found to be weaker with slight preference toward β-selectivity.89
Ye and co-workers studied 2,3-O-carbonyl protected glucose and galactose donors for preactivation based glycosylations.192 These reactions were generally β-stereoselective, but Lewis
acids additives were found to favor α-stereoselectivity (vide infra).
A beneficial effect of a bulky 4,6-O-di-tert-butylsilylene (DTBS) protecting group193-195 on
α-selective galactosylation and galactosamination was recently applied to the synthesis of a
series of human ABO histo-blood group type 2 antigens by Kiso and co-workers.196

1.4. Effect of the glycosyl acceptor
Many examples wherein different glycosyl acceptors have different selectivities can be seen
throughout the text of this Chapter. A general principle is that the alcohol reactivity is inversely
correlated with the stereoselectivity. Typically the most reactive hydroxyls give the lowest α/βratios: the stronger the nucleophile, the faster the reaction, and therefore the more difficult it is to
control. Regarding the sugar or aliphatic glycosyl acceptors, the general rule normally states:
glycosylation of more reactive primary hydroxyl generally provides poorer stereoselectivity in
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comparison to that when the secondary hydroxyls are involved.197 The same principle is
applicable for the synthesis of glycopeptides, thus, glycosylation of the secondary hydroxyl of
threonine typically gives higher α-stereoselectivity than when primary hydroxyl group of serine
is glycosylated with 2-azido-2-deoxygalactosyl bromide or trichloroacetimidates.198,199
Occasionally, primary hydroxyls provide somewhat higher stereoselectivity in comparison to
that of the secondary hydroxyl groups. This can serve as an evidence of the glycosylation
reaction proceeding via the bimolecular mechanism, at least partially. Primary alcohols gave
higher stereoselectivity in H-bond-mediated aglycone delivery reactions mediated by the remote
picolinyl groups.158
It is well established that ester electron-withdrawing substituents reduce electron density of
the neighboring hydroxyl group lowering their nucleophilicity.150,200,201 This may improve
stereoselectivity, as the reaction can be carried out in more controlled manner. As an example,
glycosylation of axial 4-OH of galactose often gives excellent 1,2-cis stereoselectivity, especially
in combination with electron-withdrawing substituents (e.g. O-benzoyl, OBz).202 However, less
reactive hydroxyls can lose their marginal reactivity completely when surrounded by the
deactivating species, resulting in lower glycosylation yields.
Recently, Demchenko and co-workers have shown that electron-withdrawing acyl
protecting groups have significant effect on the stereoselectivity obtained with thiocyanates as
glycosyl donors.203 Thus, when thiocyanate 1.73 was reacted with acyl-protected acceptors 1.74
and 1.75, the corresponding disaccharides 1.77 and 1.78 were obtained with complete αselectivity (α/β = >25/1, Scheme 1.9). However, when benzyl-protected acceptor 1.76 was used
instead, the stereoselectivity dropped (1.79, α/β = 8.3/1).
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Scheme 1.9. Acyl protecting groups in acceptor enhance stereoselectivity in glycosylations

Very recently, Toshima and co-workers reported a novel chemical glycosylation method that
makes use of the chiral recognition ability of the aglycone.204 Thus, chiral catalysts and chiral
acceptors may favor the formation of one anomer over another.

1.5. Effect of the reaction conditions
1.5.1. Temperature
Kinetically controlled glycosylations at lower temperatures generally favor β-glycoside
formation,108,205-209 although converse observations have also been reported.210,211 Since the αglycoside is thermodynamically more favored due to the anomeric effect, it is predominantly
formed at high temperatures. A number of examples have been discussed throughout other parts
of this Chapter.

1.5.2. Solvent
Effect of reaction solvents on the selectivity of glycosylation reaction has been widely
studied. In general, polar reaction solvents increase the rate of the β-glycoside formation via
charge separation between O-5 and β-O-1. If the synthesis of α-glycosides is desired, CH2Cl2,
ClCH2CH2Cl or toluene would be suitable candidates as the reaction solvents. However, there
are more powerful forces than simple solvation that have to be taken into consideration. It has
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been shown earlier, that ethereal solvents have a tendency to drive the glycosylation in αselective fashion, while nitrile solvents increase the amount of β-glycoside formation.129,212
These observations were rationalized as follows: ether type reaction solvents such as diethyl
ether,213 tetrahydrofuran,213 or dioxane214 lead to the preferential formation of the equatorial
intermediate. On the other hand, if the reactions are performed in acetonitrile, the nitrilium cation
formed in situ exclusively adopts axial orientation, allowing stereoselective formation of
equatorially substituted glycosides (Scheme 3). This approach permits the formation of 1,2-trans
glucosides with good stereoselectivity even with glycosyl donors bearing a non-participating
substituent. Recently, the Mong group proposed a revised mechanism for glycosylations in nitrile
solvents.215 According to their proposed model, the oxacarbenium ion or intermediates interact
with the nitrile solvent producing mixtures of α- and β-glycosyl nitrilium intermediates. Though
the formation of 1,2-cis nitrilium species is favored by the anomeric effect, it is further
reinforced through the participation of the oxygen atom of the C-2 ether function. The resultant
glycosyl oxazolinium intermediate is then attacked by a nucleophile from the top face leading to
the formation of β-product.
Scheme 1.10. Effect of the reaction solvents

Many applications of solvent systems are known. One recent example employing Ntrichloroacetyl carbamate group introduced by Redlich216 and Vankar,217 showed high
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selectivities, which can be switched by simply switching the solvent. Thus, Omura et al

218

showed that the α-selective glycosylations could be performed with a catalytic amount of
TMSClO4 in Et2O, whereas high β-selectivity could be achieved by activation with TMSOTf in
EtCN in the presence of 5 Å molecular sieves. For instance, when N-trichloroacetyl carbamate
1.81 was glycosylated with acceptor 1.28 in the presence of TMSClO4 in diethyl ether as the
solvent, disaccharide 1.82 was formed with high α-selectivities (entries 1 and 2, Table 1.5)
Table 1.5. One-pot synthesis and glycosidation of carbamate 1.81

Entry

Reaction conditions

Yield, α/β ratio

TMSClO4 (1.5 equiv.) Et2O

0 oC, 0.5 h

99%, 93/7

2a TMSClO4 (0.2 equiv.) Et2O

0 oC, 0.5 h

88%, 91/9

1

Activator

Solvent

3 TMSOTf (1.5 equiv.) EtCN -40 oC, 0.5 h then -23 oC, 0.5 h
a
– 5 Å molecular sieves were used

88%, 8/92

Huang et. al. have recently studied the effect of solvents and additives on the stereochemical
outcome of preactivation-based one-pot glycosylation strategy using thioglycosides as donors.219
When donor 1.83 dissolved in diethyl ether was pre-activated with 1 equiv. of p-TolSOTf,
formed in-situ from p-TolSCl and AgOTf (3 equiv.), disaccharide 1.87 was obtained in 67%
yield (α/β = 1.1/1, Scheme 1.11.). Interestingly, when the amount of AgOTf was decreased to 1.1
equiv., significant change in α-selectivity was observed (α/β = 6/1). In addition, when the
reaction was performed by increasing the volume of diethyl ether by 10 fold, further
enhancement in α-selectivity was observed (α/β = 10/1).
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Scheme 1.11. Effect of solvent and excess amount of AgOTf used on the selectivity
obtained

Moreover, when dichloromethane was used as the reaction solvent, the stereoselectivity was
switched (α/β = 1/8). With the belief that glycosyl triflates are formed as the reaction
intermediates, the observed stereoselectivity was rationalized as follows. The reactions
performed in diethyl ether proceed through a double-inversion mechanism. Under dilute
conditions and with lower excess of AgOTf, solvent participation becomes more effective,
resulting in higher α-selectivity. In case of dichloromethane, due to the non-nucleophilic and
non-polar nature of the solvent, the reaction is likely to proceed via SN2-like pathway, directly
displacing the α-glycosyl triflate leading to β-glycosides.
Ito and co-workers developed a high-throughput screening system to study the synergistic
solvent effect of combined ethereal and halogenated solvents on the course of glycosylation.212
This study employed the use of glycosyl donors, which were isotopically labeled with per34

deuterated (Bn-d7) benzyl ether protecting groups. The advantage of using Bn-d7 is the
“disappearance” of all benzylic methylene signals at around 4-5 ppm, thereby making it easier to
estimate the isomeric ratios of the glycosylated products. The labeled donor was glycosidated
with various acceptors in the presence of MeOTf as the activator and 2,6-di-tert-butyl-4methylpyridine (DTBMP) in various solvents. Although ethereal solvents are known to exert αdirecting effect, the use of mixed solvent systems containing both halogenated and ethereal
solvents was found even more beneficial for enhancing α-selectivity. Thus, a 1/1 (v/v) mixture of
CHCl3/Et2O or CHCl3/cyclopentyl methyl ether (CPME) provided the best results and the use of
such solvent systems was extended to the synthesis of a variety of 1,2-cis linkages.212,220 When
per-deuterated benzyl ether protected thioglycoside donor 1.88 was reacted with per-deuterated
glycosyl acceptor 1.89 in presence of methyl triflate (MeOTf) as a promoter, disaccharide 1.90
with selectivity up to α/β = 19.5/1 was obtained (Scheme 1.12.).
Scheme 1.12. Solvent and temperature effects on 1,2-cis glycosylation

Mong and co-workers took a different direction in studying reaction solvent by using
dimethylformamide (DMF) as a co-solvent, rather uncommon reaction solvent in
glycosylations.221 This procedure is based on pre-activation, where DMF is employed to trap the
glycosyl oxacarbenium ion as an equilibrium mixture of α/β-glycosyl imidates. Being more
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reactive, β-imidate reacts preferentially with the glycosyl acceptor producing desired α-glycoside
with high selectivity.
Scheme 1.13. DMF-mediated glycosylation

This study employed two conceptually different protocols for glycosylation. First, a
conventional method (Procedure A), wherein a mixture of glycosyl donor, acceptor, and DMF
was treated with NIS and TMSOTf. Second, a pre-activation method (Procedure B), according
to which the glycosyl donor was reacted with NIS and TMSOTf in the presence of DMF
followed by the addition of the glycosyl acceptor. Both approaches furnished the desired
glycosylation product. As shown in Table 1.6, reaction of benzylated donor 1.91 with glycosyl
acceptor 1.92 gave moderate stereoselectivity (82%, α/β = 6/1, entry 1, Table 1.4). It was also
demonstrated that the increase in the amount of DMF to 3 and 6 equiv. (entries 4 and 5)
translated into a significant increase in α-stereoselectivity (up to α/β = 19/1, entry 5).
Interestingly, the use of ethereal solvents had no benefit for the further improvement of
stereoselectivity, irrespective of the type of ethereal solvent used. The results obtained using
procedure A were then applied to the investigation of the effectiveness of glycosylation
procedure B. It was observed that due to the modulating effect provided by DMF, all
glycosylations between thioglycoside donors 1.91, 1.94, or 1.95 and acceptors 1.96-1.100
proceeded with high α-selectivity (α/β = 11-49/1, entries 4-9, Table 1.4).
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Table 1.6. Investigation of DMF-mediated glycosylations

Entry
1
2
3

DMF Temp (oC),Yield of 1.93,
(equiv.) time (h)
α/β ratio
1.5
-10, 2.0
82%, 6/1
3.0
-10, 2.0
87%, 15/1
6.0
-10, 2.0
87%, 19/1

Entry Donor Acceptor
4
5
6
7
8
9

1.91
1.91
1.91
1.91
1.94
1.95

1.96
1.97
1.98
1.99
1.100
1.97

Temp (oC) Yield, α/β
time (h) with DMF
-10, 3.0
0, 3.0
-10, 3.0
0, 2.0
0, 5.0
-10, 6

60%, 36/1
55%, 11/1
85%, 49/1
50%, 13/1
50%, 49/1
61%, 49/1

Encouraged by the α-stereodirecting effect of DMF, the preactivation protocol was extended
to a sequential one-pot oligosaccharide synthesis.221 Prior to the one-pot synthesis, the efficiency
of the procedure was tested by carrying out the synthesis of disaccharide and evaluating the
stereoselectivity obtained. An interesting feature of DMF as an additive to a one-pot multi-step
synthesis is that it is regenerated after the first coupling and hence can be engaged into the
subsequent modulation cycle. As depicted in Scheme 1.14, two contiguous 1,2-cis linkages were
efficiently assembled and trisaccharide 1.105 was isolated in an overall yield of 52%.
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Scheme 1.14. DMF- mediated synthesis of trisaccharide 1.105

1.5.3. Promoter, additives, and chelators
At the early stages of method development, glycosylations of poorly nucleophilic acceptors
were sluggish and inefficient. The first attempts to solve this problem gave rise to the
development of catalytic systems that were actively involved in facilitating the departure of the
leaving group.222 Zemplen223 and, subsequently, Helferich224 assumed that complexation of the
anomeric bromides or chlorides with reactive mercury (II) salt catalysts would significantly
improve their leaving group ability. This approach has become a valuable expansion of the
classic Koenigs-Knorr method.225 These early attempts to improve the glycosylation process
have revealed the necessity to find a delicate balance between the reactivity and stereoselectivity
because it was noted that faster reactions often result in decreased stereoselectivity.226,227
Recently, Demchenko and co-workers investigated the glycosidation of thioglycosides in the
presence of bromine.114 It was demonstrated that bromine-mediated glycosylation of
thioglycoside 1.106 leads to exclusive α-selectivity in product 1.109-1.111 (Scheme 1.15.). This
reaction was monitored by NMR, and this study demonstrated that β-bromide is the reactive
intermediate that leads to the product 1.109-1.111 with complete stereoselectivity. The NMR
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experiment showed that β-bromide can undergo a relatively rapid anomerization into the αlinked counterpart, and if this anomerization is not suppressed, the yield of the glycosylation
product can be low.
Once formed, α-bromide is totally unreactive under the established reaction conditions, but it
can be reactivated in the presence of mercury (II)-based promoters. This, however, can
compromise α-selectivity with primary alcohols. This concept complements well-known in-situ
anomerization procedure introduced by Lemieux and co-workers for reactive bromides113 and
further adapted to iodides by Gervay-Hague.112,228
Scheme 1.15. Stereoselective glycosidation of superdisarmed thioglycoside 1.106 via
reactive β-bromide intermediate
O
ox acar benium ion
OBz
O

BzO
BzO

BnO

SEt

bromine
Acceptor
(ROH)

1.106

O
Br

HgBr2

inter mediate

O

BzO
BzO

OBz
O
BnO

OR

1.109-1.111

by-product Br

Entry Acceptor (ROH)

Product

Yieldα/β ratio

1

72% 10.5/1

2

89% >25/1

3

87% >25/1
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It is a general trend that milder activating conditions are beneficial for 1,2-cis glycosylation.
Thus, halide ion-catalyzed reactions gave the best results for the glycosylation with glycosyl
halides;113 thioglycosides give higher selectivity when activated with a mild promoter, such as
iodonium dicollidine perchlorate (IDCP) 229,230 or bromine.114
Many of the current methodologies for glycosylation require the use of stoichiometric
amounts of promoters.. The use of transition metal catalysts helps achieve greener and milder
way to construct glycosidic linkages and offers new opportunities for stereocontrol.231 O’Doherty
developed a well-rounded methodology for palladium(0)-catalyzed glycosylations, wherein
carbohydrate chirality centers are installed post-glycosylationally.90,232-234 Nguyen and coworkers studied palladium(II)-catalyzed glycosidation of glycosyl trichloroacetimidates using
Pd-(CH3CN)4(BF4)2 or similar catalysts.235,236 This study evolved into the investigation of a
series of nickel catalysts providing an efficient means for glycosidation of N-pmethoxybenzylidene-protected 2-amino-2-deoxy trichloroacetimidate donor.237,238 The nature of
the ligand on nickel has been found to be the deciding factor in controlling the stereoselectivity
of glycosylations. Thus, it was observed that electron-withdrawing substituents help to decrease
the reaction time, which is translated into increased α-selectivity. The efficiency of the nickelcatalyzed glycosylations was then extended to glycosylation of a variety of acceptors and applied
to the synthesis of number of oligosaccharides. As summarized in Table 1.5, N-benzylidene
trichloroacetimidate donor 1.112 bearing different para substituents was reacted with primary
(1.27-1.28) and secondary glycosyl acceptors (1.58, 1.113-1.114) under catalysis of Ni(4-FPhCN)4(OTf)2, to provide disaccharides (1.115-1.119) with very high α-selectivity.
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Table 1.7. Nickel-catalyzed α-selective glycosidation of N-benzylidene
trichloroacetimidate donor 1.112

AcO
AcO

OAc
O
N

5-10 mol %
Ni(4-F-PhCN)4(OTf )2

O

CCl3
NH

X

OAc
O
N

CH 2 Cl2 , 25 o C,
ROH

OR

X
1.115-1.119

X = H, OMe, F and CF3

1.112

Entry

AcO
AcO

R-OH

Product

1

2

3

4

5
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Bennett and co-workers recently applied the activation of thioglycosides with Ph2SO in the
presence of TBAI to the stereoselective synthesis of 1,2-cis glycosides. It was observed that this
reaction proceeds via the intermediacy of glycosyl iodides.239 The underpinning idea of using
TBAI is that the conversion of α-glycosyl triflates into β-glycosyl iodides would favor the
formation of α-glycosides. Thus, when the armed S-phenyl thioglycoside 1.120 was reacted with
glycosyl acceptors 1.2 and 1.92 under the Ph2SO/Tf2O conditions followed by the addition of
TBAI, disaccharides 1.121 (41%, α-only) and 1.122 (79%, α/β = 20/1) were obtained in excellent
stereoselectivity (Scheme 1.16).
Scheme 1.16. Synthesis of 1,2-cis-linked glycosides by activation of
thioglycosides in the presence of TBAI

Recently there has been an explosion in the study of gold-catalyzed activation of alkynes to
exploit the low oxophilic character of gold and the excellent functional group compatibilities
these catalysts exhibit.240-244 This includes work by Hotha and co-workers where propargyl
glycosides were activated using Au(III) chloride to give α/β mixtures of glycosides and
disaccharides in good yields. Yu and co-workers conducted a similar study with glycosyl orthoalkynylbenzoates under the catalytic Au(I) activation conditions.243
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Another promising new

field is the use of chiral thioureas as organocatalysts for glycosylations.245 As of now, this
approach is limited to the synthesis of 2-deoxy α-glycosides246 and β-selective glycosylations
with 2-oxygenated sugars.247
Various additions to the promoter systems often influence the stereochemical outcome of the
glycosylation. Amongst the most remarkable examples is the use of perchlorate ion additive that
was found to be very influential in 1,2-cis glycosylations.248,249 Lately, the effectiveness of use of
silver perchlorate as activator in glycosylations of thioimidates and thioglycosides to provide
better 1,2-cis selectivity than those achieved with more common triflates, has been studied.250
Demchenko and co-workers observed that a multi-dentate metal coordination to the leaving
group, along with a protecting group at O-6 and/or O-5, has a strong effect on the
stereoselectivity of chemical glycosylation (Scheme 1.16). It was demonstrated that platinum(IV)
complexation of 6-O-picolinyl or 6-O-bipyridyl to the leaving group, such as thiazolinyl, has a
pronounced effect on the stereoselectivity of glycosylation.251 While the glycosidation of
thioimidate donor 1.123 with acceptor 1.27 in the presence of Cu(OTf)2 gave the disaccharide
1.125 with poor selectivity (α/β = 1.7/1, Scheme 1.17), the complexed glycosyl donor
counterpart 1.124 showed a significant 5-fold increase in 1,2-cis stereoselectivity (α/β = 9.4/1).
Scheme 1.17. Effect of metal complexation on the stereoselectivity of glycosylation

43

While studying 2,3-O-carbonyl protected glucose and galactose donors, which are generally
β-stereoselective, Ye and co-workers observed that Lewis acids additives favor αstereoselectivity in preactivation-based glycosylations.192 Thus, catalytic amount of BF3-OEt2 or
AgBF4 as well as 1 equiv. of AgPF6 or SnCl4 completely reversed stereoselectivity to give αlinked products. It was assumed that similar to that proven for 2,3-oxazolidinones,186,187 the
initially formed β-linked product anomerizes into the thermodynamically more stable α-anomer,
and this anomerization is facilitated by Lewis acid additives.

1.6. Other effects and special methods
High pressure applied to the reactions with participating glycosyl donors further enhances
1,2-trans selectivity;252 when the high pressure conditions were applied for glycosylations with a
non-participating glycosyl donor, remarkable increase in the reaction yield was noted with only
marginal changes in stereoselectivity.253 Unfavorable steric interactions that occur between
glycosyl donor and acceptor in the transition state or other factors or conditions may
unexpectedly govern the course and outcome of the glycosylation process. One of the most
remarkable effects, so-called “double stereodifferentiation” takes place when stereochemical
interactions between bulky substituents in glycosyl donor and glycosyl acceptor may outperform
even the strong stereodirecting effect of a neighboring participating group. The pair of reagents
where these interactions occur is called a “mismatched pair”.254
A number of methods have been developed that do not include a formal glycosylation
step.255-257 Typically, these indirect procedures include multistep syntheses and are of lower
efficiency than direct glycosylations. Therefore, practical application of these techniques is
envisaged for the synthesis of glycosidic linkages that cannot be easily accessed by conventional
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technologies. O’Doherty and co-workers developed a new method for the synthesis of di- and
oligosaccharides that can be accomplished from non-carbohydrate precursors.90,232-234 The de
novo asymmetric methodology was applied to the synthesis of mono-, di-, and oligosaccharides
via palladium-catalyzed reaction. The synthesis of 1,2-cis linkages have not yet been
accomplished.

1.6.1. Intramolecular aglycone delivery (IAD)
Barresi and Hindsgaul were the first to apply the idea of intramolecular glycosylation, which
was used for the synthesis of β-mannosides.258 Subsequently, it was demonstrated that silicon
bridge-mediated aglycone delivery provides high yields and excellent stereocontrol.259,260 Further
improvement emerged with the introduction of the allyl-mediated strategy that allows high yields
and complete stereoselectivity in α-glucosylations and β-mannosylations.261 More recently Ito
and co-workers invented naphthylmethyl ether (NAP)-mediated intramolecular aglycone
delivery.262 The versatility of this approach is that it generally provides significantly higher
yields in comparison to that of traditional approaches. Further value of this methodology is that it
allows for stereoselective synthesis of various 1,2-cis linkages, such as β-Manp, β-Araf, and αGlcp. A representative example, the synthesis of disaccharide 1.129, is depicted in Scheme 1.18.
Thus, when 2-O-NAP-protected thiomethyl glycosyl donor 1.126 was reacted with acceptor
1.127 in the presence of DDQ, followed by the removal of NAP tether and acetylation,
disaccharide 1.129 was obtained in 90% yield with complete β-selectivity.
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Scheme 1.18. β-Mannopyranosylation via NAP-tether mediated intramolecular aglycone
delivery (IAD)

1.6.2. Supported and tagged synthesis
The last decade has witnessed dramatic improvements in the area of solid phase-supported
oligosaccharide synthesis.263-267 Polymer supported synthesis is very attractive because it allows
to conduct the synthesis of oligosaccharide sequences without the necessity of purifying (and
characterizing) the intermediates. Another important advantage of oligosaccharide synthesis on
solid phase support is the ease of excess reagent removal (by filtration). This effort culminated in
the automated synthesis by Seeberger, which was the first attempt to conquer the challenge on
1,2-cis glycosidic bond formation using an automated approach.268 Careful refinement of
reaction conditions allowed 1,2-cis galactosylation in dichloromethane-ether and Globo-H
sequence was assembled as depicted in Scheme 1.19. First, glycosyl phosphate donor 1.130 was
linked to the resin 1.136 via glycosylation using TMSOTf (repeated once) as the promoter,
followed by deprotection of the Fmoc substituent with piperidine (repeated twice) to provide
polymer-bound acceptor. The general synthetic protocol consists of repetitive cycles of
glycosylation

using

either

glycosyl

phosphate
46

(1.130-1.133)

or

glycosyl

N-phenyl

trifluoroacetimidate donors (1.134 and 1.135) followed by the deprotection with piperidine. The
final product 1.137 was obtained under an atmosphere of ethylene in the presence of Grubbs’
catalyst269 in an overall yield of 30%.
Scheme 1.19. Automated synthesis of Globo H hexasaccharide

Very recently the same group has reported the total synthesis of O-antigen pentasaccharide
repeating unit obtained from pathogenic E. coli. O111. With the synthetic challenge of
constructing two unnatural and labile coitose units, the total synthesis was achieved in 21 steps
with 1.5% overall yield.270

Boons et al. presented a very elegant synthesis of

α-linked

oligosaccharide on polymer support using their recent chiral auxiliary –assisted synthesis of 1,2cis glycosides.124
A promising technique for the tagged oligosaccharide synthesis that makes use of an ionicliquid support has recently emerged.271,272 As with the polymer-supported and fluorous tag-
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supported syntheses,273-275 ionic liquid-supported assembly expedites oligosaccharide synthesis
by eliminating the need for chromatographic purification of the intermediates.

272,276-282

Differently from insoluble polymer beads, ionic liquid supports allow for homogeneous
conditions. This approach is illustrated by the synthesis of trisaccharide 1.141 (Scheme 1.20).283
Scheme 1.20. Glycosylation on ionic liquid support and product isolation.

In this synthetic strategy, the glycosyl acceptor 1.139 was grafted onto an ionic liquid support
at C-6 position of the sugar moiety. The resulting tagged glycosyl acceptor 1.139 was reacted
with trichloroacetimidate donor 1.138 to afford disaccharide 1.140 in 89% and high αstereoselectivity. The purification is accomplished by simple washing or liquid-liquid
extractions. Disaccharide 1.140 was then reacted with acceptor 1.28 followed by the removal of
the ionic liquid tag using LiOH-H2O to afford trisaccharide 1.141 in 87% yield.
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1.7. Conclusions and outlook
The progress in the area of chemical glycosylation has significantly improved our ability to
synthesize various glycosidic linkages with impressive yields and stereoselectivity. Can we
conclude that we have entirely solved the problem of chemical glycosylation? Unfortunately not,
and hopefully this Chapter has introduced the reader to the challenge of chemical glycosylation,
a variety of factors, conditions, and driving forces influencing all aspects of this complex
chemical reaction as well as informing the reader about the specialized material dedicated to
particular methods and strategies employed in modern carbohydrate chemistry. Recent progress
made in the area of development of new coupling methods and highly efficient strategies for
oligosaccharide synthesis will ultimately provide an efficient and trouble-free access to complex
saccharides. This goal cannot be achieved without the comprehensive knowledge of the
glycosylation mechanism and the driving forces of glycosylation and competing side processes.
It is likely that the consecutive scientific development in this field will be focusing on studying
the fundamental mechanistic aspects of glycosylation rather than developing additional anomeric
leaving groups.

1.8. References
(1)

BeMiller, J. N.: Oligosaccharides: Occurrence and significance. In Glycoscience:

Chemistry and Chemical Biology; Fraser-Reid, B., Tatsuta, K., Thiem, J., Eds.; Springer: Berlin Heidelberg - New York, 2001; Vol. 2; pp 1435-1444.
(2)

Holst, O.: Glycolipids: Occurrence and significance. In Glycoscience: Chemistry

and Chemical Biology; Fraser-Reid, B., Tatsuta, K., Thiem, J., Eds.; Springer: Berlin Heidelberg - New York, 2001; Vol. 3; pp 2083-2096.

49

(3)

Wittmann, V.: Glycoproteins: Occurrence and significance. In Glycoscience:

Chemistry and Chemical Biology; Fraser-Reid, B., Tatsuta, K., Thiem, J., Eds.; Springer: Berlin Heidelberg - New York, 2001; Vol. 3; pp 2253-2288.
(4)

Cao, H.; Hwang, J.; Chen, X.: Carbohydrate-containing natural products in

medicinal chemistry. In Opportunity, Challenge and Scope of Natural Products in Medicinal
Chemistry; Tiwari, V. K., Mishra, B. B., Eds., 2011; pp 411-431.
(5)

Witczak, Z. J.: Carbohydrates as new and old targets for future drug design. In

Carbohydrates in Drug Design; Witczak, Z. J., Nieforth, K. A., Eds.; Marcel Dekker, Inc.: New
York, 1997; pp 1-37.
(6)

Gruner, S. A. W.; Locardi, E.; Lohof, E.; Kessler, H.: Carbohydrate-based

mimetics in drug design: sugar amino acids and carbohydrate scaffolds. Chem. Rev. 2002, 102,
491-514.
(7)

Carbohydrate-Based Drug Discovery; Wong, C. H., Ed.; Wiley-VCH: Weinheim,

(8)

Carbohydrate Drug Design; Klyosov, A. A.; Witczak, Z. J.; Platt, D., Eds.; ACS:

2003.

Washington, 2006; Vol. 932.
(9)

Ernst, B.; Magnani, J. L.: From carbohydrate leads to glycomimetic drugs. Nat.

Rev. Drug Discov. 2009, 8, 661-677.
(10)

Ghazarian, H.; Idoni, B.; Oppenheimer, S. B.: A glycobiology review:

Carbohydrates, lectins and implications in cancer therapeutics. Acta Histochem. 2011, 113, 236247.

50

(11)

Varki, A.; Cummings, R. D.; Esko, J. D.; Freeze, H. H.; Bertozzi, C. R.; Stanley,

P.; Hart, G. W.; Etzler, M. E.: Essentials of Glycobiology; Second ed.; CSH Laboratory Press:
New York, 2009.
(12)

DeMarco, M. L.; Woods, R. J.: Structural glycobiology: A game of snakes and

ladders. Glycobiology 2008, 18, 426-440.
(13)

Bertozzi, C. R.; Kiessling, L. L.: Chemical glycobiology. Science 2001, 291,

2357-2364.
(14)

Kotra, L. P.; Mobashery, S.: A renaissance of interest in aminoglycoside

antibiotics. Curr. Org. Chem. 2001, 5, 193-205.
(15)

Yu, B.; Sun, J.; Yang, X.: Assembly of naturally occurring glycosides, evolved

tactics, and glycosylation methods. Acc. Chem. Res. 2012, 45, 1227-1236.
(16)

Wennekes, T.; van den Berg, R. J. B. H. N.; Boot, R. G.; Van der Marel, G. A.;

Overkleeft, H. S.; Aerts, J. M. F. G.: Glycosphingolipids - nature, function, and pharmacological
modulation. Angew. Chem. Int. Ed. 2009, 48, 8848-8869.
(17)

Hakomori, S.: Structure and function of glycosphingolipids and sphingolipids:

recollections and future trends. Biochim. Biophys. Acta 2008, 1780, 325-346.
(18)

Lochnit, G.; Geyer, R.; Heinz, E.; Rietschel, E. T.; Zahringer, U.; Muthing, J.:

Glycolipids: Chemical biology and biomedicine: glycolipids and glycosphingolipids. In
Glycoscience: Chemistry and Chemical Biology; Fraser-Reid, B., Tatsuta, K., Thiem, J., Eds.;
Springer: Berlin - Heidelberg - New York, 2001; Vol. 3; pp 2183-2250.
(19)

Huang, Y. L.; Hung, J. T.; Cheung, S. K.; Lee, H. Y.; Chu, K. C.; Li, S. T.; Lin,

Y. C.; Ren, C. T.; Cheng, T. J.; Hsu, T. L.; Yu, A. L.; Wu, C. Y.; Wong, C. H.: Carbohydrate-

51

based vaccines with a glycolipid adjuvant for breast cancer. Proc. Nat. Acad. Sci. 2013, 110,
2517-22.
(20)

Holst, O.: Glycolipids: Properties. In Glycoscience: Chemistry and Chemical

Biology; Fraser-Reid, B., Tatsuta, K., Thiem, J., Eds.; Springer: Berlin - Heidelberg - New York,
2001; Vol. 3; pp 2097-2106.
(21)

Payne, R. J.; Wong, C. H.: Advances in chemical ligation strategies for the

synthesis of glycopeptides and glycoproteins. Chem. Commun. 2010, 46, 21-43.
(22)

Pratt, M. R.; Bertozzi, C. R.: Synthetic glycopeptides and glycoproteins as tools

for biology. Chem. Soc. Rev. 2005, 34, 58-68.
(23)

Kahne,

D.;

Leimkuhler,

C.;

Lu,

W.;

Walsh,

C.:

Glycopeptide

and

lipoglycopeptide antibiotics. Chem. Rev. 2005, 105, 425-448.
(24)

Davis, B. G.: Synthesis of glycoproteins. Chem. Rev. 2002, 102, 579-601.

(25)

Polt, R.; Mitchell, S. A.: Glycoproteins: Chemical biology and biomedicine:

enkephalin-derived glycopeptide analgesics. In Glycoscience: Chemistry and Chemical Biology;
Fraser-Reid, B., Tatsuta, K., Thiem, J., Eds.; Springer: Berlin - Heidelberg - New York, 2001;
Vol. 3; pp 2353-2390.
(26)

Koeller, K. M.; Wong, C. H.: Glycoproteins: Synthesis and applications of

biologically relevant glycopeptides. In Glycoscience: Chemistry and Chemical Biology; FraserReid, B., Tatsuta, K., Thiem, J., Eds.; Springer: Berlin - Heidelberg - New York, 2001; Vol. 3;
pp 2305-2352.
(27)

Walczak, M. A.; Hayashida, J.; Danishefsky, S. J.: Building biologics by

chemical synthesis: practical preparation of di- and triantennary N-linked glycoconjugates. J.
Am. Chem. Soc. 2013, 135, 4700-4703.

52

(28)

Wang, L. X.; Huang, W.: Enzymatic transglycosylation for glycoconjugate

synthesis. Curr. Opin. Chem. Biol. 2009, 592-600.
(29)

Rojo, J.; Díaz, V.; de la Fuente, J.; Segura, I.; Barrientos, A. G.; Riese, H. H.;

Bernad, A.; Penadés, S.: Gold Glycoconjugates as New Tools in Antiadhesive Therapy.
ChemBioChem 2004, 5, 291-297.
(30)

Lindhorst, T. K.: Other glycoconjugates: Antitumor and antimicrobial

glycoconjugates. In Glycoscience: Chemistry and Chemical Biology; Fraser-Reid, B., Tatsuta,
K., Thiem, J., Eds.; Springer: Berlin - Heidelberg - New York, 2001; Vol. 3; pp 2393-2440.
(31)

Davis, B. G.: Recent developments in glycoconjugates. J. Chem. Soc., Perkin

Trans. 1 1999, 3215-3237.
(32)

Zhao, C.; Li, M.; Luo, Y.; Wu, W.: Isolation and structural characterization of an

immunostimulating polysaccharide from fuzi, Aconitum carmichaeli. Carbohydr. Res. 2006,
341, 485-491.
(33)

Bittencourt, V. C. B.; Figueiredo, R. T.; da Silva, R. B.; Mourão-Sá, D. S.;

Fernandez, P. L.; Sassaki, G. L.; Mulloy, B.; Bozza, M. T.; Barreto-Bergter, E.: An -Glucan of
Pseudallescheria boydii Is Involved in Fungal Phagocytosis and Toll-like Receptor Activation. J.
Biol. Chem. 2006, 281, 22614-22623.
(34)

Lopes, L. C. L.; da Silva, M. I. D.; Bittencourt, V. C. B.; Figueiredo, R. T.;

Rollin-Pinheiro, R.; Sassaki, G. L.; Bozza, M. T.; Gorin, P. A. J.; Barreto-Bergter, E.:
Glycoconjugates and polysaccharides from the Scedosporium/Pseudallescheria boydii complex:
structural characterisation, involvement in cell differentiation, cell recognition and virulence.
Mycoses 2011, 54, 28-.

53

(35)

Tzianabos, A. O.; Pantosti, A.; Baumann, H.; Brisson, J. R.; Jennings, H. J.;

Kasper, D. L.: The capsular polysaccharide of Bacteroides fragilis comprises two ionically
linked polysaccharides. J. Biol. Chem. 1992, 267, 18230-18235.
(36)

Robbins, J. B.; Lee, C. J.; Rastogi, S. C.; Schiffman, G.; Henrichsen, J.:

Comparative immunogenicity of group 6 pneumococcal type 6A (6) and type 6B (26) capsular
polysaccharides. Infect. Immun. 1979, 26, 1116-1122.
(37)

Zon, G.; Szu, S. C.; Egan, W.; Robbins, J. D.; Robbins, J. B.: Hydrolytic stability

of pneumococcal group 6 (type 6A and 6B) capsular polysaccharides. Infect. Immun. 1982, 37,
89-103.
(38)

Robbins, J. B.; Austrian, R.; Lee, C. J.; Rastogi, S. C.; Schiffman, G.; Henrichsen,

J.; Makela, P. H.; Broome, C. V.; Facklam, R. R.; et.al: Considerations for formulating the
second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the crossreactive types within groups. J. Infect. Dis. 1983, 148, 1136-1159.
(39)

Kamerling, J. P.: Pneumococcal polysaccharides: a chemical view. In

Streptococcus Pneumoniae, Molecular Biology and Mechanisms of Disease; Tomasz, A., Ed.;
Mary Ann Liebert, Inc.: Larchmont, N. Y., 2000; Vol. 3; pp 81-114.
(40)

Shields, B.: Prevnar (heptavalent pneumococcal conjugate vaccine); disease

prevention in infants and children. J. Pediatr. Health Care 2001, 15, 203-208.
(41)

Echaniz-Aviles, I. G.; Solorzano-Santos, F.: Meeting the challenge: Prevention of

pneumococcal disease with conjugate vaccines. Salud Publica Mexico 2001, 43, 352-367.
(42)

Morelli, L.; Poletti, L.; Lay, L.: Carbohydrates and Immunology: Synthetic

Oligosaccharide Antigens for Vaccine Formulation. Eur. J. Org. Chem. 2011, 5723-5777.

54

(43)

Carbohydrate-based vaccines and immunotherapies; Guo, Z.; Boons, G. J., Eds.;

Wiley: Hoboken, 2009.
(44)

Wuorimaa, T.; Kayhty, H.: Current state of pneumococcal vaccines. Scand. J.

Immunol. 2002, 56, 111-129.
(45)

Jones,

C.:

Revised

structures

for

the

capsular

polysaccharides

from

Staphylococcus aureus types 5 and 8, components of novel glycoconjugate vaccines. Carbohydr.
Res. 2005, 340, 1097-1106.
(46)

Helenius, A.; Aebi, M.: Intracellular functions of N-linked glycans. Science 2001,

291, 2364-2369.
(47)

Wang, Z.; Chinoy, Z. S.; Ambre, S. G.; Peng, W.; McBride, R.; de Vries, R. P.;

Glushka, J.; Paulson, J. C.; Boons, G. J.: A general strategy for the chemoenzymatic synthesis of
asymmetrically branched N-glycans. Science 2013, 341, 379-383.
(48)

Aussedat, B.; Vohra, Y.; Park, P. K.; Fernandez-Tejada, A.; Alam, S. M.;

Dennison, S. M.; Jaeger, F. H.; Anasti, K.; Stewart, S.; Blinn, J. H.; Liao, H. X.; Sodroski, J. G.;
Haynes, B. F.; Danishefsky, S. J.: Chemical synthesis of highly congested gp120 V1V2 Nglycopeptide antigens for potential HIV-1-directed vaccines. J. Am. Chem. Soc. 2013, 135,
13113-13120.
(49)

Futakawa, S.; Nara, K.; Miyajima, M.; Kuno, A.; Ito, H.; Kaji, H.; Shirotani, K.;

Honda, T.; Tohyama, Y.; Hoshi, K.; Hanzawa, Y.; Kitazume, S.; Imamaki, R.; Furukawa, K.;
Tasaki, K.; Arai, H.; Yuasa, T.; Abe, M.; Arai, H.; Narimatsu, H.: A unique N-glycan on human
transferrin in CSF: a possible biomarker for iNPH. Neurobiol. Aging 2012, 33, 1807-1815.
(50)

Coss, K. P.; Byrne, J. C.; Coman, D. J.; Adamczyk, B.; Abrahams, J. L.; Saldova,

R.; Brown, A. Y.; Walsh, O.; Hendroff, U.; Carolan, C.; Rudd, P. M.; Treacy, E. P.: IgG N-

55

glycans as potential biomarkers for determining galactose tolerance in Classical Galactosaemia.
Molec. Genet. Metab. 2012, 105, 212-220.
(51)

Ragupathi, G.; Koide, F.; Livingston, P. O.; Cho, Y. S.; Endo, A.; Wan, Q.;

Spassova, M. K.; Keding, S. J.; Allen, J.; Ouerfelli, O.; Wilson, R. M.; Danishefsky, S. J.:
Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs
targeting prostate and breast cancer: a synthetic route to anticancer vaccine candidates. J. Am.
Chem. Soc. 2006, 128, 2715-2725.
(52)

Yin, Z.; Huang, X.: Recent Development in Carbohydrate Based Anticancer

Vaccines. J. Carbohydr. Chem. 2012, 31, 143-186.
(53)

Goodman, L.: Neighboring-group participation in sugars. Adv. Carbohydr. Chem.

Biochem. 1967, 22, 109-175.
(54)

Fife, T. H.; Bembi, R.; Natarajan, R.: Neighboring carboxyl group participation in

the hydrolysis of acetals. Hydrolysis of O-carboxybenzaldehyde cis- and trans-1,2cyclohexanediyl acetals. J. Am. Chem. Soc. 1996, 118, 12956-12963.
(55)

Nukada, T.; Berces, A.; Zgierski, M. Z.; Whitfield, D. M.: Exploring the

mechanism of neighboring group assisted glycosylation reactions. J. Am. Chem. Soc. 1998, 120,
13291-13295.
(56)

Tvaroska, I.; Bleha, T.: Anomeric and exo-anomeric effects in carbohydrate

chemistry. Adv. Carbohydr. Chem. Biochem. 1989, 47, 45-123.
(57)

Handbook of Chemical Glycosylation: Advances in Stereoselectivity and

Therapeutic Relevance; Demchenko, A. V., Ed.; Wiley-VCH: Weinheim, Germany, 2008.
(58)

Bochkov, A. F.; Zaikov, G. E.: Chemistry of the O-glycosidic bond: formation

and cleavage; Pergamon Press: Oxford - New York - Toronto - Sydney - Paris - Frankfurt, 1979.

56

(59)

Dwek, R. A.: Glycobiology: toward understanding the function of sugars. Chem.

Rev. 1996, 96, 683-720.
(60)

Casu, B.: >>>>Amino review>>>>>>Structure and biological activity of heparin.

Adv. Carbohydr. Chem. Biochem. 1985, 43, 51-134.
(61)

Varki, A.: Biological roles of oligosaccharides: all of the theories are correct.

Glycobiology 1993, 3, 97-130.
(62)

Paulsen, H.; Lockhoff, O.: Building units for oligosaccharides. XXX. New

effective -glycoside synthesis of mannose glycosides. Syntheses of mannose containing
oligosaccharides. Chem. Ber. 1981, 114, 3102-3114.
(63)

van Boeckel, C. A. A.; Beetz, T.; van Aelst, S. F.: Substituent effects on

carbohydrate coupling reactions promoted by insoluble silver salts. Tetrahedron 1984, 40, 40974107 and references therein.
(64)

El Ashry, E. S. H.; Rashed, N.; Ibrahim, E. S. I.: Strategies of synthetic

methodologies for constructing b-mannosidic linkage. Curr. Org. Synth. 2005, 2, 175-213.
(65)

Crich, D.: Chemistry of glycosyl triflates: Synthesis of -mannopyranosides

(Reprinted from Glycochemistry: Principles, Synthesis, and Applications, pg 53-75, 2001). J.
Carbohydr. Chem. 2002, 21, 667-690.
(66)

Ito, Y.; Ohnishi, Y.: Oligosaccharides: Synthesis: Stereoselective synthesis of -

manno glycosides. In Glycoscience: Chemistry and Chemical Biology; Fraser-Reid, B., Tatsuta,
K., Thiem, J., Eds.; Springer: Berlin - Heidelberg - New York, 2001; Vol. 2; pp 1589-1620.
(67)

Gridley, J. J.; Osborn, H. M. I.: Recent advances in the construction of -D-

mannose and -D-mannosamine linkages. J. Chem. Soc., Perkin Trans. 1 2000, 1471-1491.

57

(68)

Pozsgay, V.: Stereoselective synthesis of -mannosides. In Carbohydrates in

Chemistry and Biology; Ernst, B., Hart, G. W., Sinay, P., Eds.; Wiley-VCH: Weinheim, New
York, 2000; Vol. 1; pp 319-343.
(69)

Crich, D.; Sun, S.: Formation of -mannopyranosides of primary alcohols using

the sulfoxide method. J. Org. Chem. 1996, 61, 4506-4507.
(70)

Crich,

D.;

Smith,

M.:

S-(4-Methoxyphenyl)

benzenethiosulfinate(MPBT)/trifluoromethanesulfonic anhydride (Tf2O): a convenient system
for the generation of glycosyl triflates from thioglycosides. Org. Lett. 2000, 2, 4067-4069.
(71)

Huang, M.; Garrett, G. E.; Birlirakis, N.; Bohe, L.; Pratt, D. A.; Crich, D.:

Dissecting the mechanisms of a class of chemical glycosylation using primary 13C kinetic isotope
effects. Nature: Chemistry 2012, 4, 663-667.
(72)

Crich, D.: Methodology Development and Physical Organic Chemistry: A

Powerful Combination for the Advancement of Glycochemistry. J. Org. Chem. 2011, 76, 91939209.
(73)

Crich, D.: Mechanism of a chemical glycosylation reaction. Acc. Chem. Res.

2010, 43, 1144-1153.
(74)

Gelin, M.; Ferrieres, V.; Plusquellec, D.: A general and diastereoselective

synthesis of 1,2-cis-hexofuranosides from 1,2-trans-thiofuranosyl donors. Eur. J. Org. Chem.
2000, 1423-1431.
(75)

Lowary, T. L.: D-Arabinofuranosides from mycobacteria: Synthesis and

conformation (Reprinted from Glycochemistry: Principles, Synthesis, and Applications, pg 133162, 2001). J. Carbohydr. Chem. 2002, 21, 691-722.

58

(76)

Gadikota, R. R.; Callam, C. S.; Lowary, T. L.: Stereocontrolled synthesis of 2,3-

anhydro--D-lyxofuranosyl glycosides. Org. Lett. 2001, 3, 607-610.
(77)
Anhydro

Gadikota, R. R.; Callam, C. S.; Wagner, T.; Del Fraino, B.; Lowary, T. L.: 2,3-

sugars

in

glycoside

bond

synthesis.

Highly

stereoselective

syntheses

of

oligosaccharides containing - and -arabinofuranosyl linkages. J. Am. Chem. Soc. 2003, 125,
4155-4165.
(78)

Callam, C. S.; Gadikota, R. R.; Krein, D. M.; Lowary, T. L.: 2,3-Anhydrosugars

in glycoside bond synthesis. NMR and computational investigations into the mechanism of
glycosylations with 2,3-anhydrofuranosyl glycosyl sulfoxides. J. Am. Chem. Soc. 2003, 125,
13112-13119.
(79)

Cociorva, O. M.; Lowary, T. L.: 2,3-Anhydrosugars in glycoside bond synthesis.

Application to the preparation of C-2 functionalized -D-arabinofuranosides. Tetrahedron 2004,
60, 1481-1489.
(80)

Bai, Y.; Lowary, T. L.: 2,3-Anhydrosugars in glycoside bond synthesis.

Application to -D-galactofuranosides. J. Org. Chem. 2006, 71, 9658-9671.
(81)

Zhu, X.; Kawatkar, S.; Rao, Y.; Boons, G. J.: Practical approach for the

stereoselective introduction of -arabinofuranosides. J. Am. Chem. Soc. 2006, 128, 11948-11957.
(82)

Crich, D.; Pedersen, C. M.; Bowers, A. A.; Wink, D. J.: J. Org. Chem. 2007, 72,

1553-1565.
(83)

Ishiwata, A.; Akao, H.; Ito, Y.: Org. Lett. 2006, 8, 5525-5528.

(84)

Veyrieres, A.: Special problems in glycosylation reactions: 2-deoxy sugars. In

Carbohydrates in Chemistry and Biology; Ernst, B., Hart, G. W., Sinay, P., Eds.; Wiley-VCH:
Weinheim, New York, 2000; Vol. 1; pp 367-406.
59

(85)

Marzabadi, C. H.; Franck, R. W.: The synthesis of 2-deoxyglycosides: 1988-

1999. Tetrahedron 2000, 56, 8385-8417.
(86)

Adhikari, S.; Baryal, K. N.; Zhu, D.; Li, X.; Zhu, J.: Gold-Catalyzed Synthesis of

2-Deoxy Glycosides Using S-But-3-ynyl Thioglycoside Donors. ACS Catalysis 2013, 3, 57-60.
(87)

Dıaz, G.; Ponzinibbio, A.; Bravo, R. D.: pTSA/[bmim][BF4] Ionic Liquid: A

Powerful Recyclable Catalytic System for the Synthesis of -2-Deoxyglycosides. Top. Catal.
2012, 55, 644-648.
(88)

Morris, W. J.; Shair, M. D.: Stereoselective Synthesis of 2-Deoxy--glycosides

Using Anomeric O-Alkylation/Arylation. Org. Lett. 2009, 11, 9-12.
(89)

Lu, Y.-S.; Li, Q.; Zhang, L.-H.; Ye, X.-S.: Highly Direct -Selective

Glycosylations of 3,4-O-Carbonate-Protected 2-Deoxy and 2,6-Dideoxythioglycosides by
Preactivation Protocol. Org. Lett. 2008, 10, 3445-3448.
(90)

Zhou, M.; O’Doherty, G. A.: De Novo Approach to 2-Deoxy--glycosides:

Asymmetric Syntheses of Digoxose and Digitoxin. J. Org. Chem. 2007, 72, 2485-2493.
(91)

Nogueira, J. M.; Issa, J. P.; Chu, A.-H. A.; Sisel, J. A.; Schum, R. S.; Bennett, C.

S.: Halide Effects on Cyclopropenium Cation Promoted Glycosylation with Deoxy Sugars:
Highly α-Selective Glycosylations Using a 3,3-Dibromo-1,2-diphenylcyclopropene Promoter.
Eur. J. Org. Chem. 2012, 2012, 4927-4930.
(92)

Boons, G. J.; Demchenko, A. V.: Recent advances in O-sialylation. Chem. Rev.

2000, 100, 4539-4565.
(93)

Kiso, M.; Ishida, H.; Ito, H.: Special problems in glycosylation reactions:

Sialidations. In Carbohydrates in Chemistry and Biology; Ernst, B., Hart, G. W., Sinay, P., Eds.;
Wiley-VCH: Weinheim, New York, 2000; Vol. 1; pp 345-366.

60

(94)

von Itzstein, M.; Thomson, R. J.: The synthesis of novel sialic acids as biological

probes. Topics Curr. Chem. 1997, 186, 119-170.
(95)

Ress, D. K.; Linhardt, R. J.: Sialic Acid Donors: Chemical Synthesis and

Glycosylation. Curr. Org. Synth. 2004, 1, 31-46.
(96)

De Meo, C.: Synthesis of N-5-derivatives of neuraminic acid and their application

as sialosyl donors. ACS Symp. Ser. 2007, 960, 118-131.
(97)

Tanaka, H.; Nishiura, Y.; Takahashi, T.: Stereoselective Synthesis of (2,9) Di-

to Tetrasialic Acids, Using a 5,4-N,O-Carbonyl Protected Thiosialoside. J. Org. Chem. 2009, 74,
4383-4386.
(98)

Farris, M. D.; De Meo, C.: Application of 4,5-O,N-oxazolidinone protected

thiophenyl sialosyl donor to the synthesis of -sialosides. Tetrahedron Lett. 2007, 48, 12251227.
(99)

Crich, D.; Li, W.: O-Sialylation with N-Acetyl-5-N,4-O-Carbonyl-Protected

Thiosialoside Donors in Dichloromethane: Facile and Selective Cleavage of the Oxazolidinone
Ring. J. Org. Chem. 2007, 72, 2387-2391.
(100) Tanaka, H.; Nishiura, Y.; Takahashi, T.: Stereoselective Synthesis of Oligo--(28)-Sialic Acids. J. Am. Chem. Soc. 2006, 128, 7124-7125.
(101) Zhu, X.; Schmidt, R. R.: New principles for glycoside-bond formation. Angew.
Chem. Int. Ed. 2009, 48, 1900-1934.
(102) Zhu, X.; Schmidt, R. R.: Glycoside synthesis from 1-oxygen-substituted glycosyl
imidates. In Handbook of Chemical Glycosylation; Demchenko, A. V., Ed.; Wiley-VCH:
Weinheim, Germany, 2008; pp 143-185.

61

(103) Schmidt, R. R.; Jung, K. H.: Trichloroacetimidates. In Carbohydrates in
Chemistry and Biology; Ernst, B., Hart, G. W., Sinay, P., Eds.; Wiley-VCH: Weinheim, New
York, 2000; Vol. 1; pp 5-59.
(104) Schmidt, R. R.; Jung, K. H.: Oligosaccharide synthesis with trichloroacetimidates.
In Preparative Carbohydrate Chemistry; Hanessian, S., Ed.; Marcel Dekker, Inc.: New York,
1997; pp 283-312.
(105) Zhong, W.; Boons, G.-J.: Glycoside synthesis from 1-sulfur/selenium-substituted
derivatives: thioglycosides in oligosaccharide synthesis. In Handbook of Chemical
Glycosylation; Demchenko, A. V., Ed.; Wiley-VCH: Weinheim, Germany, 2008; pp 261-303.
(106) Demchenko, A. V.: 1,2-cis O-Glycosylation: methods, strategies, principles. Curr.
Org. Chem. 2003, 7, 35-79.
(107) Demchenko, A. V.: Stereoselective chemical 1,2-cis O-glycosylation: from
"Sugar Ray" to modern techniques of the 21st century. Synlett 2003, 1225-1240.
(108) Andersson, F.; Fugedi, P.; Garegg, P. J.; Nashed, M.: Synthesis of 1,2-cis-linked
glycosides using dimethyl(methylthio)sulfonium triflate as promoter and thioglycosides as
glycosyl donors. Tetrahedron Lett. 1986, 27, 3919-3922.
(109) Kihlberg, J. O.; Leigh, D. A.; Bundle, D. R.: The in situ activation of
thioglycosides with bromine: an improved glycosylation method. J. Org. Chem. 1990, 55, 28602863.
(110) Garegg, P. J.; Oscarson, S.; Szonyi, M.: Synthesis of methyl 3-O-(-Dglucopyranosyl)-7-O-(L-glycero--D-manno-heptopyranosyl)-L-glycero--D-mannoheptopyranoside. Carbohydr. Res. 1990, 205, 125-132.

62

(111) Vermeer, H. J.; van Dijk, C. M.; Kamerling, J. P.; Vliegenthart, J. F. G.:
Fucosylation of linear alcohols: a study of parameters influencing the stereochemistry of
glycosylation. Eur. J. Org. Chem. 2001, 193-203.
(112) Hadd, M. J.; Gervay, J.: Glycosyl iodides are highly efficient donors under neutral
conditions. Carbohydr. Res. 1999, 320, 61-69.
(113) Lemieux, R. U.; Hendriks, K. B.; Stick, R. V.; James, K.: Halide ion catalyzed
glycosylation reactions. Syntheses of -linked disaccharides. J. Am. Chem. Soc. 1975, 97, 40564062 and references therein.
(114) Kaeothip, S.; Yasomanee, J. P.; Demchenko, A. V.: Glycosidation of
thioglycosides in the presence of bromine: mechanism, reactivity, and stereoselectivity. J. Org.
Chem. 2012, 77, 291-299.
(115) Kochetkov, N. K.; Klimov, E. M.; Malysheva, N. N.: Novel highly stereospecific
method of 1,2-cis-glycosylation. Synthesis of -D-glucosyl-D-glucoses. Tetrahedron Lett. 1989,
30, 5459-5462.
(116) Kochetkov, N. K.; Klimov, E. M.; Malysheva, N. N.; Demchenko, A. V.: A new
stereospecific method for 1,2-cis-glycosylation. Carbohydr. Res. 1991, 212, 77-91.
(117) Guo, J.; Ye, X. S.: Protecting groups in carbohydrate chemistry: influence on
stereoselectivity of glycosylations. Molecules 2010, 15, 7235-7265.
(118) Fraser-Reid, B.; Jayaprakash, K. N.; López, J. C.; Gómez, A. M.; Uriel, C.:
Protecting Groups in Carbohydrate Chemistry Profoundly Influence All Selectivities in Glycosyl
Couplings. In ACS Symp. Ser. (Frontiers in Modern Carbohydrate Chemistry) Demchenko, A.
V., Ed.; Oxford Univ. Press, 2007; Vol. 960; pp 91-117.

63

(119) Smoot, J. T.; Demchenko, A. V.: How the arming participating moieties can
broaden the scope of chemoselective oligosaccharide synthesis by allowing the inverse armeddisarmed approach J. Org. Chem. 2008, 73, 8838-8850.
(120) Smoot, J. T.; Pornsuriyasak, P.; Demchenko, A. V.: Development of an arming
participating group for stereoselective glycosylation and chemoselective oligosaccharide
synthesis. Angew. Chem. Int. Ed. 2005, 44, 7123-7126.
(121) Kim, J. H.; Yang, H.; Boons, G. J.: Stereoselective glycosylation reactions with
chiral auxiliaries. Angew. Chem. Int. Ed. 2005, 44, 947-949.
(122) Kim, J. H.; Yang, H.; Park, J.; Boons, G. J.: A general strategy for stereoselective
glycosylations. J. Am. Chem. Soc. 2005, 127, 12090-12097.
(123) Boltje, T. J.; Kim, J.-H.; Park, J.; Boons, G.-J.: Stereoelectronic Effects
Determine Oxacarbenium vs -Sulfonium Ion Mediated Glycosylations. Org. Lett. 2011, 13,
284-287.
(124) Boltje, T. J.; Kim, J. H.; Park, J.; Boons, G. J.: Chiral-auxiliary-mediated 1,2-cisglycosylations for the solid-supported synthesis of a biologically important branched α-glucan.
Nature Chemistry 2010, 2, 552-557.
(125) Fang, T.; Mo, K.-F.; Boons, G.-J.: Stereoselective Assembly of Complex
Oligosaccharides Using Anomeric Sulfonium Ions as Glycosyl Donors. J. Am. Chem. Soc. 2012,
134, 7545-7552.
(126) Fascione, M. A.; Adshead, S. J.; Stalford, S. A.; Kilner, C. A.; Leach, A. G.;
Turnbull, W. B.: Stereoselective glycosylation using oxathiane glycosyl donors. Chem. Commun.
2009, 5841-5843.

64

(127) Fascione, M. A.; Webb, N. J.; Kilner, C. A.; Warriner, S. L.; Turnbull, W. B.:
Stereoselective glycosylations using oxathiane spiroketal glycosyl donors. Carbohydr. Res.
2012, 348, 6-13.
(128) Ishikawa, T.; Fletcher, H. G.: The synthesis and solvolysis of some Dglucopyranosyl bromides having a benzyl group at C-2. J. Org. Chem. 1969, 34, 563-571.
(129) Eby, R.; Schuerch, C.: The use of 1-O-tosyl-D-glucopyranose derivatives in -Dglucoside synthesis. Carbohydr. Res. 1974, 34, 79-90 and references therein.
(130) Koto, S.; Yago, K.; Zen, S.; Tomonaga, F.; Shimada, S.: -D-glucosylation by 6O-acetyl-2,3,4-tri-O-benzyl-D-glucopyranose using trimethylsilyl triflate and pyridine-synthesis
of -maltosyl and -isomaltosyl -D-glucosides. Bull. Chem. Soc. Jpn. 1986, 59, 411-414.
(131) Dasgupta, F.; Garegg, P. J.: Use of the methylsulfenyl cation as an activator for
glycosylation reactions with alkyl (aryl) 1-thioglycopyranosides: synthesis of methyl O-(2acetamido-2-deoxy

-D-glucopyranosyl)-(1->6)-O--D-glucopyranosyl-(1->2)--D-

glucopyranoside, a derivative of the core trisaccharide of E. coli K12. Carbohydr. Res. 1990,
202, 225-238.
(132) Mukaiyama, T.; Suenaga, M.; Chiba, H.; Jona, H.: Highly -selective
glycosylation with glycopyranosyl fluorides having diethylthiocarbamoyl group. Chem. Lett.
2002, 56-57.
(133) Nakahara, Y.; Ogawa, T.: Synthetic studies on plant-cell wall glycans. 2. A highly
efficient, practical, and stereoselective approach to the synthesis of -1->4 linked
galactooligosaccharides. Tetrahedron Lett. 1987, 28, 2731-2734.

65

(134) Demchenko, A. V.; Rousson, E.; Boons, G. J.: Stereoselective 1,2-cisgalactosylation assisted by remote neighboring group participation and solvent effects.
Tetrahedron Lett. 1999, 40, 6523-6526.
(135) Cheng, Y. P.; Chen, H. T.; Lin, C. C.: A convenient and highly stereoselective
approach for -galactosylation performed by galactopyranosyl dibenzyl phosphite with remote
participating groups. Tetrahedron Lett. 2002, 43, 7721-7723.
(136) Corey, E. J.; Carpino, P.: Enantiospecific total synthesis of pseudopterosins A and
E. J. Am. Chem. Soc. 1989, 111, 5472-5473.
(137) Zuurmond, H. M.; van der Laan, S. C.; van der Marel, G. A.; van Boom, J. H.:
Iodonium

ion-assisted

glycosylation

of

alkyl(aryl)1-thio-glycosides:

regulation

of

stereoselectivity and reactivity. Carbohydr. Res. 1991, 215, c1-c3.
(138) Gerbst, A. G.; Ustuzhanina, N. E.; Grachev, A. A.; Tsvetkov, D. E.; Khatuntseva,
E. A.; Nifant'ev, N. E.: Effect of the nature of protecting group at O-4 on stereoselectivity of
glycosylation by 4-O-substituted 2,3-di-O- benzylfucosyl bromides. Mendeleev Commun. 1999,
114-116.
(139) Yamanoi, T.; Nakamura, K.; Takeyama, H.; Yanagihara, K.; Inazu, T.: New
synthetic

methods

and

reagents

for

complex

carbohydrates.

8.

stereoselective

-

mannopyranoside and -mannopyranoside formation from glycosyl dimethylphosphinothioates
with the C-2 axial benzyloxyl group. Bull. Chem. Soc. Jpn. 1994, 67, 1359-1366.
(140) De Meo, C.; Kamat, M. N.; Demchenko, A. V.: Remote participation-assisted
synthesis of -mannosides. Eur. J. Org. Chem. 2005, 706-711.

66

(141) van Boeckel, C. A. A.; Beetz, T.: Substituent effects in carbohydrate chemistry,
Part II. Coupling reactions involving gluco- and galacto-pyranosyl bromides promoted by
insoluble silver salts. Recl. Trav. Chim. Pays-Bas 1985, 104, 171-173.
(142) Ustyuzhanina, N.; Komarova, B.; Zlotina, N.; Krylov, V.; Gerbst, A. G.;
Tsvetkov, Y.; Nifantiev, N. E.: Stereoselective -glycosylation with 3-O-Acetylated D-Gluco
Donors. Synlett 2006, 6, 921-923.
(143) Baek, J. Y.; Lee, B. Y.; Jo, M. G.; Kim, K. S.: -Directing effect of electronwithdrawing groups at O-3, O-4, and O-6 positions and -directing effect by remote
participation of 3-O-acyl and 6-O-acetyl groups of donors in mannopyranosylations. J. Am.
Chem. Soc. 2009, 131, 17705-17713.
(144) Komarova, B. S.; Orekhova, M. V.; Tsvetkov, Y. E.; Nifantiev, N. E.: Is an acyl
group at O-3 in glucosyl donors able to control -stereoselectivity of glycosylation? The role of
conformational mobility and the protecting group at O-6. CArbohydr. Res. 2014, 384, 70–86.
(145) Fei, C. P.; Chan, T. H.: Stereoselective synthesis of -D-glucopyranosides via 6silyl--D-glucopyranosyl bromides. Tetrahedron Lett. 1987, 28, 849-852.
(146) Houdier, S.; Vottero, P. J. A.: Steric effect of a bulky 6-substituent in the I+promoted glycosylation with pent-4-enyl and thioethyl glycosides. Carbohydr. Res. 1992, 232,
349-352.
(147) Fukase, K.; Kinoshita, I.; Kanoh, T.; Nakai, Y.; Hasuoka, A.; Kusumoto, S.: A
novel method for stereoselective glycosidation with thioglycosides: promotion by hypervalent
iodine reagents prepared from PhIO and various acids. Tetrahedron 1996, 52, 3897-3904.

67

(148) Fukase, K.; Nakai, Y.; Kanoh, T.; Kusumoto, S.: Mild but efficient methods for
stereoselective glycosylation with thioglycosides: activation by [N-phenylselenophthalimideMg(ClO4)2] and [PhIO-Mg(ClO4)2]. Synlett 1998, 84-86.
(149) Fukase, K.; Nakai, Y.; Egusa, K.; Porco, J. A.; Kusumoto, S.: A novel oxidatively
removable linker and its application to -selective solid-phase oligosaccharide synthesis on a
macroporous polystyrene support. Synlett 1999, 1074-1078.
(150) Green, L. G.; Ley, S. V.: Protecting groups: effects on reactivity, glycosylation
specificity and coupling efficiency. In Carbohydrates in Chemistry and Biology; Ernst, B., Hart,
G. W., Sinay, P., Eds.; Wiley-VCH: Weinheim, New York, 2000; Vol. 1; pp 427-448.
(151) Takatani, M.; Matsuo, I.; Ito, Y.: Pentafluoropropionyl and trifluoroacetyl groups
for temporary hydroxyl group protection in oligomannoside synthesis. Carbohydr. Res. 2003,
338, 1073-1081.
(152) Kalikanda, J.; Li, Z.: Study of the stereoselectivity of 2-azido-2-deoxygalactosyl
donors: remote protecting group effects and temperature dependency. J. Org. Chem. 2011, 76,
5207-5218.
(153) Ngoje, G.; Li, Z.: Study of the stereoselectivity of 2-azido-2-deoxyglucosyl
donors: protecting group effects. Org. Biomol. Chem. 2013, 11, 1879-1886.
(154) Crich, D.; Cai, W.; Dai, Z.: Highly diastereoselective -mannopyranosylation in
the absence of participating protecting groups. J. Org. Chem. 2000, 65, 1291-1297.
(155) Crich, D.; Jayalath, P.; Hutton, T. K.: Enhanced diastereoselectivity in mannopyranosylation through the use of sterically minimal propargyl ether protecting groups. J.
Org. Chem. 2006, 71, 3064-3070.

68

(156) Walvoort, M. T. C.; Lodder, G.; Overkleeft, H. S.; Codee, J. D. C.; van der Marel,
G. A.: Mannosazide Methyl Uronate Donors. Glycosylating Properties and Use in the
Construction of β-ManNAcA-Containing Oligosaccharides. J. Org. Chem. 2010, 75, 7990–8002.
(157) Codee, J. D. C.; van den Bos, L. J.; de Jong, A.-R.; Dinkelaar, J.; Lodder, G.;
Overkleeft, H. S.; van der Marel, G. A.: The Stereodirecting Effect of the Glycosyl C5Carboxylate Ester: Stereoselective Synthesis of -Mannuronic Acid Alginates. J. Org. Chem.
2009, 74, 38-47.
(158) Yasomanee, J. P.; Demchenko, A. V.: The effect of remote picolinyl and picoloyl
substituents on the stereoselectivity of chemical glycosylation. J. Am. Chem. Soc. 2012, 134,
20097-20102.
(159) Pistorio, S. G.; Yasomanee, J. P.; Demchenko, A. V.: Hydrogen bond-mediated
aglycone delivery: focus on β-mannosylation. Org. Lett. 2014, 16, 716−719.
(160) Yasomanee, J. P.; Demchenko, A. V.: Hydrogen bond-mediated aglycone
delivery: adventures in the synthesis of linear and branched α-glucans. submitted 2014.
(161) Zulueta, M. M.; Lin, S. Y.; Lin, Y. T.; Huang, C. J.; Wang, C. C.; Ku, C. C.; Shi,
Z.; Chyan, C. L.; Irene, D.; Lim, L. H.; Tsai, T. I.; Hu, Y. P.; Arco, S. D.; Wong, C. H.; Hung, S.
C.: -Glycosylation by D-glucosamine-derived donors: synthesis of heparosan and heparin
analogues that interact with mycobacterial heparin-binding hemagglutinin. J. Am. Chem. Soc.
2012, 134, 8988-8995.
(162) Crich, D.; Cai, W.: Chemistry of 4,6-O-benzylidene-D-glucopyranosyl triflates:
Contrasting behavior between the gluco and manno series. J. Org. Chem. 1999, 64, 4926-4930.

69

(163) Crich, D.; Chandrasekera, N. S.: Mechanism of 4,6-O-benzylidene-directed mannosylation as determined by -deuterium kinetic isotope effects. Angew. Chem. Int. Ed.
2004, 43, 5386-5389 and references therein.
(164) Crich, D.; Sun, S.: Direct synthesis of -mannopyranosides by the sulfoxide
method. J. Org. Chem. 1997, 62, 1198-1199.
(165) Crich, D.; Sun, S.: Are glycosyl triflates intermediates in the sulfoxide
glycosylation method? a chemical and 1H, 13C, and 19F NMR spectroscopic investigation. J. Am.
Chem. Soc. 1997, 119, 11217-11223.
(166) Crich, D.; Sun, S.: Direct formation of -mannopyranosides and other hindered
glycosides from thioglycosides. J. Am. Chem. Soc. 1998, 120, 435-436.
(167) Weingart, R.; Schmidt, R. R.: Can preferential -mannopyranoside formation
with

4,6-O-benzylidene

protected

mannopyranosyl

sulfoxides

be

reached

with

trichloroacetimidates? Tetrahedron Lett. 2000, 41, 8753–8758.
(168) Kim, K. S.; Kim, J. H.; Lee, Y. J.; Lee, Y. J.; Park, J.: 2-(Hydroxycarbonyl)benzyl
glycosides: a novel type of glycosyl donors for highly efficient -mannopyranosylation and
oligosaccharide synthesis by latent-active glycosylation. J. Am. Chem. Soc. 2001, 123, 84778481.
(169) Codee, J. D. C.; Hossain, L. H.; Seeberger, P. H.: Efficient Installation of Mannosides Using a Dehydrative Coupling Strategy. Org. Lett. 2005, 7, 3251-3254.
(170) Baek, J. Y.; Choi, T. J.; Jeon, H. B.; Kim, K. S.: A highly reactive and
stereoselective -mannosylation system: mannosyl 4-pentenoate/PhSeOTf. Angew. Chem. Int.
Ed. 2006, 45, 7436-7440.

70

(171) Kim, K. S.; Lee, Y. J.; Kim, H. Y.; Kang, S. S.; Kwon, S. Y.: Glycosylation with
glycosyl benzyl phthalates as a new type of glycosyl donor. Org. Biomol. Chem. 2004, 2, 24082410.
(172) Kim, K. S.; Fulse, D. B.; Baek, J. Y.; Lee, B. Y.; Jeon, H. B.: Stereoselective
Direct Glycosylation with Anomeric Hydroxy Sugars by Activation with Phthalic Anhydride and
Trifluoromethanesulfonic Anhydride Involving Glycosyl Phthalate Intermediates. J. Am. Chem.
Soc. 2008, 130, 8537-8547.
(173) El-Badr, M. H.; Willenbring, D.; Dean J. Tantillo; Gervay-Hague, a.: Mechanistic
Studies on the Stereoselective Formation of ‚beta-Mannosides from Mannosyl Iodides Using Deuterium Kinetic Isotope Effects. J. Org. Chem. 2007, 72, 4663-4672.
(174) Fraser-Reid, B.; Wu, Z.; Andrews, C. W.; Skowronski, E.: Torsional effects in
glycoside reactivity: saccharide couplings mediated by acetal protecting groups. J. Am. Chem.
Soc. 1991, 113, 1434-1435.
(175) Jensen, H. H.; Nordstrom, L. U.; Bols, M.: The disarming effect of the 4,6-acetal
group on glycoside reactivity: torsional or electronic? J. Am. Chem. Soc. 2004, 126, 9205-9213.
(176) Crich, D.; Banerjee, A.; Yao, Q.: Direct chemical synthesis of the -D-mannans:
the -(1-2) and -(1-4) series. J. Am. Chem. Soc. 2004, 126, 14930-14934.
(177) Brand, C.; Granitzka, M.; Stalke, D.; Werz, D. B.: Reducing the conformational
flexibility of carbohydrates: locking the 6-hydroxyl group by cyclopropanes. Chem. Commun.
2011, 47, 10782-10784.
(178) Benakli, K.; Zha, C.; Kerns, R. J.: Oxazolidinone protected 2-amino-2-deoxy-Dglucose derivatives as versatile intermediates in stereoselective oligosaccharide synthesis and the
formation of -linked glycosides. J. Am. Chem. Soc. 2001, 123, 9461-9462.

71

(179) Kerns, R. J.; Zha, C.; Benakli, K.; Liang, Y.-Z.: Extended applications and
potential limitations of ring-fused 2,3-oxazolidinone thioglycosides in glycoconjugate synthesis.
Tetrahedron Lett. 2003, 44, 8069-8072.
(180) Wei, P.; Kerns, R. J.: Factors affecting stereocontrol during glycosidation of 2,3oxazolidinone-protected 1-tolylthio-N-acetyl-D-glucosamine. J. Org. Chem. 2005, 70, 41954198.
(181) Wei, P.; Kerns, R. J.: Chemoselective deprotection and functional group
interconversion of ring-fused 2N,3O-oxazolidinones of N-acetyl-D-glucosamine. Tetrahedron
Lett. 2005, 46, 6901-6905.
(182) Boysen, M.; Gemma, E.; Lahmann, M.; Oscarson, S.: Ethyl 2-acetamido-4,6-diO-benzyl-2,3-N,O-carbonyl-2-deoxy-1-thio--D-glycopyranoside as a versatile GlcNAc donor.
Chem. Commun. 2005, 24, 3044-3046.
(183) Geng, Y.; Zhang, L.-H.; Ye, X.-S.: Stereoselectivity investigation on
glycosylation of oxazolidinone protected 2-amino-2-deoxy-D-glucose donors based on preactivation protocol. Tetrahedron 2008, 64, 4949-4958.
(184) Geng, Y.; Zhang, L.-H.; Ye, X.-S.: Pre-activation protocol leading to highly
stereoselectivity-controllable glycosylations of oxazolidinone protected glucosamines. Chem.
Commun. 2008, 597–599.
(185) Yang, L.; Ye, X. S.: A highly -selective glycosylation for the convenient
synthesis of repeating -(1-->4)-linked N-acetyl-galactosamine units. Carbohydr. Res. 2010,
345, 1713-21.
(186) Olsson, J. D. M.; Eriksson, L.; Lahmann, M.; Oscarson, S.: J. Org. Chem. 2008,
73, 7181-7188.

72

(187) Satoh, H.; Manabe, S.; Ito, Y.; Lüthi, H. P.; Laino, T.; Hutter, J.: Endocyclic
cleavage in glycosides with 2,3-trans cyclic protecting groups. J. Am. Chem. Soc. 2011, 133,
5610-5619.
(188) Manabe, S.; Ishii, K.; Ito, Y.: N-benzyl-2,3-oxazolidinone as a glycosyl donor for
selective -glycosylation and one-pot oligosaccharide synthesis involving 1,2-cis-glycosylation.
J. Am. Chem. Soc. 2006, 128, 10666-10667.
(189) Manabe, S.; Ishii, K.; Ito, Y.: N-Benzyl-2,3-trans-Carbamate-Bearing Glycosyl
Donors for 1,2-cis-Selective Glycosylation Reactions. Eur. J. Org. Chem. 2011, 497-516.
(190) Crich, D.; Picione, J.: Direct synthesis of the -L-rhamnopyranosides. Org. Lett.
2003, 5, 781-784.
(191) Crich, D.; Jayalath, P.: Stereocontrolled formation of -glucosides and related
linkages in the absence of neighboring group participation: influence of a trans-fused 2,3-Ocarbonate group. J. Org. Chem. 2005, 70, 7252-7259.
(192) Geng, Y.; Qin, Q.; Ye, X.-S.: Lewis Acids as α-Directing Additives in
Glycosylations by Using 2,3-O-Carbonate-Protected Glucose and Galactose Thioglycoside
Donors Based on Preactivation Protocol. J. Org. Chem. 2012, 77, 5255-5270.
(193) Imamura, A.; Ando, H.; Ishida, H.; Kiso, M.: Di-tert-butylsilylene-Directed aSelective Synthesis of 4-Methylumbelliferyl T-Antigen. Org. Lett. 2005, 7, 4415-4418.
(194) Imamura, A.; Ando, H.; Ishida, H.; Kiso, M.: DTBS effect: the unique sterically
driven director for -galactosylation. Heterocycles 2008, 76, 883-908.
(195) Imamura, A.; Ando, H.; Korogi, S.; Tanabe, G.; Muraoka, O.; Ishida, H.; Kiso,
M.: Di-tert-butylsilylene (DTBS) group-directed α-selective galactosylation unaffected by C-2
participating functionalities. Tetrahedron Lett. 2003, 44, 6725-6728.

73

(196) Hara, A.; Imamura, A.; Ando, H.; Ishida, H.; Kiso, M.: A new chemical approach
to human ABO histo-blood group type 2 antigens. Molecules 2014, 19, 414-437.
(197) Chen, Q.; Kong, F.: Stereoselective glycosylation using fully benzylated
pyrimidin-2-yl 1-thio--D-glycopyranosides. Carbohydr. Res. 1995, 272, 149-157.
(198) Sames, D.; Chen, X. T.; Danishefsky, S. J.: Convergent total synthesis of a tumorassociated mucin motif. Nature 1997, 389, 587-591.
(199) Schwartz, J. B.; Kuduk, S. D.; Chen, X. T.; Sames, D.; Glunz, P. W.;
Danishefsky, S. J.: A broadly applicable method for the efficient synthesis of O-linked
glycopeptides and clustered sialic acid residues. J. Am. Chem. Soc. 1999, 121, 2662-2673.
(200) Sinay, P.: Recent advances in glycosylation reactions. Pure Appl. Chem. 1978, 50,
1437-1452.
(201) Paulsen,

H.:

Advances

in

selective

chemical

syntheses

of

complex

oligosaccharides. Angew. Chem. Int. Edit. Engl. 1982, 21, 155-173.
(202) Hashimoto, S. I.; Sakamoto, H.; Honda, T.; Abe, H.; Nakamura, S. I.; Ikegami, S.:
"Armed-disarmed" glycosidation strategy based on glycosyl donors and acceptors carrying
phosphoroamidate as a leaving group: a convergent synthesis of globotriaosylceramide.
Tetrahedron Lett. 1997, 38, 8969-8972.
(203) Kaeothip, S.; Akins, S. J.; Demchenko, A. V.: On the stereoselectivity of
glycosidation of thiocyanates, thioglycosides, and thioimidates. Carbohydr. Res. 2010, 345,
2146-2150.
(204) Tomoya Kimura; Maiko Sekine; Daisuke Takahashi, a.; Toshima, K.: Chiral
Bronsted Acid-Mediated Glycosylation with Recognition of Alcohol Chirality 2014.

74

(205) Wegmann, B.; Schmidt, R. R.: Glycosylimidates. 27. The application of the
trichloroacetimidate

method

to

the

synthesis

of

-D-glucopyranosides

and

-D-

galactopyranosides. J. Carbohydr. Chem. 1987, 6, 357-375.
(206) Nishizawa, M.; Shimomoto, W.; Momii, F.; Yamada, H.: Stereoselective thermal
glycosylation

of

2-deoxy-2-acetoamino-3,4,6-tri-O-acetyl--D-glucopyranosyl

chloride.

Tetrahedron Lett. 1992, 33, 1907-1908.
(207) Shimizu, H.; Ito, Y.; Ogawa, T.: PhSeNPhth - TMSOTf as a promoter of
thioglycoside. Synlett 1994, 535-536.
(208) Chenault, H. K.; Castro, A.; Chafin, L. F.; Yang, J.: The chemistry of isopropenyl
glycopyranosides. Transglycosylations and other reactions. J. Org. Chem. 1996, 61, 5024-5031.
(209) Manabe, S.; Ito, Y.; Ogawa, T.: Solvent effect in glycosylation reaction on
polymer support. Synlett 1998, 628-630.
(210) Schmidt, R. R.; Rucker, E.: Stereoselective glycosidations of uronic acids.
Tetrahedron Lett. 1980, 21, 1421-1424.
(211) Dohi, H.; Nishida, Y.; Tanaka, H.; Kobayashi, K.: O-Methoxycarbonylphenyl 1thio--D-galactopyranoside, a non-malodorous thio glycosylation donor for the synthesis of
globosyl -(1-4)-linkages. Synlett 2001, 1446-1448.
(212) Ishiwata, A.; Munemura, Y.; Ito, Y.: Synergistic solvent effect in 1,2-cisglycosides formation. Tetrahedron 2008, 64, 92-102.
(213) Wulff, G.; Rohle, G.: Results and problems of O-glycoside synthesis. Angew.
Chem., Int. Edit. Engl. 1974, 13, 157-170.
(214) Demchenko, A.; Stauch, T.; Boons, G. J.: Solvent and other effects on the
stereoselectivity of thioglycoside glycosidations. Synlett 1997, 818-820.

75

(215) Chao, C. S.; Lin, C. Y.; Mulani, S.; Hung, W. C.; Mong, K. K.: Neighboringgroup participation by C-2 ether functions in glycosylations directed by nitrile solvents. Chem.
Eur. J. 2011, 17, 12193-202.
(216) Knoben, H.; Schuluter, U.; Redlich, H.: Synthesis of N-unsubstituted, mono- and
di-substituted carbohydrate-1-O-carbamates and their behaviour in glycoside syntheses.
Carbohydr. Res. 2004, 339, 2821-2833.
(217) Jayakanthan, K.; Vankar, Y. D.: Glycosyl trichloroacetylcarbamate: a new
glycosyl donor for O-glycosylation. Carbohydr. Res. 2005, 340, 2688-2692.
(218) Shirahata, T.; Matsuo, J.-i.; Teruya, S.; Hirata, N.; Kurimoto, T.; Akimoto, N.;
Sunazuka, T.; Kaji, E.; Omura, S.: Improved catalytic and stereoselective glycosylation with
glycosyl N-trichloroacetylcarbamate: application to various 1-hydroxy sugars. Carbohydr. Res.
2010, 345, 740-749.
(219) Wasonga, G.; Zeng, Y.; Huang, X.: Pre-activation based stereoselective
glycosylations: Stereochemical control by additives and solvent. Sci. China Chem. 2011, 54, 6673.
(220) Satoh, H.; Hansen, H. S.; Manabe, S.; van Gunsteren, W. F.; Hunenberger, P. H.:
Theoretical investigation of solvent effects on glycosylation reactions: stereoselectivity
controlled by preferential conformations of the intermediate oxacarbenium-counterion complex.
J. Chem. Theory Comput. 2010, 6, 1783-1797.
(221) Liu, C.-Y. I.; Mulani, S.; Mong, K.-K. T.: Iterative One-Pot α-Glycosylation
Strategy: Application to Oligosaccharide Synthesis. Adv. Synth. Catal. 2012, 354, 3299-3310.
(222) Igarashi, K.: The Koenigs-Knorr reaction. Adv. Carbohydr. Chem. Biochem.
1977, 34, 243-283.

76

(223) Zemplen, G.; Gerecs, A.: Action of mercury salts on acetohalogenosugars. IV.
Direct preparation of alkyl biosides of the -series. Ber. Dtsch. Chem. Ges. 1930, 63B, 27202729.
(224) Helferich,

B.;

Wedemeyer,

K.

F.:

Preparation

of

glucosides

from

acetobromoglucose. Ann. 1949, 563, 139-145.
(225) Koenigs, W.; Knorr, E.: Über einige Derivate des Traubenzuckers und der
Galactose. Ber. Deutsch. Chem. Ges. 1901, 34, 957-981.
(226) Helferich, B.; Zirner, J.: Synthesis of tetra-O-acetyhexoses with a free 2-hydroxyl
group. Synthesis of disaccharides. Chem. Ber. 1962, 95, 2604-2611.
(227) Conrow, R. B.; Bernstein, S.: Steroid conjugates. VI. An improved KoenigsKnorr synthesis of aryl glucuronides using cadmium carbonate, a new and effective catalyst. J.
Org. Chem. 1971, 36, 863-870.
(228) Kulkarni, S. S.; Gervay-Hague, J.: Glycosyl chlorides, bromides and iodides. In
Handbook of Chemical Glycosylation; Demchenko, A. V., Ed.; Wiley-VCH: Weinheim,
Germany, 2008; pp 59-93.
(229) Veeneman, G. H.; van Leeuwen, S. H.; van Boom, J. H.: Iodonium ion promoted
reactions at the anomeric centre. II. An efficient thioglycoside mediated approach toward the
formation of 1,2-trans linked glycosides and glycosidic esters. Tetrahedron Lett. 1990, 31, 13311334.
(230) Veeneman, G. H.; van Boom, J. H.: An efficient thioglycoside-mediated
formation of alpha-glycosidic linkages promoted by iodonium dicollidine perchlorate.
Tetrahedron Lett. 1990, 31, 275-278.

77

(231) McKay, M. J.; Nguyen, H. M.: Recent Advances in Transition Metal-Catalyzed
Glycosylation. ACS Catal. 2012, 2, 1563-1595.
(232) Babu, R. S.; Zhou, M.; O'Doherty, G. A.: De Novo Synthesis of Oligosaccharides
Using a Palladium-Catalyzed Glycosylation Reaction. J. Am. Chem. Soc. 2004, 126, 3428-3429.
(233) Guo, H.; O’Doherty, G. A.: De Novo Asymmetric Synthesis of Anthrax
Tetrasaccharide and Related Tetrasaccharide. J. Org. Chem. 2008, 73, 5211-5220.
(234) Zhou, M.; O’Doherty, G. A.: The De Novo Synthesis of Oligosaccharides:
Application to the Medicinal Chemical Study of Digitoxin. Curr. Topics Med. Chem. 2008, 8,
114-125.
(235) Yang, J.; Cooper-Vanosdell, C.; Mensah, E. A.; Nguyen, H. M.: Cationic
Palladium(II)-Catalyzed Stereoselective Glycosylation with Glycosyl Trichloroacetimidates. J.
Org. Chem. 2008, 73, 794-800.
(236) Mensah, E. A.; Azzarelli, J. M.; Nguyen, H. M.: Palladium-Controlled β-Selective
Glycosylation in the Absence of the C(2)-Ester Participatory Group. J. Org. Chem. 2009, 74,
1650-1657.
(237) Mensah, E. A.; Nguyen, H. M.: Nickel-Catalyzed Stereoselective Formation of α2-Deoxy-2-Amino Glycosides. J. Am. Chem. Soc. 2009, 131, 8778-8780.
(238) Mensah, E. A.; Yu, F.; Nguyen, H. M.: Nickel-Catalyzed Stereoselective
Glycosylation with C(2)-N-Substituted Benzylidene D-Glucosamine and Galactosamine
Trichloroacetimidates for the Formation of 1,2-cis-2-Amino Glycosides. Applications to the
Synthesis of Heparin Disaccharides, GPI Anchor Pseudodisaccharides, and -GalNAc. J. Am.
Chem. Soc. 2010, 132, 14288-14302.

78

(239) Chu, A.-H. A.; Nguyen, S. H.; Sisel, J. A.; Minciunescu, A.; Bennett, C. S.:
Selective Synthesis of 1,2-cis--Glycosides without Directing Groups. Application to Iterative
Oligosaccharide Synthesis. Org. Lett. 2013, 15, 2566–2569.
(240) Hotha, S.; Kashyap, S.: Propargyl glycosides as stable glycosyl donors: anomeric
activation and glycosyl syntheses. J. Am. Chem. Soc. 2006, 128, 9620-9621.
(241) Sureshkumar, G.; Hotha, S.: Propargyl 1,2-orthoesters as glycosyl donors:
stereoselective synthesis of 1,2-trans glycosides and disaccharides. Tetrahedron Lett. 2007, 48,
6564-6568.
(242) Hashmi, A. S. K.: Gold-Catalyzed Organic Reactions. Chem. Rev. 2007, 107,
3180-3211.
(243) Li, Y.; Yang, X.; Liu, Y.; Zhu, C.; Yang, Y.; Yu, B.: Gold(I)-Catalyzed
Glycosylation with Glycosyl ortho-Alkynylbenzoates as Donors: General Scope and Application
in the Synthesis of a Cyclic Triterpene Saponin. Chem. Eur. J. 2010, 16, 1871-1882.
(244) Ma, Y.; Li, Z.; Shi, H.; Zhang, J.; Yu, B.: Assembly of Digitoxin by gold(I)catalyzed glycosidation of glycosyl o-alkynylbenzoates. J. Org. Chem. 2011, 76, 9748-9756.
(245) Reisman, S. E.; Doyle, A. G.; Jacobsen, E. N.: Enantioselective ThioureaCatalyzed Additions to Oxocarbenium Ions. J. Am. Chem. Soc. 2008, 130, 7198–7199.
(246) Balmond, E. I.; Coe, D. M.; Galan, M. C.; McGarrigle, E. M.: -Selective
Organocatalytic Synthesis of 2-Deoxygalactosides. Angew. Chem. Int. Ed. 2012, 51, 9152-9155.
(247) Geng, Y.; Kumar, A.; Faidallah, H. M.; Albar, H. A.; Mhkalid, I. A.; Schmidt, R.
R.: Cooperative Catalysis in Glycosidation Reactions with O-Glycosyl Trichloroacetimidates as
Glycosyl Donors. Angew. Chem. Int. Ed. 2013, 52, 10089 –10092.

79

(248) Mukaiyama, T.; Matsubara, K.: Stereoselective glycosylation reaction starting
from 1-O-trimethylsilyl sugars by using diphenyltin sulfide and a catalytic amount of active
acidic species. Chem. Lett. 1992, 1041-1044.
(249) Fukase, K.; Hasuoka, A.; Kinoshita, I.; Aoki, Y.; Kusumoto, S.: A stereoselective
glycosidation using thioglycosides, activation by combination of N-bromosuccinimide and
strong acid salts. Tetrahedron 1995, 51, 4923-4932.
(250) Hasty, S. J.; Ranade, S. C.; Demchenko, A. V.: A study of silver(I) perchlorate as
an effective promoter for chemical glycosylation with thioimidates and thioglycosides Reports
Org. Chem. 2014, 4, 1-10.
(251) Pornsuriyasak, P.; Vetter, C.; Kaeothip, S.; Kovermann, M.; Balbach, J.;
Steinborn, D.; Demchenko, A. V.: Coordination chemistry approach to the long-standing
challenge of anomeric stereoselectivity. Chem. Commun. 2009, 6379-6381.
(252) Klimov, E. M.; Malysheva, N. N.; Demchenko, A. V.; Makarova, Z. G.; Zhulin,
V. M.; Kochetkov, N. K.: The effect of high-pressure on the stereochemistry of glycosylation of
sugars by 1,2-trans-acetates - synthesis of gentioligosaccharides. Dokl. Akad. Nauk 1989, 309,
110-114 and references therein.
(253) Sasaki, M.; Gama, Y.; Yasumoto, M.; Ishigami, Y.: Glycosylation reaction under
high-pressure. Tetrahedron Lett. 1990, 31, 6549-6552.
(254) Spijker, N. M.; van Boeckel, C. A. A.: Double stereodifferentiation in
carbohydrate coupling reactions:

the mismatched interaction of donor and acceptor as an

unprecedented factor governing the /-ratio of glycoside formation. Angew. Chem. Int. Edit.
Engl. 1991, 30, 180-183.

80

(255) Paquet, F.; Sinay, P.: Intramolecular oximercuration-demercuration reaction: A
new stereocontrolled approach to sialic acid containing disaccharides. Tetrahedron Lett. 1984,
25, 3071-3074.
(256) Paquet, F.; Sinay, P.: New stereocontrolled approach to 3-deoxy-D-manno-2octulosonic acid containing disaccharides. J. Am. Chem. Soc. 1984, 106, 8313-8315.
(257) Ohtake, H.; Ichiba, N.; Ikegami, S.: A highly stereoselective construction of glycosyl linkages by reductive cleavage of cyclic sugar ortho esters. J. Org. Chem. 2000, 65,
8171-8179.
(258) Barresi, F.; Hindsgaul, O.: Synthesis of -mannosides by intramolecular aglycon
delivery. J. Am. Chem. Soc. 1991, 113, 9376-9377.
(259) Stork, G.; Kim, G.: Stereocontrolled synthesis of disaccharides via the temporary
silicon connection. J. Am. Chem. Soc. 1992, 114, 1087-1088.
(260) Bols, M.: Stereocontrolled synthesis of -glucosides by intramolecular
glycosidation. J. Chem. Soc., Chem. Commun. 1992, 913-914.
(261) Seward, C. M. P.; Cumpstey, I.; Aloui, M.; Ennis, S. C.; Redgrave, A. J.;
Fairbanks, A. J.: Stereoselective cis glycosylation of 2-O-allyl protected glycosyl donors by
intramolecular aglycon delivery (IAD). Chem. Commun. 2000, 1409-1410.
(262) Ishiwata, A.; Munemura, Y.; Ito, Y.: NAP ether mediated intramolecular aglycone
delivery: a unified strategy for 1,2-cis-glycosylation. Eur. J. Org. Chem. 2008, 4250-4263.
(263) Osborn, H. M. I.; Khan, T. H.: Recent developments in polymer supported
syntheses of oligosaccharides and glycopeptides. Tetrahedron 1999, 55, 1807-1850.

81

(264) Krepinsky, J. J.; Douglas, S. P.: Polymer-supported synthesis of oligosaccharides.
In Carbohydrates in Chemistry and Biology; Ernst, B., Hart, G. W., Sinay, P., Eds.; Wiley-VCH:
Weinheim, New York, 2000; Vol. 1; pp 239-265.
(265) Seeberger, P. H.; Haase, W. C.: Solid-phase oligosaccharide synthesis and
combinatorial carbohydrate libraries. Chem. Rev. 2000, 100, 4349-4393.
(266) Fukase, K.: Oligosaccharides: Synthesis: Combinatorial and solid phase methods
in oligosaccharide synthesis. In Glycoscience: Chemistry and Chemical Biology; Fraser-Reid, B.,
Tatsuta, K., Thiem, J., Eds.; Springer: Berlin - Heidelberg - New York, 2001; Vol. 2; pp 16211660.
(267) Seeberger, P. H.: Solid phase oligosaccharide synthesis (Reprinted from
Glycochemistry: Principles, synthesis, and applications, pg 1- 32, 2001). J. Carbohydr. Chem.
2002, 21, 613-643.
(268) Werz, D. B.; Castagner, B.; Seeberger, P. H.: Automated synthesis of the tumorassociated carbohydrate antigens Gb-3 and Globo-H: incorporation of -galactosidic linkages. J.
Am. Chem. Soc. 2007, 129, 2770-2771.
(269) Grubbs, R. H.; Miller, S. J.; Fu, G. C.: Ring-closing metathesis and related
processes in organic synthesis. Acc. Chem. Res. 1995, 28, 446-452.
(270) Calin, O.; Eller, S.; Hahm, H. S.; Seeberger, P. H.: Total Synthesis of the
Escherichia coli O111 O-Specific Polysaccharide Repeating Unit. Chem. Eur. J. 2013, 19, 3995
– 4002.
(271) Huo, C.; Chan, T. H.: A novel liquid-phase strategy for organic synthesis using
organic ions as soluble supports. Chem. Soc. Rev. 2010, 39, 2977-3006.

82

(272) Pathak, A. K.; Yerneni, C. K.; Young, Z.; Pathak, V.: Oligomannan synthesis
using ionic liquid supported glycosylation. Org. Lett. 2008, 10, 145-148.
(273) Miura, T.; Goto, K.; Waragai, H.; Matsumoto, H.; Hirose, Y.; Ohmae, M.; Ishida,
H.; Satoh, A.; Inazu, T.: Rapid oligosaccharide synthesis using a fluorous protective group. J.
Org. Chem. 2004, 69, 5348-5353.
(274) Jaipuri, F. A.; Pohl, N. L.: Toward solution-phase automated iterative synthesis:
Fluorous-tag assisted solution-phase synthesis of linear and branched mannose oligomers. Org.
Biomol. Chem. 2008, 6, 2686-2691.
(275) Liu, L.; Pohl, N. L. B.: A Fluorous Phosphate Protecting Group with Applications
to Carbohydrate Synthesis. Org. Lett. 2011, 13, 1824–1827.
(276) Sasaki, K.; Nagai, H.; Matsumura, S.; Toshima, K.: A novel greener glycosidation
using an acid–ionic liquid containing a protic acid. Tetrahedron Lett. 2003, 44, 5605-5608.
(277) Sasaki, K.; Matsumura, S.; Toshima, K.: A novel glycosidation of glycosyl
fluoride using a designed ionic liquid and its effect on the stereoselectivity. Tetrahedron Lett.
2004, 45, 7043-7047.
(278) Rencurosi, A.; Lay, L.; Russo, G.; Caneva, E.; Poletti, L.: Glycosylation with
Trichloroacetimidates in Ionic Liquids: Influence of the Reaction Medium on the Stereochemical
Outcome. J. Org. Chem. 2005, 70, 7765-7768.
(279) Huang, J.-Y.; Lei, M.; Wang, Y.-G.: A novel and efficient ionic liquid supported
synthesis of oligosaccharides. Tetrahedron Lett. 2006, 47, 3047-3050.
(280) Rencurosi, A.; Lay, L.; Russo, G.; Caneva, E.; Poletti, L.: NMR evidence for the
participation of triflated ionic liquids in glycosylation reaction mechanisms. Carbohydr. Res.
2006, 341, 903-908.

83

(281) Galan, M. C.; Corfield, A. P.: Ionic liquids in oligosaccharide synthesis: Towards
mucin-type glycan probes. Biochem. Soc. Trans. 2010, 38, 1368-1373.
(282) Galan, M. C.; Jouvin, K.; Alvarez-Dorta, D.: Scope and limitations of
imidazolium-based ionic liquids as room temperature glycosylation promoters. Carbohydr. Res.
2010, 345, 45-49.
(283) Pépin, M.; Hubert-Roux, M.; Martin, C.; Guillen, F.; Lange, C.; Gouhier, G.: First
Examples of α-(1→4)-Glycosylation Reactions on Ionic Liquid Supports. Eur. J. Org. Chem.
2010, 6366-6371.

84

Chapter 2

O-Benzoxazolyl imidates as
versatile glycosyl donors for
chemical glycosylation

Swati S. Nigudkar, Archana R. Parameswar, Papapida Pornsuriyasak, Keith J. Stine, and
Alexei V. Demchenko. O-Benzoxazolyl imidates as versatile glycosyl donors for
chemical glycosylation. Org. Biomol. Chem., 2013, 11, 4068-4076.

85

2.1. Introduction
Complex carbohydrates play important roles in many life-sustaining and lifethreatening processes including embryonic growth, cell differentiation, immune response,
infections, and carcinogenesis.1 Our understanding of these processes is often dependent
on the knowledge of the structure and properties of the carbohydrates involved. Many
classes of complex carbohydrates can be isolated from natural sources, but it is chemical
or enzymatic synthesis that allows for obtaining sufficient quantities of pure natural
compounds or unnatural mimetics thereof.2 Amongst the synthetic steps required to
obtain complex carbohydrates from simple building blocks, chemical glycosylation
reactions create the greatest synthetic hurdle for chemists.3,4 Hence, the development of
new leaving groups for chemical glycosylation and the optimization of reaction
conditions for their activation represents an important and challenging area of research.5
The tremendous progress made in the area of glycosciences has resulted in the
development of a variety of leaving groups amongst which O-trichloroacetimidates
(TCAI)6 and thioglycosides7 have arguably become the most widespread glycosyl donors
to date.
Figure 2.1. Designing new O-benzoxazolyl leaving group
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As a part of the ongoing research effort to develop new methods for chemical
glycosylation, our laboratory reported a series of new thioimidoyl leaving groups that
have shown superior properties in glycosylation to that of many other methods.8,9
Amongst these, S-benzoxazolyl donors (cyclic S-imidate)10-17 have shown excellent
glycosyl donor properties for simple one-step glycosylations and easily fit into a variety
of concepts for expeditious oligosaccharide synthesis.18 Aiming to develop a similar
method for chemical glycosylation, we became interested in studying cyclic O-imidates.
As the first step towards accomplishment of this aim, we report the investigation of a
novel leaving group, O-benzoxazolyl (OBox), which represents a bridging structure
between O-imidates and SBox glycosides (Figure 2.1). This study is also expected to
complement previous work of Mukaiyama19-23 and Chirva24 dedicated to a study of
structurally related O-imidate derivatives.

2.2. Results and discussion
We determined that the novel OBox leaving group can be introduced by several
modes using commercially available and inexpensive precursors. For the sugar part, both
hemiacetals and glycosyl bromides were found to be suitable starting materials. In this
context, Mukaiyama’s imidate was similarly synthesized by direct condensation reaction
between anomeric hydroxyl group and 2-chloro-6-nitrobenzthiazole giving a mixture of
isomers.21 As summarized in Table 2.1, a variety of OBox derivatives of the D-gluco
(2.2, 2.4, 2.8, 2.10), D-manno (2.6, 2.14), and D-galacto (2.12) series were readily
obtained in yields up to 85%. The transformation of hemiacetals 2.1,25 2.3,25 and 2.526
into the corresponding OBox imidates 2.2, 2.4, and 2.6 involved a base-catalyzed (DBU
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or KOH) reaction with 2-chlorobenzoxazole (ClBox, entries 1-3, Table 2.1). With
exception of benzylated OBox derivative 2.4 (entry 2) that was obtained as a mixture of
anomers (α/β = 2.5/1), other substitutions proceeded stereoselectively.
The OBox glycosides could also be obtained from halides using 2-benzoxazolinone
(HOBox), but the conversion was more efficient when the corresponding silver salt
(AgOBox) was used instead (entries 4-7). To our surprise, conversion of acetylated
bromide 2.727 resulted in the formation of a relatively stable OBox orthoester 2.8 along
with a small amount of the expected OBox derivative 2.2 (entry 4). Orthoesters have
been known for long time and found broad application in regioselective protection of
carbohydrates and glycosylation.28 However, to the best of our knowledge, no occurrence
of O-imidate-based orthoester derivatives has been reported. On the other hand, reaction
of benzobromo derivatives of the gluco 2.9,29 galacto 2.11,30 and manno series 2.1331
with AgOBox in the presence of Bu4NI and 2,6-lutidine afforded the corresponding
OBox imidates 2.10, 2.12, and 2.14 in good yields with exclusive 1,2-trans anomeric
selectivity and no orthoester formation detected. In this context, transformation of the
tetrabenzoylated hemiacetal to the corresponding OBox imidate 2.10 was found to be
inefficient and incomplete probably due to the reversibility of the reaction.

The

formation of the N-linked glycosides along with O- or S-linked derivatives upon reaction
with bi- or multi-dentate aglycones is not uncommon.12,32,33 In this particular case,
however, no N-linked products were isolated.
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Table 2.1. Synthesis of O-benzoxazolyl derivatives
Entry

Starting material
AcO
AcO
AcO

Conditions,a time

O

Product

Yield
α/β ratio

A, 2 h

85%
1.5/1

2

B, 2.5 h

80%
2.5/1

3

B, 2 h

50%
α only

4

C, 1.25 h

79%
+ 9%
(β-2.2)

5

D, 10 h

83%
β only

6

D, 2.5 h

82%
β only

7

D, 1.5 h

81%
α only

1

AcO OH
2.1

a

– Conditions: A: ClBox, DBU, CH2Cl2, 0 oC; B: ClBox, KOH, acetone, molec. sieves
3Å, 0 oC; C: AgOBox, CH2Cl2, molec. sieves 3Å, 40 oC; D: AgOBox, Bu4NI, 2,6lutidine, CH2Cl2, rt (entry 6 and 7) or 45 oC (entry 5)
Occasionally, N-linked glycosides are also obtained as by-products of the synthesis of
O- and S-imidates. Based on the literature data for per-acetylated SBox glycosides and
their N-linked counterparts (2.17 and 2.18),34 we found that UV spectroscopy would
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adequately serve our needs for structure determinations.15 To this end, it should be
possible to unambiguously distinguish the isomers by simple and reproducible
comparison of the absorption bands. Thus, the thioimide (SH) derivative has two narrow
bands (λmax) at around 280 and 290 nm (C=N), whereas the thioamide (NH) has a single
broad band at ~300 nm (C=S, entries 1 and 2, Table 2.2). Resultantly, we anticipated that
UV spectroscopy could be used to differentiate O-imidates from their N-linked
counterparts. Indeed, OBox glycoside 2.2 showed two narrow bands at 273 and 279 nm
indicative of the imide (C=N) structure (entry 3). Along these lines, HOBox derivative
2.15 exists as an amide (C=O, single band at 275 nm, entry 4), whereas its silver salt 2.16
is an imide (C=N, two bands at 274 and 280 nm, entry 5). In addition to the previously
reported data for per-benzylated S-benzoxazolyl (SBox) glycosides and their N-linked
counterparts (2.19 and 2.20, entries 7 and 8, respectively),15 herein we report UV data for
per-benzylated OBox derivative 2.4. The UV spectrum confirms the imide structure
(C=N, λmax = 270 and 276, entry 8).
Having performed the synthesis and thorough characterization of the novel OBox
imidates, we turned our attention to studying their glycosyl donor properties. A typical
activation of TCAI is affected under catalysis of a Lewis acid (BF3-OEt2 or TMSOTf)
and leads to the corresponding disaccharides in good to excellent yields.6,35 A typical
activation of SBox glycoside requires different reaction conditions and can be affected in
the presence of stoichiometric amount of Ag(I), Cu(II), Bi(III), or TMS triflates.
Alternatively, SBox glycosides can be activated in the presence of thiophilic promoters,
typical for thioglycoside activation,7 including MeOTf, DMTST, NIS/TMSOTf, etc.9
With this prior knowledge and a range of OBox donors in hand, we planned on studying
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their reactivity in glycosylation reactions with standard glycosyl acceptors 2.21-2.24
(Figure 2.2).36
Table 2.2. Comparative UV data for O, N and S-linked derivatives
Band 1
λmax (nm)

Band 2
λmax (nm)

Ref.

1

275

-

This work

2

274

280

This work

3

280

290

34

4

300

--

34

5

273

279

This work

6

274

280

This work

7

280

290

15

9

270

276

This work

Entry

Compound

A coupling reaction of per-O-benzylated OBox imidate 2.4 with glycosyl acceptor
2.2137 in the presence of MeOTf (10 mol %) was completed within 5 min at -78 oC and
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provided the corresponding disaccharide 2.2538 in 97% (α/β = 1/1.7, entry 1, Table 2.3).
Activation of OBox imidate 2.4 for reaction with acceptor 2.21 was nearly as efficient in
the presence of either TfOH (10 mol %) or TMSOTf (10 mol %) and provided the
corresponding disaccharide 2.25 in 85% (α/β = 1/1.2, entry 2) or 95% yield (α/β = 1/4.0,
entry 3). Both reactions were completed in less than 5 min at -20 oC (entry 2) or -78 oC
(entry 3). The latter reaction conditions (TMSOTf, -78 oC) were applied to glycosylation
of secondary glycosyl acceptors 2.22-2.2439-41 with OBox donor 2.4. Again, all couplings
were completed within 5 min and provided the corresponding disaccharides 2.26-2.2842-44
in 89-95% yields (α/β = 1/1.0-2.4, entries 4-6). Other promoters including AgOTf,
MeOTf, Bi(OTf)3, and Cu(OTf)2 also provided very efficient activation of OBox
glycosides (vide infra). Although OBox donor 2.4 showed very satisfactory results,
relatively low stereoselectivity was observed in practically all glycosidations of 2.4 using
1,2-dichloroethane as the solvent. A similar reactivity profile was recorded for perbenzylated mannosyl donor 2.6 with an exception that a moderate selectivity was
obtained with primary acceptor 2.21 and complete 1,2-trans selectivity was observed with
secondary acceptors 2.22-2.24 (entries 7-10) to provide the respective disaccharides 2.292.32 in excellent yields of 90-94%.
Figure 2.2. Glycosyl acceptors investigated
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Table 2.3. Synthesis of 1,2-cis glycosides
Entry

Donor + Acceptor,
Conditions,a time

1

2.4 + 2.21
Method A, 15 min

2
3

Product

Yield,
α/β ratio
97%, 1/1.7

2.4 + 2.21
Method B, 5 min
2.4 + 2.21
Method C, 5 min

2.25

85%, 1/1.2

2.25

95%, 1/4.0

4

2.4 + 2.22
Method C, 5 min

89%, 1/1.5

5

2.4 + 2.23
Method C, 5 min

95%, 1/1.0

6

2.4 +2.24
Method C, 5 min

92%, 1/2.4

7

2.6 + 2.21
Method C, 5 min

93%, 2.9/1

8

2.6 + 2.22
Method C, 5 min

91%,
α only

9

2.6 + 2.23
Method C, 5 min

90%,
α only

10

2.6 + 2.24
Method C, 5 min

94%,
α only
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Having investigated the reactivity of per-O-benzylated OBox glycosyl donors 2.4 and
2.6, we turned our attention to studying their per-O-acylated counterparts. The disarming
(deactivating) effect of electron-withdrawing substituents on the reactivity of building
blocks in glycosylation is well known.45-47 Therefore, we anticipated substantially
reduced reactivity of per-acylated OBox derivatives. Surprisingly, the reactivity of peracylated derivatives was similar to that observed with their per-benzylated counterparts.
Although the reactions were fast, per-acetylated OBox glycoside 2.2 provided somewhat
low yields (data not shown) when TMSOTf was used as the promoter. We relate this to
the competing acetyl migration from the O-2 of the glycosyl donor to the free hydroxyl of
the glycosyl acceptor. In this context, SnCl4-promoted glycosidations of glycosyl donor
2.2 with glycosyl acceptors 2.21 and 2.22 were much cleaner, showed minimal acetyl
migration, and provided the corresponding 1,2-trans-linked disaccharides 2.3344 and
2.3448 in good yields of 85% and 77%, respectively (entries 1 and 2, Table 2.4). SnCl4promoted glycosidation of the acetylated OBox orthoester 2.8 provided a very similar
outcome in comparison to the glycosylation of glycosyl imidate 2.2 (entries 3 and 4).
The reactivity of per-benzoylated glucose derivative 2.10 in presence of TMSOTf at 78 oC was also quite similar to that observed with its per-benzylated counterpart 2.4. All
glycosidations of donor 2.10 were completed within 5-10 min and provided the
corresponding disaccharides 2.35-2.3836,49,50 in excellent yields of 87-97% (entries 5-8).
Very high reactivity was also observed for per-benzoylated galactosyl and mannosyl
donors 2.12 and 2.14, respectively. All glycosylations in the presence of TMSOTf at -78
o

C were completed within 5-15 min and provided the corresponding disaccharides 2.39-

2.4251-53 in excellent yields of 78-97% (entries 9-12).
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Table 2.4. Synthesis of 1,2-trans glycosides
Yield,
α/β ratio

Entry

Donor + Acceptor,
Conditions,a time

1

2.2 + 2.21
Method D, 5 min

85%,
β only

2

2.2 + 2.22
Method D, 5 min

77%,
β only

3
4

Product

2.8 + 2.21
Method D, 15 min
2.8 + 2.22
Method D, 15 min

2.33
2.34

82%,
β only
75%,
β only

5

2.10 +2.21
Method C, 10 min

89%,
β only

6

2.10 + 2.22
Method C, 10 min

88%,
β only

7

2.10 + 2.23
Method C, 10 min

88%,
β only

8

2.10 + 2.24
Method C, 10 min

87%,
β only

9

2.12 + 2.21
Method C, 5 min

83%,
β only

10

2.12 + 2.22
Method C, 5 min

78%,
β only

95

11

2.14 + 2.21
Method C, 15 min

95%,
α only

12

2.14 + 2.22
Method C, 15 min

97%,
α only

With the high reactivity of OBox glycosides observed even under relatively mild and
catalytic activation conditions, we aimed at establishing the comparative reactivity profile
of the OBox imidates along with known glycosyl donors. Using the previously
established protocol for competitive glycosylations, two per-O-benzoylated glycosyl
donors, OBox 2.10 and SBox 2.43,15 were set to compete for a limited quantity of
glycosyl acceptor 2.21. Competitive glycosylations performed in the presence of 10 mol.
% of TMSOTf, AgOTf or Cu(OTf)2 all showed OBox donor 2.10 to be much more
reactive. This was judged by nearly complete recovery of the unreacted SBox donor 2.43
(Table 2.5). Similar observations were made in the competitive reaction between OBox
donor 2.10 and TCAI donor 2.44. Again, the OBox donor was more reactive under all of
the following activation conditions: TMSOTf (0.05 equiv.), AgOTf (0.1 equiv.), or
Bi(OTf)3 (0.03 equiv.), whereas TCAI donor 2.44 was recovered in 82-93% yield (Table
2.5).
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Table 2.5. OBox imidate 2.10 showed consistently higher reactivity in
comparison with SBox glycoside 2.43 and trichloroacetimidate 2.44

a
Glycosyl donors Conditions, temp. Yield of 2.45 Donor recovery
2.43: 93%
Method C, 0 oC
93%
2.43: 92%
Method E, rt
94%
2.10 + 2.43

2.10 + 2.44

Method F, rt

99%

2.43: 95%

Method C,b -78 oC

96%

2.44: 87%

Method E, rt

91%

2.44: 82%

Method G, rt

90%

2.44: 93%

a

– Method C: TMSOTf (0.1 equiv. to donor), molec. sieves 4Å, ClCH2CH2Cl; Method
E: Cu(OTf)2 (0.1 equiv. to donor), molec. sieves 4Å, ClCH2CH2Cl; Method F: AgOTf
(0.1 equiv. to donor), molec. sieves 4Å, ClCH2CH2Cl; Method G: Bi(OTf)3 (0.03 equiv.
to donor), molec. sieves 4Å, ClCH2CH2Cl, rt; b – 0.05 equiv. of TMSOTf was used
Polymer-supported synthesis is very attractive because it allows for rapid synthesis of
oligosaccharide sequences without the necessity of purifying (and characterizing) the
intermediates.54,55 On achieving a series of solution-based experiments, we decided to
investigate possible beneficial effects of using highly reactive OBox imidates in
glycosylations on polymer support using our recently developed HPLC-assisted
automated technology.56

This experimental setup based on an unmodified HPLC
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instrument was executed as follows. The Omnifit SolventPlus chromatography glass
column was loaded with the resin-bond glycosyl acceptor. The loaded column was
connected to the HPLC and solutions of glycosyl donor and promoter in CH2Cl2 were
then delivered concomitantly using different heads of the multi-headed HPLC pump.
Upon completion of glycosylation, as judged by the HPLC detector, the resulting
disaccharide can be cleaved off from the polymer support or the oligosaccharide
sequencing can be continued as desired.
In this particular application, Tentagel resin-bound glycosyl acceptor 2.46,56 attached
via the anomeric center, was loaded into the Omnifit column, which was connected to the
HPLC equipment (Scheme 2.1). Reagent bottles, one containing a 22 mM solution of
glycosyl donor 2.10 in CH2Cl2 and another one containing a 27 mM solution of TMSOTf
in CH2Cl2 were connected to inlets for pumps A and B, respectively. Pumps A/B were
then programmed to deliver the mixed solution of donor/promoter concomitantly in the
ratio of 4/1 (v/v) at the total flow rate of 0.3 mL/min. Upon exiting the column, a solution
containing unreacted donor and promoter was collected in a separate vial that would be
subsequently used as a recirculating chamber connected to Pump C. Upon consumption
of the fresh solution of glycosyl donor 2.10 (10 equiv., ~20 min), Pump A was switched
to Pump C connected to the recirculating chamber (80%), while Pump B continued to
deliver fresh TMSOTf (20%) at a combined flow rate of 0.3 mL/min for 10 min. After
that, Pump C was set to 100% flow rate and the information about the consumption of
donor 2.10 and accumulation of the corresponding hemiacetal, the product of the
competing hydrolysis, was acquired by periodic monitoring of the solution phase by
TLC. Upon complete hydrolysis of glycosyl donor 2.10 (about 60 min of recirculation),
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pump C was stopped and the column was purged with CH2Cl2 (pump A, 2.0 mL/min) for
10 min. The formation of disaccharide 2.4756 was determined by cleaving off the sugar
molecule from the resin using 0.1 M solution of NaOCH3 in CH3OH/CH2Cl2 followed by
acetylation (Ac2O/pyridine). The treatment with the NaOCH3 solution can be performed
using either HPLC set-up directly or by transferring the resin into a separate flask and
performing conventional deprotection. Resultantly, product 2.47 was isolated in 79%
yield along with 2% of a monosaccharide product 2.4856 derived from the unreacted
acceptor 2.46.
Scheme 2.1. Exploratory study of the coupling efficiency of glycosyl donor 2.10 with
the polymer-bound acceptor 2.46
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2.3. Conclusions
We have discovered a new class of O-imidoyl glycosyl donors that were shown to be
more reactive than previously investigated O- and S-imidates. These donors can be
activated using a catalytic amount of a Lewis acid, as little as 3 mol %. High reactivity
profile of OBox imidates was confirmed in direct competitive experiments with known
glycosyl donors and was applied to HPLC-assisted glycosylation on polymer support.
Further application of OBox donors to automated oligosaccharide synthesis and
investigation of their structure-reactivity-stereoselectivity profile is underway in our
laboratories

2.4. Experimental Section

2.4.1. General Remarks
All reactions were conducted under argon with dry, freshly distilled solvents unless
otherwise noted. CH2Cl2, ClCH2CH2Cl, and acetone were distilled from CaH2 directly
prior to application. 2-Chlorobenzoxazole and 2-benzoxazolinone were used as is. AgOTf
was co-evaporated with toluene (3 x 10 mL) and dried for 2-3 h directly prior to
application. Cu(OTf)2 and Bi(OTf)3 were dried in vacuo for 3-4 h directly prior to use.
TMSOTf and SnCl4 were used as is. Molecular sieves (3 Å or 4 Å), used for reactions,
were crushed and activated overnight at 390 oC and then for 2-3 h at 390 oC prior to
application. Reactions were monitored by TLC on Kieselgel 60 F254 and the compounds
were detected by examination under UV light and by charring with 10% sulfuric acid in
methanol. Solvents were removed under reduced pressure at < 40

o

C. Column

chromatography was performed on silica gel 60 (70-230 mesh). Optical rotations were
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measured at ‘Jasco P-1020’ polarimeter. 1H-NMR spectra were recorded at 300MHz,
13

C-NMR spectra were recorded at 75MHz (Bruker Avance). The 1H chemical shifts are

referenced to the signal of the residual CHCl3 (δH = 7.27 ppm) for solutions in CDCl3.
The 13C chemical shifts are referenced to the central signal of CDCl3 (δC = 77.23 ppm) for
solutions in CDCl3. HRMS determinations were made with the use of JEOL MStation
(JMS-700) Mass Spectrometer.

Silver benzoxazol-2-olate (AgOBox, 2.16). A solution of 2-benzoxazolinone (HOBox,
2.0 g, 14.8 mmol) and NaOH (0.6 g, 14.8 mmol) in water (14 mL) was added dropwise to
a solution of AgNO3 (2.5 g, 14.8 mmol) in water (14 mL) and the resulting mixture was
stirred for 10 min at rt. The solid was filtered off and rinsed successively with water (10
mL), MeOH (3 mL), and water (10 mL). The solid was collected and dried in vacuo for
16 h to afford the title compound (3.3 g, 92% yield) as a brown solid. The title compound
can be stored for extended period of time but was additionally dried for 4-5 h directly
prior to application. Analytical data for 2.16: 1H-NMR (300 MHz): δ, 6.77 (t, 1H,
aromatic), 6.95 (m, 3H, aromatic);

13

C-NMR (75 MHz): δ, 107.2, 111.5, 118.3, 121.9,

142.5, 146.4, 163.3; UV: λmax = 274, 280 nm.

2.4.2. Synthesis of OBox glycosyl donors
Benzoxazolyl

2,3,4,6-tetra-O-acetyl-α,β-D-glucopyranoside

(2.2).

2-

Chlorobenzoxazole (79.5 μL, 0.7 mmol) and DBU (0.14 mL, 0.93 mmol) were added to a
stirring solution of 2,3,4,6-tetra-O-acetyl-α,β-D-glucopyranose25 (2.1, 0.16 g, 0.46 mmol)
in dry CH2Cl2 (1.6 mL) and the resulting mixture was stirred for 2 h at 0 oC. After that,
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the solid was filtered off and washed successively with CH2Cl2. The combined filtrate
(~60 mL) was washed with 1% aq. NaOH (2 x 20 mL), water (20 mL), and brine (20
mL). The organic phase was separated, dried with MgSO4, and concentrated in vacuo.
The residue was purified by column chromatography on silica gel (ethyl acetate - hexane
gradient elution) to obtain the title compound (187 mg, 85% yield) as a white foam.
Analytical data for α-2.2: Rf = 0.42 (ethyl acetate/hexanes, 1/1, v/v); [α]D22 +84.5 (c= 1.0,
CHCl3); 1H-NMR (300 MHz): δ, 2.04-2.11 (m, 12H, 4 x COCH3), 4.13 (m, 1H, H-6a),
4.30 (m, 2H, H-5, 6b), 5.25 (m, 2H, J2,3 = 9.9 Hz, J4,5 = 3.5 Hz, H-2, 4), 5.70 (dd, 1H,
J3,4 = 9.9 Hz, H-3), 6.57 (d, 1H, J1,2 = 3.5 Hz, H-1), 7.20-7.50 (m, 4H, aromatic), 7.44 (d,
1H, aromatic), 7.21-7.50 (m, 4H, aromatic) ppm; 13C-NMR (75 MHz): δ, 22.7 (x 4), 61.2,
67.6, 69.3, 69.5, 70.1, 96.7, 110.2, 118.6, 123.6, 124.7, 140.4, 148.4, 161.5, 169.4, 169.9,
170.1, 170.6; UV: λmax = 273, 279 nm; HR-FAB MS [M+Na]+ calculated for
C21H23NO11Na+ 488.1168, found 488.1168.

Benzoxazolyl

2,3,4,6-tetra-O-benzyl-α/β-D-glucopyranoside

(2.4).

2-

Chlorobenzoxazole (0.20 g, 1.9 mmol) and KOH (0.021 g, 0.37 mmol) were added to a
stirring solution of 2,3,4,6-tetra-O-benzyl-α/β-D-glucopyranose (2.3, 0.2 g, 0.37 mmol) in
acetone (4.0 mL) and the resulting mixture was stirred for 3 h at 0 oC. After that, the solid
was filtered off and washed successively with CH2Cl2. The combined filtrate (~60 mL)
was washed with water (3 x 20 mL). The organic phase was separated, dried with
MgSO4, and concentrated in vacuo. The residue was purified by column chromatography
on silica gel (ethyl acetate – hexanes gradient elution) to obtain the title compound (195
mg, 80% yield, α/β = 2.5/1) as a colorless syrup. Analytical data for α-2.4: Rf = 0.43
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(ethyl acetate/hexanes, 1/4, v/v); 1H-NMR (300 MHz): δ, 3.61 (dd, 1H, J5,6a = 1.6 Hz,
J6a,6b = 11.0 Hz, H-6a), 3.77 (m, 3H, H-2, 4, 6b), 4.00 (m, 1H, H-5), 4.11 (dd, 1H, J3,4 =
9.4 Hz, H-3), 4.48 (dd, 2H, 2J = 12.0 Hz, CH2Ph), 4.67 (dd, 2H, 2J = 10.7 Hz, CH2Ph),
4.73 (s, 2H, CH2Ph), 4.90 (dd, 2H, 2J = 10.9 Hz, CH2Ph), 6.47 (d, 1H, J1,2 = 3.3 Hz, H-1),
7.17-7.31 (m, 24H, aromatic) ppm;

13

C-NMR (75 MHz): δ, 68.1, 73.5, 73.7 (x 2), 75.4,

76.0, 76.8, 79.2, 81.6, 98.8, 110.0, 118.6, 123.2, 124.5, 127.9 (x 2), 128.0 (x 3), 128.1 (x
4), 128.2 (x 2), 128.6 (x 9), 137.6, 138.0, 138.3, 138.8, 141.0, 148.4, 162.3; UV: λmax =
270, 276 nm; HR-FAB MS [M+Na]+ calculated for C41H39NO7Na+ 680.2624, found
680.2624.

Benzoxazolyl

2,3,4,6-tetra-O-benzyl-α-D-mannopyranoside

(2.6).

2-

Chlorobenzoxazole (0.056 g, 0.37 mmol) and KOH (0.054 g, 0.96 mmol) were added to a
stirring solution of 2,3,4,6-tetra-O-benzyl-D-mannopyranose26 (2.5, 0.2 g, 0.37 mmol) in
acetone (4.0 mL) and the resulting mixture was stirred for 2 h at 0 oC. After that, the
solid was filtered off and washed successively with CH2Cl2. The combined filtrate (~60
mL) was washed with water (3 x 20 mL). The organic phase was separated, dried with
MgSO4, and concentrated in vacuo. The residue was purified by column chromatography
on silica gel (ethyl acetate - hexanes gradient elution) to obtain the title compound (122
mg, 50 % yield) as a colorless syrup. Analytical data for 2.6: Rf = 0.4 (ethyl
acetate/hexanes, 1/4, v/v); [α]D21 +36.2 (c= 1.0, CHCl3); 1H-NMR (300 MHz): δ, 3.65
(dd, 1H, J5,6b =1.8 Hz, J6a,6b = 11.2 Hz, H-6b), 3.74 (dd, 1H, J5,6a = 4.4 Hz, H-6a), 3.903.97 (m, 3H, J3,4 = 9.4 Hz, H-2, 3, 5), 4.09 (dd, 1H, J4,5 = 9.4 Hz, H-4), 4.50 (dd, 2H, 2J =
12.0 Hz, CH2Ph), 4.54 (dd, 2H, 2J = 11.7 Hz, CH2Ph), 4.65 (dd, 2H, 2J = 10.8 Hz,
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CH2Ph), 4.74 (dd, 2H, 2J = 12.3 Hz, CH2Ph), , 6.36 (d, 1H, J1,2 = 1.9 Hz, H-1), 7.11-7.51
(m, 24H, aromatic) ppm;

13

C-NMR (75 MHz): δ, 68.90, 72.68, 72.97, 73.51, 73.64,

74.21, 75.01, 75.36, 79.21, 99.56, 110.04, 118.66, 123.36 (x 2), 124.60 (x 2), 127.66 (x
2), 127.97 (x 2), 128.03 (x 2), 128.14 (x 2), 128.22 (x 2), 128.47 (x 2), 128.55 (x 2),
137.89 (x 2), 138.29 (x 2), 138.43 (x 2), 138.47 (x 2), 141.03, 148.54, 161.60; HR-FAB
MS [M+Na]+ calculated for C41H39NO7Na+ 680.2624, found 680.2626.

3,4,6-Tri-O-acetyl-1,2-O-(1-benzoxazolyloxyethylidene)-α-D-glucopyranose (2.8). A
mixture of 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide27 (2.7, 0.50 g, 1.2 mmol)
and freshly activated molecular sieves (3Å, 1.5 g) in dry CH2Cl2 (5.0 mL) was stirred
under argon for 1 h at rt. After that, AgOBox (2.16, 0.59 g, 2.43 mmol) was added and
the resulting mixture was stirred for 1.5 h at 40 oC. The solid was filtered off and rinsed
successively with CH2Cl2. The combined filtrate (~100 mL) was washed with 1% aq.
NaOH (2 x 40 mL), water (2 x 40 mL), and brine (40 mL). The organic phase was
separated, dried with MgSO4, and concentrated in vacuo. The residue was purified by
column chromatography on silica gel (ethyl acetate-hexanes gradient elution) to afford
the title compound (447 mg, 79% yield) as a pale-yellow foam. Analytical data for 2.8: Rf
= 0.5 (ethyl acetate/hexanes, 1/1, v/v); [α]D26 -3.7 (c = 1.0, CHCl3); 1H-NMR (300 MHz):
δ, 2.08, 2.10, 2.13, 2.15 (4 s, 12H, 4 x COCH3), 4.06 (m, 1H, H-5), 4.25-4.28 (m, 3H, J2,3
= 2.4 Hz, H-2, 6a, 6b), 4.95 (dd, 1H, J4,5 = 9.5 Hz, H-4), 5.32 (dd, 1H, J3,4 = 2.4 Hz, H-3),
5.82 (d, 1H, J1,2 = 5.3 Hz, H-1), 7.10-7.47 (m, 4H, aromatic) ppm; 13C-NMR (75 MHz):
δ, 20.7, 20.8, 20.9, 22.4, 63.0, 67.3, 68.0, 69.3, 73.1, 97.5, 110.2, 111.7, 113.5, 124.0,
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124.4, 129.4, 142.5, 151.6, 169.0, 169.7, 170.7 ppm; UV: λmax = 274, 280 nm; HR-FAB
MS [M+Na]+ calculated for C21H23NO11Na+ 488.1168, found 488.1170.

Benzoxazolyl 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranoside (2.10).

A mixture of

2,3,4,6-tetra-O-benzoyl-α-D-glucopyranosyl bromide29 (2.9, 0.40 g, 0.56 mmol) and
freshly activated molecular sieves (3Å, 1.2 g) in dry CH2Cl2 (4.0 mL) was stirred under
argon for 1 h at rt. After that, AgOBox (2.16, 0.20 g, 0.84 mmol), 2,6-lutidine (0.09 g,
0.84 mmol), and tetrabutylammonium iodide (TBAI, 0.012 g, 0.033 mmol) were added
and the resulting mixture was stirred for 10 h at rt. The solid was filtered off and rinsed
successively with CH2Cl2. The combined filtrate (~60 mL) was washed with 1% aq.
NaOH (2 x 20 mL), water (2 x 20 mL), and brine (20 mL). The organic phase was
separated, dried with MgSO4, and concentrated in vacuo. The residue was purified by
column chromatography on silica gel (ethyl acetate-hexanes gradient elution) to afford
the title compound (0.36 g, 83% yield) as a pale-yellow amorphous solid. Analytical data
for 2.10: Rf = 0.46 (ethyl acetate/hexanes, 2/3, v/v); [α]D26 +35.9 (c= 1.0, CHCl3); 1HNMR (300 MHz): δ, 4.50 (m, 2H, J5,6a = 3.2 Hz, H-5, 6a), 4.70 (dd, 1H, J5,6b = 1.5 Hz,
H-6b), 5.76 (m, 1H, J2,3 = 5.5 Hz, H-2), 5.87 (dd, 1H, J4,5 = 4.6 Hz, H-4), 6.03 (dd, 1H,
J3,4 = 9.2 Hz, H-3), 6.38 (d, 1H, J1,2 = 7.6 Hz, H-1), 7.15-7.92 (m, 24H, aromatic), ppm;
13

C-NMR: δ, 62.6, 68.9, 70.9, 72.5, 73.4, 98.7, 110.2, 118.5, 123.6 (x 2), 124.6 (x 2),

128.4 (x 2), 128.4 (x 2), 128.5 (x 4), 128.6, 129.5, 129.8 (x 2), 129.9 (x 4), 130.0 (x 2),
133.1, 133.5, 133.6 (x 2), 140.4, 148.5, 161.6, 164.9, 165.1, 165.7, 166.1 ppm; HR-FAB
MS [M+Na]+ calculated for C41H31NO11Na+ 736.1795, found 736.1794.
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Benzoxazolyl 2,3,4,6-tetra-O-benzoyl-β-D-galactopyranoside (2.12). A mixture of
2,3,4,6-tetra-O-benzoyl-α-D-galactopyranosyl bromide30 (2.11, 0.20 g, 0.28 mmol) and
freshly activated molecular sieves (3Å, 0.6 g) in dry CH2Cl2 (2.0 mL) was stirred under
argon for 1 h at rt. After that, AgOBox (2.16, 0.10 g, 0.42 mmol), 2,6-lutidine (0.045 g,
0.42 mmol), TBAI (0.006 g, 0.016 mmol) were added and the resulting mixture was
stirred for 3 h at rt. The solids were filtered off and rinsed successively with CH2Cl2. The
combined filtrate (~40 mL) was washed with 1% aq. NaOH (2 x 10 mL), water (2 x 10
mL), and brine (10 mL). The organic phase was separated, dried with MgSO4, and
concentrated in vacuo. The residue was purified by column chromatography on silica gel
(ethyl acetate-hexanes gradient elution) to afford the title compound (177 mg, 82% yield)
as a yellow foam. Analytical data for 2.12: Rf = 0.50 (ethyl acetate/hexanes, 2/3, v/v);
[α]D26 +81.5 (c = 1.0, CHCl3); 1H-NMR (300 MHz): δ, 4.51 (m, 1H, J5,6a = 5.2 Hz, J6a,6b =
9.6 Hz, H-6a), 4.68 (m, 2H, J5,6b = 6.8 Hz, H-5, 6b), 5.78 (dd, 1H, J3,4 = 3.4 Hz, H-3),
6.14 (m, 2H, J2,3 = 10.2 Hz, H-2, 4), 6.39 (d, 1H, J1,2 = 8.0 Hz, H-1), 7.19-8.13 (m, 24H,
aromatic), ppm; 13C-NMR (75 MHz): δ, 61.8, 67.7, 68.8, 71.6, 72.6, 99.1, 110.2, 118.5,
123.6, 124.6, 128.6 (x 6), 128.7, 128.8 (x 4), 129.3, 129.9 (x 4), 129.9 (x 2), 130.1 (x 2),
133.3, 133.5, 133.6, 133.8, 140.4, 148.5, 161.7, 165.1, 165.5 (x 2), 166.0 ppm; HR-FAB
MS [M+Na]+ calculated for C41H31NO11Na+ 736.1795, found 736.1800.

Benzoxazolyl 2,3,4,6-tetra-O-benzoyl-α-D-mannopyranoside (2.14).

A mixture of

2,3,4,6-tetra-O-benzoyl-α-D-mannopyranosyl bromide31 (2.13, 0.20 g, 0.28 mmol) and
freshly activated molecular sieves (3Å, 0.6 g) in dry CH2Cl2 (2.0 mL) was stirred under
argon for 1 h at rt. After that, AgOBox (2.16, 0.10 g, 0.42 mmol), 2,6-lutidine (0.045 g,
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0.42 mmol), and TBAI (0.006 g, 0.016 mmol) were added and the resulting mixture was
stirred for 1.5 h 45 oC. The solid was filtered off and rinsed successively with CH2Cl2.
The combined filtrate (~40 mL) was washed with 1% aq. NaOH (2 x 10 mL), water (2 x
10 mL), and brine (10 mL). The organic phase was separated, dried with MgSO4, and
concentrated in vacuo. The residue was purified by column chromatography on silica gel
(ethyl acetate-hexanes gradient elution) to afford the title compound (175.2 mg, 81%
yield) as a white foam. Analytical data for 2.14: Rf = 0.44 (ethyl acetate/hexanes, 3/7,
v/v); [α]D22 +0.62 (c = 1.0, CHCl3); 1H-NMR (300 MHz): δ, 4.50 (dd, 1H, J5,6a = 4.9 Hz,
J6a,6b = 12.9 Hz, H-6a), 4.68 (dd, 1H, J5,6b = 2.4 Hz, H-5, 6b), 6.04 (dd, 1H, J2,3 = 2.0 Hz,
H-2), 6.09 (dd, 1H, J3.4 = 10.0 Hz, H-3), 6.25 (dd, 1H, J4,5 = 9.9 Hz, H-4), 6.64 (d, 1H,
J1,2 = 1.9 Hz, H-1), 7.25-8.08 (m, 24H, aromatic), ppm;
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C-NMR (75 MHz): δ, 62.3,

66.0, 68.8, 69.4, 71.3, 97.7, 110.1, 118.9, 123.7, 124.7, 128.4 (x 3), 128.6 (x 3), 128.7 (x
3), 128.8 (x 2), 129.7, 129.7 (x 2), 129.8 (x 2), 129.9 (x 2), 130.0 (x 2), 133.1, 133.5,
133.7, 133.8, 140.5, 148.6, 160.8, 165.1, 165.3, 165.5, 166.0 ppm; HR-FAB MS
[M+Na]+ calculated for C41H31NO11Na+ 736.1795, found 736.1769.

2,3,4,6-Tetra-O-benzoyl-α-D-glucopyranosyl

trichloroacetimidate

(2.44).

This

compound was obtained from 2,3,4,6-tetra-O-benzoyl-α/β-D-glucopyranose57 by method
previously described58 in 83% yield as a white foam. Analytical data for 2.44: Rf = 0.44
(ethyl acetate/hexanes, 3/7, v/v); [α]D27 +76.6 (c= 1.0, CHCl3); 1H-NMR (300 MHz): δ,
4.49 (dd, 1H, J5,6a = 5.4 Hz, J6a,6b = 12.8 Hz, H-6a), 4.64 (m, 2H, J5,6b = 2.6 Hz, H-5, 6b),
5.62 (dd, 1H, J2,3 = 9.8 Hz, H-2), 5.83 (dd, 1H, J4,5 = 9.8 Hz, H-4), 6.28 (dd, 1H, J3,4 =
9.8 Hz, H-3), 6.84 (d, 1H, J1,2 = 3.7 Hz, H-1), 7.26-8.17 (m, 20H, aromatic), 8.64 (s, 1H,

107

-NH) ppm; 13C-NMR (75 MHz): δ, 62.7, 68.8, 70.4, 70.9, 90.9, 93.3, 128.6 (x 5), 128.7
(x 5), 128.8 (x 1), 129.0, 129.7, 129.9 (x 2), 130.0 (x 5), 133.4, 133.5, 133.8 (x 2), 160.7,
165.4, 165.6, 165.9, 166.3; HR-FAB MS [M+Na]+ calculated for C36H28Cl3NO10Na+
762.0676, found 762.0671.

2.4.3. General glycosylation procedures
Method A. Typical MeOTf-promoted glycosylation procedure: A mixture of glycosyl
donor (0.13 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular
sieves (3 Å, 90 mg) in 1,2-dichloroethane (0.5 mL) was stirred under argon for 1 h at rt.
The mixture was cooled to -20 oC, MeOTf (0.013 mmol) was added and the resulting
mixture was stirred for 15 min. The solids were filtered off through a pad of Celite and
rinsed successively with CH2Cl2. The combined filtrate (~30 mL) was washed with 1%
aq. NaOH (2 x 5 mL) and water (2 x 5 mL). The organic phase was separated, dried with
MgSO4, and concentrated in vacuo. The residue was purified by column chromatography
on silica gel (ethyl acetate - hexanes gradient elution) to obtain the respective
disaccharide in a yield listed in Table 2.3.

Method B. Typical TfOH-promoted glycosylation procedure: A mixture of glycosyl
donor (0.13 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular
sieves (4 Å, 90 mg) in 1,2-dichloroethane (0.5 mL) was stirred under argon for 1 h at rt.
The mixture was cooled to -20 oC, TfOH (0.013 mmol) was added and the resulting
mixture was stirred for 10 min. The solids were filtered off through a pad of Celite and
rinsed successively with CH2Cl2. The combined filtrate (~30 mL) was washed with 1%
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aq. NaOH (2 x 5 mL) and water (2 x 5 mL). The organic phase was separated, dried with
MgSO4, and concentrated in vacuo. The residue was purified by column chromatography
on silica gel (ethyl acetate - hexanes gradient elution) to obtain the respective
disaccharide in a yield listed in Table 2.3.

Method C. Typical TMSOTf-promoted glycosylation procedure: A mixture of glycosyl
donor (0.12 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular
sieves (4Å, 90 mg) in 1,2-dichloroethane (0.5 mL) was stirred under argon for 1 h at rt.
On most occasions (see Table 2.3) the mixture was cooled to -78 oC, TMSOTf (0.012
mmol) was added and the resulting mixture was stirred for 5-15 min. The solids were
filtered off through a pad of Celite and rinsed successively with CH2Cl2. The combined
filtrate (~30 mL) was washed with 1% aq. NaOH (2 x 5 mL) and water (2 x 5 mL). The
organic phase was separated, dried with MgSO4, and concentrated in vacuo. The residue
was purified by column chromatography on silica gel (ethyl acetate - hexanes gradient
elution) to obtain the respective disaccharide in a yield listed in Table 2.3.

Method D. Typical SnCl4-promoted glycosylation procedure: A mixture of glycosyl
donor (0.12 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular
sieves (4 Å, 90 mg) in 1,2-dichloroethane (0.5 mL) was stirred under argon for 1 h at rt.
After that, SnCl4 (0.012 mmol) was added and the resulting mixture was stirred for 5-15
min at rt (Table 2.3). The solids were filtered off through a pad of Celite and rinsed
successively with CH2Cl2. The combined filtrate (~30 mL) was washed with 1% aq.
NaOH (2 x 5 mL) and water (2 x 5 mL). The organic phase was separated, dried with
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MgSO4, and concentrated in vacuo. The residue was purified by column chromatography
on silica gel (ethyl acetate - hexane gradient elution) to obtain the respective disaccharide
in a yield listed in Table 2.4.

2.4.4. General procedures for competitive glycosylations
Method E. Typical Cu(OTf)2-promoted glycosylation procedure: A mixture of glycosyl
donor A (0.12 mmol), glycosyl donor B (0.12 mmol), glycosyl acceptor (0.10 mmol), and
freshly activated molecular sieves (4Å, 90 mg) in 1,2-dichloroethane (0.5 mL) was stirred
under argon for 1 h at rt. After that, Cu(OTf)2 (0.012 mmol) was added and the resulting
mixture was stirred for 5 min. The solids were filtered off through a pad of Celite and
rinsed successively with CH2Cl2. The combined filtrate (~30 mL) was washed with 1%
aq. NaOH (2 x 5 mL) and water (2 x 5 mL). The organic phase was separated, dried with
MgSO4, and concentrated in vacuo. The residue was purified by column chromatography
on silica gel (ethyl acetate - hexane gradient elution) to obtain the respective disaccharide
in a yield listed in Table 2.5.

Method F. Typical AgOTf-promoted glycosylation procedure: A mixture of glycosyl
donor A (0.12 mmol), glycosyl donor B (0.12 mmol), glycosyl acceptor (0.10 mmol), and
freshly activated molecular sieves (4Å, 90 mg) in 1,2-dichloroethane (0.5 mL) was stirred
under argon for 1 h at rt. After that, AgOTf (0.012 mmol) was added and the resulting
mixture was stirred for 10 min. The solids were filtered off through a pad of Celite and
rinsed successively with CH2Cl2. The combined filtrate (~30 mL) was washed with 1%
aq. NaOH (2 x 5 mL) and water (2 x 5 mL). The organic phase was separated, dried with
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MgSO4, and concentrated in vacuo. The residue was purified by column chromatography
on silica gel (ethyl acetate - hexane gradient elution) to obtain the respective disaccharide
in a yield listed in Table 2.5.

Method G. Typical Bi(OTf)3-promoted glycosylation procedure: A mixture of glycosyl
donor A (0.12 mmol), glycosyl donor B (0.12 mmol), glycosyl acceptor (0.10 mmol), and
freshly activated molecular sieves (4Å, 90 mg) in 1,2-dichloroethane (0.5 mL) was stirred
under argon for 1 h at rt. After that, Bi(OTf)3 (0.004 mmol) was added and the resulting
mixture was stirred for 10 min. The solids were filtered off through a pad of Celite and
rinsed successively with CH2Cl2. The combined filtrate (~30 mL) was washed with 1%
aq. NaOH (2 x 5 mL) and water (2 x 5 mL). The organic phase was separated, dried with
MgSO4, and concentrated in vacuo. The residue was purified by column chromatography
on silica gel (ethyl acetate - hexane gradient elution) to obtain the respective disaccharide
in a yield listed in Table 2.5.

2.4.5. HPLC-mediated synthesis of disaccharide 40
General procedure for HPLC-mediated glycosylation of 2.46 with glycosyl donor 2.10.
A solution of glycosyl donor 10 (78.5 mg, 0.11 mmol, pump A, percentage flow: 80%) in
CH2Cl2 (5.0 mL) and a solution of TMSOTf (11 μL, 0.055 mmol, pump B, percentage
flow: 20%) in CH2Cl2 (2.0 mL) were passed concomitantly through a column containing
resin-bound acceptor (50 mg, 0.011 mmol) at the combined flow rate of 0.3 mL min−1
for 20 min. The pump A was then switched to pump C (recirculating chamber, percentage
flow: 80%) while pump B remained the same (TMSOTf soln., percentage flow: 20%) and
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the resulting solutions were passed concomitantly through a column with the combined
flow rate of 0.3 mL min−1 for 10 min. After that, the system was switched to pump C
(recirculating chamber, percentage flow 100%) and the solution was recirculated at a
flow rate of 0.3 mL min−1 for 1 h. Pump C was stopped and the column was purged with
CH2Cl2 (pump A, 2.0 mL min−1) for 10 min.

Procedure for cleavage of sugar from resin. A 1 M solution of sodium methoxide in
methanol (0.3 mL) was added to a suspension or a mixture of resin in methanol (2.0 mL)
and the resulting mixture was kept for 24 h at rt. After that, the reaction mixture was
neutralized with Dowex H+ resin. The resin was filtered off and rinsed successively with
MeOH (10 × 5 mL). The combined filtrate (∼50 mL) was separated, dried with MgSO4,
concentrated in vacuo, and dried. The crude product obtained from this step was then
acetylated according to the procedure described below.

Acetylation of the crude product. Ac2O (0.3 mL) was added to a solution of the crude
deacylated product (∼19.7 mg, 0.0079 mmol) in pyridine (0.5 mL) and the resulting
mixture was stirred under argon for 16 h at rt. The reaction mixture was quenched by the
addition of CH3OH (∼1.0 mL). The volatiles were evaporated under reduced pressure
and the residue was co-evaporated with toluene (3 × 5 mL). The resulting residue was
purified by column chromatography on silica gel (ethyl acetate–hexanes gradient elution)
to afford the corresponding disaccharide 2.47 in 79% yield.
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Chapter 3
Regenerative Glycosylation
under Nucleophilic Catalysis
with HOFox

Swati S. Nigudkar, Keith J. Stine, and Alexei V. Demchenko. Regenerative glycosylation
under nucleophilic catalysis, J. Am. Chem. Soc., 2014, 136, 921-923.

3.1. Introduction
Practically all complex carbohydrates have an oligomeric sequence wherein
monosaccharide residues are linked via glycosidic linkages.1 Both simple methods and
sophisticated strategies for glycoside synthesis and oligosaccharide assembly exist.2,3
However, the complexity of glycosylation reactions4-7 is responsible for many drawbacks
that all current methods experience. In spite of significant progress, chemical
glycosylation remains challenging due to the requirement to achieve complete
stereocontrol and to suppress side reactions.8 Amongst a plethora of leaving groups
developed, a vast majority of glycosylations make use of thioglycosides9-12 and Otrichloroacetimidates (TCAI).13-15 Our laboratory has also been developing new leaving
groups for chemical glycosylation.16,17 For instance, we developed S-benzoxazolyl
(SBox) donors18 and more recently introduced O-benzoxazolyl (OBox) imidates,19 which
represent a hybrid structure between SBox and TCAI (Scheme 1), but it is more reactive
than either.
Scheme 3.1. O-Imidates, established and new.

Since the early days, stereoselective formation of glycosidic linkages has been the main
challenge and the driving force for innovations in the area of carbohydrate chemistry.
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Among a plethora of methods developed, glycosyl trichloroacetimidates (TCAI)
introduced by Schmidt in 1980,20 exhibit excellent glycosyl donor properties and often
lead to high stereocontrol during glycosidation.2 Despite their usefulness as glycosyl
donors, the high reactivity and poor stability sometimes result in low yields during
preparation, isolation, and glycosidation with TCAI.13-15,21,22 As a modification to this
approach, Yu reported glycosyl N-phenyl trifluoroacetimidates (PTFAI) as a new class of
glycosyl donors.23,24 Practically at the same time, Iadonisi and co-workers also reported
the use of PTFAI as glycosyl donors.25,26 These O-imidates showed similar properties in
terms of their reactivity in glycosylations, but also showed improved stability and higher
reaction yields in comparison to those with TCAI.27
As described in Chapter 2, we introduced O-benzoxazolyl (OBox) imidates that also
fall into this generic category of O-imidoyl glycosyl donors.

19

OBox imidates showed

higher reactivity profile than similarly structured TCAI counterparts. However it lacked
stability, which complicated its handling and reduced its shelf-life. Thus, with an aim of
expanding the arsenal of heterocyclic O-imidates with enhanced glycosyl donor
properties, herein we describe the investigation of novel 3,3-difluoro-3H-indol-2-yl
(OFox) imidates.

3.2. Results and discussion
3.2.1. The synthesis of OFox glycosides
3,3-Difluoroxindole aglycone (HOFox) was readily synthesized by reacting
commercially available Isatin with a slight excess of DAST in anhydrous CH2Cl2 at room
temperature.28 The 3,3-difluoroxindole group was then introduced at the anomeric
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position by reaction of HOFox with different glycosyl halides (X = Br, Cl), used either
directly or obtained in situ from the corresponding hemiacetals or esters, as suitable
starting materials (Table 3.1). It was observed that almost all anomeric substitutions
proceeded stereoselectively providing corresponding 1,2-trans or 1,2-cis-linked OFox
imidates in 60-85% yields. Additionally, the synthesis of OFox glycosides was free of
side reactions such as formation of N-glycosides or 1,2-dehydro derivatives (glycals).29
As starting materials, a series of differentially protected glucosyl halides bearing arming
(3.1), disarming (3.7, 3.9), and superdisarming (3.5) protecting group patterns have been
investigated. The synthesis of common D-galacto (3.12), D-manno (3.4 and 3.14) and
azido (3.14) OFox glycosyl donors was also performed. The formation of OFox imidates
was confirmed by changes in the 19F values from -112.4 ppm for 3,3-difluoro-2-oxindole
to -121 to -122 ppm for the coupled product.30

3.2.2. Comparative investigation of O-imidates 3.2, 3.17 and 3.18
After synthesizing a variety of OFox imidates, we turned our focus to studying their
properties in glycosylation reactions and stability under various acidic reaction
conditions. These studies of OFox glycosyl donors were conducted as a comparison with
similarly protected TCAI and PTFAI. It has been previously demonstrated that the
activation of TCAI and PTFAI donors can be accomplished in the presence of the
catalytic amount of promoters including TMSOTf,21 BF3OEt2,15 p-TsOH,20 Bi(OTf)3,31
Yb(OTf)3,32 Sm(OTf)3,32 and AgOTf33 Among these, TMSOTf and BF3-OEt2 are
arguably the most commonly used promoters. Hence our initial focus has been centered
on examining the effect of these activators on OFox glycosides.
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Table 3.1. Synthesis of 3,3-difluoro-3H-indol-2-yl (OFox) imidates

Entry

Starting
material

Conditions,a
temp, time

Product

Yield, α/β ratio

1

A, rt, 8 h

62%, 10/1

2

A, rt, 12 h

61%, α only

3

B, 0 oC, 40 min

80%, β only

B, rt, 5 h

81%, α only

5

C, rt, 6 h

80%, α only

6

B, rt, 10 h

75%, α only

7

D, 0 oC to rt, 6
h

75%, β only

8

D, rt, 2.5 h

84%, α only

9

B, 0 oC to rt, 3
h

70%, β only

4

3.5

a

– Conditions: A: i) SOCl2, DMF, CH2Cl2, ii) 3,3-difluoroxindole, Ag2O, DIPEA,
CH2Cl2; B: 3,3-difluoroxindole, Ag2O, DIPEA, CH2Cl2; C: 3,3-difluoroxindole, Ag2O,
DIPEA, toluene; D: i) 33% HBr/AcOH, CH2Cl2, ii) 3,3-difluoroxindole, Ag2O, DIPEA,
CH2Cl2.
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A comparative study of different O-imidates as glycosyl donors in TMSOTf-promoted
glycosylations is summarized in Table 3.2. Thus, coupling of glycosyl donors 3.2, 3.16,
3.17 with acceptor 3.18 produced disaccharide 3.19 in 5 min either at -78 oC or ambient
temperature in comparable yields and stereoselectivities. Similar results were obtained in
BF3-OEt2 promoted glycosylations. A further exploratory study of OFox imidates
dedicated to investigating various factors that affect stereoselectivity and reactivity of
these glycosyl donors was conducted and will be described in the following subchapter.
Table 3.2. Comparative investigation of glycosylations with O-imidates 3.2, 3.17,
and 3.18 in the presence of TMSOTf

Entry

Donor

Temp

Yield of 3.20

Ratio, α/β

1

3.17

-78 oC

92%

1/15

2
3
4
5
6

3.17
3.18
3.18
3.2
3.2

rt
-78 oC
rt
-78 oC
rt

94%
70%
91%
94%
93%

4.0/1
1/4.4
1/2.2
1/24
1/1.2

For conducting the comparative hydrolytic stability studies, per-benzoylated OFox
glycosyl donor 3.10 was compared with 2,3,4,6-tetra-O-benzoyl-α-D-glucopyranosyl
trichloroacetimidate

3.21

and

2,3,4,6-tetra-O-benzoyl-α,β-D-glucopyranosyl

N-

phenyltrifluoroacetimidate 3.22. These studies summarized in Table 3.3 were performed
in the presence of various Lewis acids in wet ClCH2CH2Cl. A mixture of imidate (3.10,
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3.21, or 3.22, 0.01 mmol), activator (conditions A-D, 0.013 mmol, Table 3.3) in
ClCH2CH2Cl/H2O (0.5 mL, 500/1, v/v) was stirred for 24 h at rt. Quantitative estimates
were made at 1, 16 and 24 h time points and are based on the accumulation of 2,3,4,6tetra-O-benzoyl-D-glucopyranose 3.23, as observed by TLC (Rf = 0.45, ethyl
acetate/hexanes, 3/7, v/v). Among these, the first procedure involved hydrolysis in the
presence of BF3-OEt2 as the activator (Table 3.3, entries 1-3).
Table 3.3. Comparative hydrolytic stability study of OFox imidates, TCAI, and
PTFAI under various reaction conditions.

% of hemiacetal 3.23 formed after
1h
16 h
24 h
1
A
quant.
quant.
quant.
3.10
2
A
50
60
60
3.21
3
A
40
50
50
3.22
4
B
0
0
0
3.10
5
B
0
0
0
3.21
6
B
0
0
0
3.22
7
C
0
quant.
quant.
3.10
8
C
0
0
20
3.21
9
C
0
0
0
3.22
10
D
0
0
50
3.10
11
D
0
10
quant.
3.21
12
D
0
70
quant.
3.22
a
Conditions: A: BF3-OEt2 (0.1 equiv.); B: Bi(OTf)3 (0.1equiv.); C: MeOTf (1.0 equiv.);
D: PdCl2 (0.1 equiv.)
Entry

Donor

Conditionsa
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Under these reaction conditions, OFox imidate 3.10 underwent a nearly quantitative
hydrolysis in 5 min, whereas their TCAI (3.21) PTFAI (3.22) counterparts showed 50%
and 40% hydrolysis, respectively, in 5 min or even after 24 h of reaction. Yields listed in
Table 3.3 are estimated based on TLC. On the other hand, practically no hydrolysis in
cases of all three imidates took place in the presence of Bi(OTf)3 (0.1 equiv., entries 4-6).
In a similar series of experiments, we determined that PTFAI 3.22 could be reliably
differentiated from the OFox donor 3.10 and TCAI counterpart 3.21 under MeOTfmediated activation conditions (entries 7-9). Conversely, we found out that PdCl2
mediated reactions OFox donor 3.10 and TCAI donor 3.21 are more stable than their
PTFAI counterpart 3.22 (entries 12-14).

3.2.4. Glycosidation of OFox donors: optimization of the reaction conditions
Encouraged by the observed selectivity and overall high reactivity of OFox imidates,
we planned on exploring the effect of different experimental conditions and factors
including the structure of glycosyl donor, glycosyl acceptor, activator, solvent, and
temperature on the reaction outcome.
The effect of solvents on the stereoselectivity of glycosidation has been studied for a
long time and resulted in a good level of understanding of the modes by which solvents
may affect the reaction. For instance, it has been shown that nitrilic solvents strongly
favor the formation of equatorial (β-D) glycosides, whereas ethereal solvents are often
beneficial for the synthesis of axial (α-D) glycosides. With the exploration of the solvent
effect on the stereoselectivity of glycosidation of OFox donors in mind, glycosylation in
CH2Cl2 was chosen as the benchmark. Along this study, we also investigated the
temperature effect of glycosylation with OFox imidates with the anticipation that low
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temperatures will favor the equatorial (kinetic) product, whereas high temperature would
be beneficial for axial (thermodynamic) product.
Thus,

glycosylation

of

3,3-difluoro-3H-indol-2-yl

2,3,4,6-tetra-O-benzyl-α/β-D-

glucopyranoside 3.2 with glycosyl acceptor 3.19 was performed in the presence of
TMSOTf (5 mol %) at -40 oC. Resultantly, disaccharide 3.20 was obtained in 97% yield
and good β-selectivity (α/β = 1/8.0, entry 1, Table 3.4). A notable improvement of
already commendable β-selectivity was achieved by changing the reaction solvent from
CH2Cl2 to CH3CN. Under these reaction conditions disaccharide 3.20 was obtained in
87% yield (α/β = 1/14, entry 2). Interestingly, when a solvent mixture of CH2Cl2/CH3CN
(1/2, v/v) was used a decrease in stereoselectivity was recorded (α/β = 1/6.0, entry 3).
Table 3.4. The effect of solvents and temperature on the stereoselectivity of
glycosidation of per-benzylated OFox donor 3.2.

Entry
1
2
3
4
5
6
7
8
9

Solvent
CH2Cl2
CH3CN
CH2Cl2/CH3CN
(1/2, v/v)
CH2Cl2

Temp Yield of 3.20 α/β ratio
-40 oC
97%
1/8.0
o
-40 C
87%
1/14
-40 oC

96%

1/6.0

-78 oC

94%

1/24

CH2Cl2/CH3CN/EtCN (1/2/1, v/v/v) -78 oC
EtCN
-78 oC
Et2O
-78 oC
Et2O
50 oC
THF
50 oC

99%
99%
84%
81%
79%

β only
β only
1/5.0
1.6/1
1.4/1
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The use of acetonitrile as the reaction solvent has its limitations because the reactions
cannot be cooled below -40 oC. Therefore, to achieve direct comparison of excellent βselectivity (α/β = 1/24, entry 4) obtained in CH2Cl2 at -78 oC we incorporated
propionitrile (EtCN) in our study. To our delight, when MeCN was used either as an
additive or neat, disaccharide 3.20 was obtained in a nearly quantitative yield and
complete β-stereoselectivity (entries 5 and 6). Along similar lines, the effect of diethyl
ether as the reaction solvent was also investigated. Since diethyl ether favors the
formation of α-glucosides, we observed dramatically reduced β-stereoselectivity in
reactions at -78 oC (α/β = 1/5.0, entry 7). The same reaction performed at higher
temperatures of 50 oC, gave disaccharide 3.20 with preferential α-stereoselectivity. (α/β =
1.6/1, entry 7). Similar results were obtained using THF as the reaction solvent.
A result of this study confirmed that OFox imidates adequately respond to the solvent
and temperature effects. A similar trend to that established for other classes of glycosyl
donors was also observed herein. As an expansion of this study we investigated whether
different Lewis acid activators would provide further enhancement of the OFox based
glycosylation method. A valuable insight into the mode of activation and departure of the
OFox leaving group would be another anticipated outcome of this study. A majority of
leaving groups in carbohydrate chemistry, even the most reactive ones, would not depart
on their own. Instead, the leaving group departure is typically affected via the interaction
with electrophilic promoters. Resultantly, the leaving group ability is further enhanced
and it departs as neutral species or a complex. For the glycosyl imidate series, the
activation can be affected directly, via the anomeric atom (oxygen or sulfur), or remotely,
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via the nitrogen atom (Figure 3.1). For instance, it has become common knowledge that
TCAI donors are activated via the remote nitrogen.
Figure 3.1. Direct vs. remote activation of S- and O-imidates.

In principle, the activation mode can be determined by means of isolation and
characterization of the departed aglycone that represents the leaving group-promoter
conjugate. As previously shown in our laboratory, S-thiazolinyl donors are activated via
the remote nitrogen.34 In strong contrast, bicyclic leaving groups SBox or OBox are
activated via the anomeric sulfur or oxygen atom, respectively (Figure 3.1).35 This is due
to the propensity of the benzoxazolyl group to retain the aromaticity of its heterocyclic
ring, which otherwise would have been disrupted if the activation were taking place via
the endocyclic nitrogen. In regards to the OFox imidates, the five-membered ring is nonaromatic, therefore, our working hypothesis was that the activation of the OFox leaving
group is affected via the remote nitrogen. Further experiments were dedicated to studying
various activators, designed with proving the viability of this hypothesis. However, since
all the reactions were done in 5-10 min in the presence of only catalytic amount of the
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promoter, the isolation of the departed leaving group as an elusive OFox-promoter
conjugate was proven impossible. Instead, only “free” HOFox could be isolated from the
reaction medium because the departed aglycone would release the activator. The latter
would be then available for the next catalytic cycle.
A study dedicated to the activation of OFox imidate 3.2 using common promoters for
the activation of imidate donors is summarized in Table 3.5. Glycosylations using
TMSOTf as the promoter have been used as the benchmark (entries 1 and 2). Using BF3OEt2, Cu(OTf)2 or MeOTf as promoters gave very comparable results (entries 3-5) to
those achieved with TMSOTf. All of these reactions proceeded with a nearly complete βselectivity for the formation of disaccharide 3.20, which is rather unusual for benzylated
glycosyl donors.
Table 3.5. The effect of promoter on the stereoselectivity of glycosidation of perbenzylated OFox donor 3.2 with acceptor 3.19
Entry
Promoter (equiv.)
Temp, time
Yield of 3.20 α/β ratio
o
1
TMSOTf (0.05 equiv.)
-78 C, 5 min
94%
1/24
a
o
2
TMSOTf (0.05 equiv.)
-78 C, 10 min
84%
1/5.0
3
BF3-OEt2 (0.1 equiv.)
-78 oC, 5 min
93%
1/20
o
4
Cu(OTf)2 (0.2 equiv.)
-78 C, 5 min
97%
β only
o
5
MeOTf (0.2 equiv.)
-78 C, 10 min
91%
1/>25
6
AgOTf (0.5 equiv.)
rt, 24 h
71%
1/1.6
7
PdCl2 (0.3 equiv.)
rt, 36 h
57%
1/1.7
o
8
Bi(OTf)3 (0.1 equiv.)
-78 C, 5 min
85%
1/7
a
9
TMSClO4 (0.1 equiv.)
rt, 5 min
75%
5.0/1
10
TMSClO4 (0.1 equiv.)b
rt, 5 min
54%
6.2/1
a
- Et2O was used as the reaction solvent
b
- A mixture of Et2O/1,4-dioxane (1/1, v/v) was used as the reaction solvent
When metal salt-based promoters AgOTf or PdCl2 were used, the reactions became
much slower, did not proceed to completion even in 24-36 h, and stereoselectivity also
dropped (entries 6 and 7). Bi(OTf)3-promoted reactions were swift (entry 8), but the
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stereoselectivity has dropped in all cases of metal promoter-based activations. As a result
of the preliminary screening of reaction conditions; we conclude that reactions in the
presence of 5 mol % of TMSOTf in either CH2Cl2 or EtCN at -78 oC were found to be the
most effective for β-glycosidation of OFox imidate 3.2.
Having obtained high, and rather unexpected, levels of β-selectivity in glycosylations
with OFox imidates, we were curious to investigate whether by changing the activation
conditions, OFox glycosides could provide α-selectivity. For this purpose we chose
trimethylsilyl perchlorate (TMSClO4) as an activator because our recent study dedicated
to the effect of the counter anion on the stereoselectivity showed that perchlorates
typically outperform other counter ions and provide superior α-selectivity. To further
shift the selectivity towards α-linked products, TMSClO4 was used in cooperation with
ethereal solvents that are known to favor axially substituted products. Thus, reaction in
diethyl ether gave disaccharide 3.20 in 75% yield in good α-selectivity (α/β = 5.0/1, entry
9). The stereoselectivity was further improved when diethyl ether/1,4-dioxane (1/1, v/v)
was used as a solvent mixture (α/β = 6.2/1, entry 10)
With the most favorable reaction conditions for glycosidation of the OFox donors, we
were bound to extend the scope of this procedure to glycosylation of various glycosyl
acceptors ranging from highly reactive primary alcohols to sterically hindered and less
reactive or sterically hindered secondary alcohols. The result of this study is summarized
in Table 3.6. As aforementioned, glycosidation of donor 3.2 with primary acceptor 3.19
gave glycoside 3.20 in a nearly quantitative yield and complete β-selectivity using either
CH2Cl2 or EtCN reaction solvent (entries 1 and 2). Glycosidation of donor 3.2 with 2propanol 3.26 was also quite selective and gave glycoside 3.27 in 77% yield and
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Table 3.6. TMSOTf-promoted glycosidation of OFox donor 3.2 with different
acceptors in CH2Cl2 or EtCN at -78 oC

Yieldb

α/β
ratioc

94%

1/24

99%

β only

EtCN

77%

β only

CH2Cl2

89%

1/11

87%

1/18

85%

1/12

89%

β only

94%

1/4.0

92%

1/12

90%

1/6.0

88%

1/15

86%

β-only

88%

1/23

Entry

Acceptor

Solvent

1

3.19

CH2Cl2

2

3.19

EtCN

3

2-propanol
3.26

4
5

3.28

6
7

3.30

12

13

EtCN

3.29

EtCN

3.31

CH2Cl2
3.32

10
11

3.20

CH2Cl2

8
9

Product

EtCN

3.33

CH2Cl2
3.24

EtCN

3.25

CH2Cl2

CH2Cl2
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complete β-selectivity (entry 3). Along similar lines, glycosylations with other primary
acceptors 3.28 and 3.30 provided similar results, and afforded the corresponding
disaccharides 3.29 and 3.31 in good yields and high 1,2-trans selectivity (up to α/β =
1/18, entries 4-7). On the other hand, reactions with secondary acceptors 3.32 and 3.34
showed somewhat lower selectivity for the synthesis of disaccharides 3.33 and 3.35 (up
to α/β = 1/15, entries 8-11). Glycosylations with sterically hindered alcohols, cholesterol
3.34 and adamantanol 3.36, proceeded smoothly generating the desired glycosides 3.35
and adamantanol 3.37 in good yields and nearly complete 1,2-trans stereoselectivity
(entries 12 and 13). These glycosylations indicate that OFox glycosyl donors can be used
to obtain β-linked glycosides in high yields and selectivities. It is noteworthy that the
high β-selectivity obtained from glycosyl donors without the neighboring participating
acyl group is relatively rare.
With success in achieving excellent glycosylation yields and 1,2-trans stereoselectivity
using per-O-benzylated (armed) OFox imidate donor 3.2, we turned our attention to
studying their expectedly less reactive acylated counterparts. It should be noted that
glycosyl donors of this class would provide an even more straightforward access to 1,2trans-linked products. As discussed in the previous Chapter, the presence of acyl
substituents provides a disarming effect thereby substantially reducing the reactivity of
acylated glycosyl donors. However, as in case with OBox glycosides, even acylated
OFox imidates showed similar level of reactivity to that observed with their perbenzylated counterparts.
Starting with per-acetylated donor 3.8, in the reaction with acceptor 3.19 in the
presence of TMSOTf we observed very low yields for the formation of 3.38 due to high
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Table 3.7. Glycosylation with per-acylated glucosyl, galactosyl, and mannosyl OFox
donors in CH2Cl2 with TMSOTf as a promoter at rt.
Entry

Donor

Acceptor

Product

Yield

1a

3.19

80%

2

3.19

94%

3

3.10

3.30

86%

4

3.10

3.32

90%

5

3.10

3.24

93%

3.19

98%

3.32

98%

3.19

93%

3.32

90%

6

7

3.12

9

10

3.14

a

– SnCl4 was used as a promoter to prevent acetyl migration to the C-6 of acceptor that
was observed in the presence of TMSOTf.
rates of the competing acetyl migration to the C-6 of the glycosyl acceptor. Interestingly,
we were able to overcome this issue by performing essentially the same glycosylation
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reaction using SnCl4 as an activator. As a result of this experiment, disaccharide 3.38 was
obtained in 80% with very minimal impact from the acetyl migration (Table 3.7, entry 1).
Nevertheless, to avoid complications related to possible competing acetyl migration,
further study was conducted with per-benzoylated OFox imidates of the D-gluco, Dgalacto, and D-manno series (3.10, 3.12, and 3.14, respectively) using glycosyl acceptors
3.19, 3.30, 3.32, and 3.24. All these glycosylations proceeded smoothly giving excellent
yields and complete 1,2-trans stereoselectivity (entries 2-10).
Since per-benzylated OFox donor 3.2 was generally β-selective, in the expansion of our
studies to obtaining 1,2-cis glycosides we wanted to investigate whether OFox imidates
with the superdisarming 2-O-benzyl-3,4,6-tri-O-acyl protecting group pattern would be
beneficial for the synthesis of α-glucosides. For this purpose we obtained OFox imidate
3.6, which was subjected to comparative glycosylations along with the standard
perbenzylated OFox donor 3.2. Alongside, we wanted to look into the possible effect of
the anomeric group orientation on the stereoselectivity of glycosylations. For this
purpose, we obtained α-3.6 and β-3.6 and glycosylations were performed with primary
and secondary acceptors 3.19 and 3.24. The result of this study is summarized in Table
3.8. Thus, perbenzylated OFox donor 3.2 (α/β = 10/1) gave essentially the same result as
that obtained with α-3.2. In both cases, disaccharide 3.20 was obtained with excellent
selectivity of α/β = 1/24. Even more dramatic result was obtained with the superdisarmed
glycosyl donor 3.6. Thus, both α-3.2 and β-3.2 provided the corresponding disaccharide
3.25 in practically identical yield of 88-89% and complete α-stereoselectivity. As a result
of this study, we conclude that irrespective of the orientation of the OFox group of the
glycosyl donor, complete 1,2-cis stereoselectivity was achieved in all reactions.
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Table 3.8. The effect of anomeric configuration on the stereoselectivity of
glycosidation of OFox donors 3.2 and 3.6

RO
RO

OR
O

BnO
BnO
BnO

OH
O

TMSOTf (10 mol %)
+ BnO
BnO
OFox
CH2Cl2
BnO OMe
BnO
3.19
molec. sieve 4Å
3.2: R = Bn
OBn
3.6: R = Ac
O
BnO
BnO
3.24 HO OMe

3.20

AcO
AcO
3.25

O
BnO

O

BnO
BnO
OAc
OBn
O BnO
BnO
O
MeO

O

O
BnO
OMe

OBn

Entry
Donor
Acceptor Temp, time Product, yield, % α/β ratio
1
3.2 (α/β = 10/1)
-78 oC, 5min
3.20, 94
1/24
3.19
o
2
-78 C, 5min
3.20, 98
1/24
α-3.2
3.19
3
rt,
15min
3.25,
88
α
only
3.24
α-3.6
4
rt, 15min
3.25, 89
α only
β-3.6
3.24
3.3. Regenerative glycosylation
While developing the new class of O-imidates we noticed a feature of the OFox
leaving group that differentiates it from all others. The aglycone structure needed to
introduce OFox and that of the departed leaving group are essentially the same cyclic
amide 3,3-difluoroxindole (HOFox).28,36 The significance of this observation is that, in
principle, one should be able to conduct both the introduction and activation of this
leaving group in the catalytic “donor-regenerative” fashion, which is routinely done in
enzymatic glycosylations,37,38 but represents a new direction in the field of chemical
glycosylation.
Having established basic principles of the synthesis and activation of OFox imidates,
we turned our attention to the investigation of the regenerative glycosylation, a concept
that sets OFox donors apart from other known methods for glycosylation. Both TCAI
and PTFAI are obtained from hemiacetal precursors, using cheap trichloroacetonitrile or
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rather costly 2,2,2-trifluoro-N-phenylacetimidoyl chloride, respectively, but their
synthesis is often originated from thioglycosides (Scheme 3.2). The use of thioglycosides
as general building blocks is very broad. Thioglycosides are also excellent glycosyl
donors, but their relatively low reactivity profile and the requirement for stoichiometric
promoters limit their application. Conversely, O-imidates are very reactive and require
only catalytic amount of the activator. Many O-imidates can be purified, but none can be
stored and hence have to be used in glycosidations right away. Leaving groups in the
previously studied imidates TCAI or

PTFAI depart as unreactive amides,

trichloroacetamide or 2,2,2-trifluoro-N-phenylacetamide, respectively, and cannot be
reused directly (Scheme 3.2).
Scheme 3.2. Common approaches and the new concept

Differently, since both the reagent for the introduction of the OFox leaving group and
the departed leaving group are essentially the same (HOFox), both the synthesis and
glycosidation of OFox imidates can be conducted using catalytic amount of the HOFox
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aglycone. HOFox aglycone will first react with a stable precursor to form highly reactive
OFox imidate donor. The latter will then react with the acceptor while regenerating
HOFox aglycone, which will be available for the next catalytic cycle to regenerate the
OFox donor. Resultantly, only a small amount of the reactive donor is present in the
reaction depending on the amount of added HOFox, whereas the OFox donor gets
regenerated only upon its consumption (Scheme 3.2).
In our preliminary study of the regenerative concept, we first reacted S-ethyl glycoside
3.47 with stoichiometric bromine to form glycosyl bromide 3.48. The latter gets readily
converted into OFox imidate 3.2 in the presence of HOFox. OFox imidates have
reasonable shelf-life but are readily activated with TMSOTf, Bi(OTf)3 or other Lewis
acid promoters (10 mol %). The amount of the reactive glycosyl donor present in the
reaction medium can be controlled by the amount of HOFox added (range studied 0.1-1.0
equiv.). We managed to achieve reasonable glycosylation rates (5 h) with as little as 10%
of HOFox aglycone and with yields between 79-90% (entries 2-6, Table 3.9). For
comparison, bromide 3.48 would require at least 16-24 h to react completely under these
reaction conditions (entry 1). After confirming the effectiveness of the regenerative
glycosylation procedure, we next investigated its scope towards secondary acceptors. For
comparison, these reactions were performed using 0.1 and 0.25 equiv. of OFox, and the
glycosylations proceeded smoothly providing corresponding disaccharides in 75% and
62% yields respectively (entries 7 and 8). At the same time, the procedure was also
performed on galactosyl and mannosyl sugars. However, the reaction yields were on
average lower than those observed with glucosyl donor (entries 9 and 10).
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Table 3.9. Regenerative glycosylation

Entry

Donor

Acceptor

1

HOFox Reaction
(equiv.)
time
0

5h

0.10
0.25
0.50
0.75
1.0

3h
2h
40 min
30 min
10 min

Product

Yield

Ratio
α/β

9% 1/1.1

2
3
4
5
6

3.47
3.47
3.47
3.47
3.47

7

3.47

0.1

3h

72% 1/1.7

8

3.47

0.25

3h

62% 1/1.0

3.19
3.19
3.19
3.19
3.19

3.20
3.20
3.20
3.20
3.20

84%
79%
86%
88%
90%

1/1.9
1/1.9
1/1.2
1/1.2
1/1.2

9

3.19

0.1

2.5 h

69% 1/1.1

10

3.19

0.1

3h

75% 2.5/1

141

To obtain the ultimate proof that the regenerative reaction proceeds via the formal
formation of the OFox imidate, we performed an NMR monitoring as follows. A reaction
using bromide donor 3.48 and Ag2O (3 equiv.) in CD2Cl2 was set up in the standard 5
mm NMR tube at 0 oC in absence of a glycosyl acceptor. HOFox (0.25 equiv.) was then
added and the 1H NMR spectrum recorded after 5 min clearly showed the formation of
OFox imidate (Scheme 3.3). Thus, two new peaks, one at around 5.87 ppm, indicative of
the formation of β-OFox imidate 3.2, and one at around 6.50 ppm indicative of the
formation of α-OFox imidate were formed. In our opinion, this NMR-monitoring
experiment clearly proves that OFox imidates are the essential intermediates en route to
the glycosylation prodicts.
Scheme 3.3. “Regenerative glycosylation” monitored by the NMR

0.03
6.50

0.82
6.45

0.17
6.40

6.35

6.30

6.25

6.20
6.15
6.10
Chemical Shift (ppm)

6.05

6.00

5.95

5.90

5.85

3.4. Conclusions
A new class compounds, OFox imidates, have been synthesized in high yields and
employed as versatile glycosyl donors in the synthesis of 1,2-cis and 1,2-trans glycosides.
These glycosylations show notable features such as operational simplicity, rapid reaction
times, high yields and excellent stereocontrol in presence of Lewis acids used in catalytic
amounts. Achieving complete β-stereoselectivity with the use of propionitrile as the
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solvent, suggests a possibility of solvent participation during glycosylation. At the same
time, good α-selectivities could also be achieved by changing the promoter or using
OFox of the superdisarmed series. A new regenerative concept for chemical
glycosylation that proceeds via reactive glycosyl OFox intermediates and activation
thereof in the catalytic fashion in situ was discovered. The concept has some similarities
with the two-step activation by Nicolaou39-41 and Danishefsky42-45 and preactivation
strategy by Huang and Ye,46-49 but differs in the catalytic conversion and continuous
regeneration of the glycosyl donor. In the previous methods, the entire precursor
(thioglycoside or glycal) is first converted into reactive intermediates (Br, F, OTf/NTf2 or
epoxide) and then acceptor is added. This regenerative approach is expected to help
reduce side reactions commonly found in conventional glycosylations wherein excess of
the highly reactive or stoichiometrically preactivated glycosyl donor is present from the
beginning.

3.5. Experimental Section
3.5.1. General Remarks
All reactions were performed under argon with dry, freshly distilled solvents unless
otherwise noted. CH2Cl2, ClCH2CH2Cl, toluene, CH3CN, and EtCN were distilled from
CaH2 directly prior to application. Anhydrous 1,4-dioxane, tetrahydrofuran, and diethyl
ether were used as is. AgOTf was co-evaporated with toluene (3 x 10 mL) and dried in
vacuo for 2-3 h directly prior to application. TMSOTf, SnCl4, MeOTf, BF3-OEt2,
Cu(OTf)2, PdCl2, TMSClO4 and Bi(OTf)3 were used as is. Molecular sieves (3 Å or 4 Å),
used for the reactions, were crushed and activated at 390 °C and then for 2-3 h at 390 °C
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prior to application. Reactions were monitored by TLC on Kieselgel 60 F254 and the
compounds were detected by examination under UV light and by charring with 10%
sulfuric acid in methanol. Solvents were removed under reduced pressure at < 40 oC.
Column chromatography was performed on silica gel 60 (70-230 mesh). Optical rotations
were measured at ‘Jasco P-1020’ polarimeter. 1H n.m.r. spectra were recorded at 300
MHz, 500 MHz, or 600 MHz. 13C n.m.r. spectra were recorded at 75 MHz or 150 MHz.
19

F spectra were recorded at 282.2 MHz. The 1H chemical shifts are referenced to the

signal of the residual CHCl3 (δH = 7.27 ppm) for solutions in CDCl3. The

13

C chemical

shifts are referenced to the central signal of CDCl3 (δC = 77.23 ppm) for solutions in
CDCl3. HRMS determinations were made with the use of JEOL MStation (JMS-700)
Mass Spectrometer.

3.5.2. Synthesis of 3,3-difluoroxindole (HOFox, 3,3-difluoroindolin-2-one).
HOFox was obtained from Isatin and DAST as previously described. Analytical data
were in accordance with that previously reported.28

3.5.3. Preparation of OFox imidates
Method A. A typical procedure for the preparation from hemiacetals via glycosyl
chlorides. SOCl2 (81.1 μL, 1.11 mmol) was added dropwise to a solution of hemiacetal
(3.1 or 3.3, 0.20 g, 0.37 mmol) in dry CH2Cl2 (2.0 mL) and dry DMF (14.3 μL) and the
resulting mixture was stirred under argon for 7 h at rt. Upon completion, the reaction
mixture was diluted with CH2Cl2 (~30 mL) and washed with sat. aq. NaHCO3 (2 x 15
mL) and cold water (2 x 15 mL). The organic phase was separated, dried with MgSO4,
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and concentrated in vacuo. The residue containing crude glycosyl halide (0.37 mmol) was
dried under high vacuum for 4 h. Freshly activated molecular sieves (3 Å, 600 mg) and
dry CH2Cl2 (2.0 mL) were added and the resulting mixture was stirred under argon for 1 h
at rt. After that, 3,3-difluorooxindole (69 mg, 0.41 mmol), Ag2O (258 mg, 1.11 mmol),
and diisopropylethylamine (DIPEA, 97 μL, 0.56 mmol) were added and the resulting
mixture was stirred for 8-12 h. The solids were filtered off through a pad of Celite and
rinsed successively with CH2Cl2. The combined filtrate (~40 mL) was washed with 1%
aq. NaOH (2 x 15 mL) and water (2 x 15 mL). The organic phase was separated, dried
with MgSO4, and concentrated in vacuo. The residue was purified by column
chromatography on silica gel (ethyl acetate-hexanes gradient elution) to afford the
corresponding OFox imidates 3.2 or 3.4 in yields listed in Table 3.1.

Methods B and C. A typical procedure for the preparation from glycosyl bromides. A
mixture of a glycosyl bromide (3.5, 3.7, 3.9 or 3.15, 0.15 mmol) and freshly activated
molecular sieves (3 Å, 300 mg) in dry CH2Cl2 (Method B, 1.0 mL) or toluene (Method C,
1.0 mL) was stirred under argon for 1 h at rt. After that, 3,3-difluorooxindole (25.7 mg,
0.15 mmol), Ag2O (105 mg, 0.45 mmol), and DIPEA (39.7 μL, 0.23 mmol) were added
and the resulting mixture was stirred for 40 min-10 h at the temperature indicated in
Table 1S. The solids were filtered off through a pad of Celite and rinsed successively
with CH2Cl2. The combined filtrate (~40 mL) was washed with 1% aq. NaOH (2 x 15
mL) and water (2 x 15 mL). The organic phase was separated, dried with MgSO4, and
concentrated in vacuo. The residue was purified by column chromatography on silica gel
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(ethyl acetate-hexanes gradient elution) to afford the corresponding OFox imidates in
yields listed in Table 3.1.

Method D. A typical procedure for the preparation from pentabenzoates via glycosyl
bromides. A 33% solution of HBr in AcOH (0.10 mL, 1.7 mmol) was added to a solution
of a 1,2,3,4,6-penta-O-benzoyl-D-galacto or mannopyranose (3.11 or 3.13, 100 mg, 0.14
mmol) in dry CH2Cl2 (0.2 mL) and the resulting mixture was stirred under argon for 2-4 h
at rt. The reaction mixture was then diluted with CH2Cl2 (~40 mL) and washed with cold
sat. aq. NaHCO3 (2 x 15 mL) and cold water (2 x 15 mL). The organic phase was
separated, dried with MgSO4, and concentrated in vacuo. The residue containing crude
glycosyl bromide (0.14 mmol) was dried under high vacuum for 4 h. After that, freshly
activated molecular sieves (3 Å) and dry CH2Cl2 (1.4 mL) were added and the resulting
mixture was stirred under argon for 1 h at rt. After that, the resulting mixture was cooled
to 0 oC in case of galactose sugar and at rt for mannose sugar, followed by addition of
3,3-difluorooxindole (26.7 mg, 0.16 mmol), Ag2O (99.2 mg, 0.43 mmol) and DIPEA
(37.4 μL, 0.21 mmol) were added and the resulting mixture was stirred for 2-6 h as
indicated in Table 3.1. The solids were then filtered off through a pad of Celite and rinsed
successively with CH2Cl2. The combined filtrate (~40 mL) was washed with 1% aq.
NaOH (2 x 15 mL) and water (2 x 15 mL). The organic phase was separated, dried with
MgSO4, and concentrated in vacuo. The residue was purified by column chromatography
on silica gel (ethyl acetate-hexanes gradient elution) to afford the corresponding OFox
imidates in yields listed in Table 3.1.
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3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-benzyl-α/β-D-glucopyranoside (3.2). The
title compound was obtained from 2,3,4,6-tetra-O-benzyl-D-glucopyranose 3.150 by
Method B in 62% yield (α/β = 10/1) as a white foam. Analytical data for α-3.2: Rf = 0.43
(ethyl acetate/hexanes, 1/4, v/v); 1H n.m.r. (300 MHz): δ, 3.66 (dd, 1H, J5,6a = 1.8 Hz,
J6a,6b = 10.9 Hz, H-6a), 3.79 (dd, 1H, J2,3 = 9.3 Hz, H-2, ), 3.79 (dd, 1H, J5,6b = 3.3 Hz, H6b), 3.83 (dd, 1H, J4,5 = 9.3 Hz, H-4), 4.01 (m, 1H, H-5), 4.13 (dd, 1H, J3,4 = 9.3 Hz, H3), 4.52 (dd, 2H, 2J = 12.0 Hz, CH2Ph), 4.69 (dd, 2H, 2J = 10.5 Hz, CH2Ph), 4.73 (s, 2H,
CH2Ph), 4.93 (dd, 2H, 2J = 10.9 Hz, CH2Ph), 6.50 (d, 1H, J1,2 = 3.3 Hz, H-1), 7.11-7.42
(m, 24H, aromatic) ppm; 13C n.m.r. (75 MHz): δ, 68.1, 73.2, 73.5, 73.6 (x 2), 75.2, 75.3,
79.4, 81.5, 99.8, 117.4, 120.4, 123.3, 125.7, 127.8, 127.9, 128.0 (x 4), 128.0 (x 2), 128.1
(x 7), 128.6 (x 8), 133.6, 137.9, 138.0, 138.2, 138.8 ppm; 19F n.m.r.: δ, -121.3 (s, 2F, CF2)
ppm; HR-FAB MS [M+Na]+ calculated for C42H39F2NO6Na+ 714.2643, found 714.2645.

3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-benzyl-α-D-mannopyranoside (3.4). The
title compound was obtained from 2,3,4,6-tetra-O-benzyl-α/β-D-mannopyranose 3.351 by
Method A in 61% yield as a white foam. Analytical data for 3.4: Rf = 0.45 (ethyl
acetate/hexanes, 2/3, v/v); [α]D24 +13.7 (c = 1.0, CHCl3); 1H n.m.r. (300 MHz): δ, 3.74
(dd, 1H, J5,6a = 1.8 Hz, J6a,6b = 11.3 Hz, H-6a), 3.84 (dd, 1H, J5,6b = 4.3 Hz, H-6b), 3.954.03 (m, 3H, H-2, 4, 5), 4.14 (m, 1H, J3,4 = 9.5 Hz, H-3), 4.60 (dd, 2H, 2J = 11.6 Hz,
CH2Ph), 4.62 (dd, 2H, 2J = 12.1 Hz, CH2Ph), 4.70 (dd, 2H, 2J = 10.7 Hz, CH2Ph), 4.78
(s, 2H, CH2Ph), 6.40 (d, 1H, J1,2 = 1.1 Hz, H-1), 7.15-7.47 (m, 24H, aromatic) ppm; 13C
n.m.r. (75 MHz): δ, 69.1, 72.6, 72.8, 73.1, 73.4, 74.0, 74.8, 75.3, 79.0, 97.7, 120.5 (x 2),
123.4 (x 2), 125.9, 126.7, 127.7, 127.7 (x 2), 128.0 (x 3), 128.1 (x 2), 128.2 (x 2), 128.3
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(x 3), 128.5 (x 2), 128.6 (x 6), 133.7, 138.0, 138.2, 138.4 (x 2), ppm; 19F n.m.r.: δ, -121.5
(s, 2F, CF2) ppm; HR-FAB MS [M+Na]+ calculated for C42H39F2NO6Na+ 714.2643,
found 714.2639.

3,4,6-Tri-O-acetyl-2-O-benzyl-α-D-glucopyranosyl bromide (3.5). The title compound
was obtained from 1,3,4,6-tetra-O-acetyl-2-O-benzyl-D-glucopyranose52 in 90% yield as
a white foam as previously described.53 Analytical data for 3.5: Rf = 0.43 (ethyl
acetate/hexanes, 2/3, v/v); 1H n.m.r. (300 MHz): δ, 1.96, 1.98, 2.00 (3s, 9H, 3 x COCH3),
3.57 (dd, 1H, J2,3 = 9.6 Hz, H-2), 4.12 (m, 1H, J5,6a = 4.1 Hz, H-6a), 4.22 (m, 1H, H-5),
4.27 (dd, 1H, J5,6b = 4.0 Hz, J6a,6b = 12.6 Hz, 6b), 4.63 (dd, 2H, 2J = 12.3 Hz, CH2Ph),
5.06 (dd, 1H, J4,5 = 9.8 Hz, H-4), 5.48 (dd, 1H, J3,4 = 9.5 Hz, H-3), 6.34 (d, 1H, J1,2 = 3.9
Hz, H-1) ppm; 13C n.m.r. (75 MHz): δ, 20.8, 20.9 (x 2), 61.3, 67.3, 72.2 (x 2), 72.9, 76.5,
89.2, 128.1 (x 2), 128.5, 128.8 (x 2), 137.0, 169.9, 170.1, 170.7 ppm; HR-FAB MS
[M+Na]+ calculated for C19H23BrO8Na+ 481.0474, found 481.0483.

3,3-Difluoro-3H-indol-2-yl
3.6).

3,4,6-tri-O-acetyl-2-O-benzyl-β-D-glucopyranoside (β-

The title compound was obtained from 3,4,6-tri-O-acetyl-2-O-benzyl-α-D-

glucopyranosyl bromide 3.5 by Method B at rt in 80% yield as a white foam. Analytical
data for β-3.6: Rf = 0.39 (ethyl acetate/hexanes, 2/3, v/v); [α]D26 +13.7 (c = 1.0, CHCl3);
1

H n.m.r. (300 MHz): δ, 1.95, 2.03, 2.07 (3s, 9H, 3 x COCH3), 3.80 (dd, 1H, J2,3 = 7.9

Hz, H-2), 3.95 (m, 1H, H-5), 4.14 (dd, 1H, J5,6a = 2.3 Hz, J6a,6b = 12.5 Hz, H-6a), 4.34
(dd, 1H, J5,6b = 4.4 Hz, H-6b), 4.74 (dd, 2H, 2J = 11.6 Hz, CH2Ph), 5.11 (dd, 1H, J4,5 =
9.5 Hz, H-4), 5.27 (dd, 1H, J3,4 = 9.2 Hz, H-3), 5.94 (d, 1H, J1,2 = 7.8 Hz, H-1), 7.18-7.49
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(m, 9H, aromatic) ppm;

13

C n.m.r. (75 MHz): δ, 20.7 (x 2), 20.8, 61.5, 67.9, 72.6, 73.6,

74.7, 77.6, 99.1, 120.6, 123.3, 126.2, 128.1 (x 2), 128.3 (x 3), 128.5 (x 3), 133.7, 137.1,
150.3, 169.7, 170.0, 170.7 ppm;
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F n.m.r.: δ, -122.0 (d, 2F, CF2) ppm; HR-FAB MS

[M+Na]+ calculated for C27H27F2NO9Na+ 570.1552, found 570.1562.

3,3-Difluoro-3H-indol-2-yl
3.6).

3,4,6-tri-O-acetyl-2-O-benzyl-α-D-glucopyranoside (α-

The title compound was obtained from 3,4,6-tri-O-acetyl-2-O-benzyl-α-D-

glucopyranosyl bromide 3.5 by Method B at 0 oC in 81% yield as a white foam.
Analytical data for α-3.6: Rf = 0.38 (ethyl acetate/hexanes, 2/3, v/v); [α]D25 +101.4 (c =
1.0, CHCl3); 1H n.m.r. (300 MHz): δ, 2.02, 2.03, 2.05 (3s, 9H, 3 x COCH3), 3.81 (dd, 1H,
J2,3 = 9.9 Hz, H-2), 4.06 (dd, 1H, J5,6a = 2.0 Hz, J6a,6b = 12.4 Hz, H-6a), 4.18 (m, 1H, H5), 4,29 (dd, 1H, J5,6b = 4.1 Hz, H-6b), 4.67 (s, 2H, CH2Ph), 5.11 (dd, 1H, J4,5 = 10.0 Hz,
H-4), 5.57 (d, 1H, J3,4 = 9.7 Hz, H-3), 6.45 (d, 1H, J1,2 = 3.5 Hz, H-1), 7.17-7.40 (m, 9H,
aromatic) ppm; 13C n.m.r. (75 MHz): δ, 20.7 (x 2), 20.8, 61.4, 67.8, 69.8, 71.4, 73.3, 75.7,
95.0, 120.4, 123.3, 125.9, 126.8, 127.9 (x 3), 128.2, 128.6 (x 3), 133.5, 137.2, 150.4,
168.7, 169.8, 170.1 ppm; 19F n.m.r.: δ, -121.6 (s, 1F, CF2a), -121.5 (s, 1F, CF2b); HR-FAB
MS [M+Na]+ calculated for C27H27F2NO9Na+ 570.1552, found 570.1569.

3,3-Difluoro-3H-indol-2-yl

2,3,4,6-tetra-O-acetyl-α-D-glucopyranoside (3.8).

The

title compound was obtained from 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide
3.754 by Method C in 62% yield as a white foam. Analytical data for 3.8: Rf = 0.42 (ethyl
acetate/hexanes, 1/1, v/v); [α]D21 +5.2 (c= 1.0, CHCl3); 1H n.m.r. (300 MHz): δ, 1.96,
1.97, 1.98, 2.01 (4s, 12H, 4 x COCH3), 3.95 (m, 1H, H-5), 4.15 (dd, 1H, J5,6a = 2.3 Hz,
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J6a,6b = 12.5 Hz, H-6a), 4.30 (dd, 1H, J5,6b = 4.3 Hz, H-6b), 5.17-5.32 (m, 3H, H-2, 3, 4),
5.95 (m, 1H, H-1), 7.14-7.40 (m, 4H, aromatic) ppm; 13C n.m.r. (75 MHz): δ, 20.4, 20.6
(x 2), 20.7, 61.4, 67.6, 70.3, 72.4, 72.9, 96.6, 120.5 (x 2), 123.3 (x 2), 126.2, 126.8, 133.6,
150.0, 169.3, 169.4, 170.2, 170.8 ppm; 19F n.m.r.: δ, -122.4 (s, 1F, CF2a), -122.3 (s, 1F,
CF2b) ppm; HR-FAB MS [M+H]+ calculated for C22H23F2NO10 500.1290, found
500.1361.

3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-benzoyl-α-D-glucopyranoside (3.10). The
title compound was obtained from 2,3,4,6-tetra-O-benzoyl-α-D-glucopyranosyl bromide
3.955 by Method B in 75% yield as a pale yellow foam. Analytical data for 3.10: Rf = 0.41
(ethyl acetate/hexanes, 3/7, v/v); [α]D23 +45.8 (c= 1.0, CHCl3); 1H n.m.r. (300 MHz): δ,
4.48 (dd, 1H, J5,6a = 4.7 Hz, J6a,6b = 12.4 Hz, H-6a), 4.64 (m, 2H, J5,6b = 2.3 Hz, H-5, 6b),
5.69 (dd, 1H, J2,3 = 10.2 Hz, H-2), 5.83 (dd, 1H, J4,5 = 10.0 Hz, H-4), 6.31 (dd, 1H, J3,4 =
10.0 Hz, H-3), 6.82 (d, 1H, J1,2 = 3.7 Hz, H-1), 7.05-7.99 (m, 24H, aromatic) ppm;

13

C

n.m.r. (75 MHz): δ, 62.4, 68.6, 70.1, 70.3, 70.6, 94.8, 120.6, 123.2, 126.0, 126.5, 128.3,
128.4 (x 2), 128.4 (x 2), 128.5 (x 4), 128.6 (x 2), 128.8, 129.1, 129.5, 129.7 (x 2), 129.8
(x 2), 130.0 (x 4), 133.1, 133.4 , 133.5, 133.6, 133.7, 150.1, 165.2, 165.5, 165.6, 166.0
ppm; 19F n.m.r.: δ, -121.8 (s, 1F, CF2a), -121.6 (s, 1F, CF2b) ppm; HR-FAB MS [M+Na]+
calculated for C42H31F2NO10Na+ 770.1813, found 770.1800.

3,3-Difluoro-3H-indol-2-yl

2,3,4,6-tetra-O-benzoyl-β-D-galactopyranoside

(3.12).

The title compound was obtained from 2,3,4,6-tetra-O-benzoyl-α-D-galactopyranosyl
bromide 3.1156 by Method D in 75% yield as a white foam. Analytical data for 3.12: Rf =
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0.39 (ethyl acetate/hexanes, 3/7, v/v); [α]D22 +2.7 (c= 1.0, CHCl3); 1H n.m.r. (300 MHz):
δ, 4.51 (dd, 1H, J5,6a = 5.9 Hz, J6a,6b = 10.6 Hz, H-6a), 4.63 (m, 1H, H-5), 4.72 (dd, 1H,
J5,6b = 6.6 Hz, H-6b), 5.75 (dd, 1H, J3,4 = 3.4 Hz, H-3), 6.11 (m, 2H, H-2, 4), 6.34 (d, 1H,
J1,2 = 7.8 Hz, H-1), 7.14-8.14 (m, 24H, aromatic) ppm;

13

C n.m.r. (75 MHz): δ, 61.8,

67.6, 68.9, 71.4, 72.7, 97.4, 120.4, 123.6, 124.7, 125.4, 128.3, 128.6 (x 4), 128.7, 128.8,
128.9 (x 2), 129.0, 129.2 (x 2), 129.4, 129.9 (x 9), 130.1 (x 2), 133.3, 133.5, 133.6, 133.8,
165.1, 165.5 (x 2), 166.0 ppm; 19F n.m.r.: δ, -122.2 (s, 2F, CF2); HR-FAB MS [M+Na]+
calculated for C42H31F2NO10Na+ 770.1813, found 770.1791.

3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-benzoyl-α-D-mannopyranoside (3.14). The
title compound was obtained from 2,3,4,6-tetra-O-benzoyl-α-D-mannopyranosyl bromide
3.1357 by Method D in 84% yield as a white foam. Analytical data for 3.14: Rf = 0.43
(ethyl acetate/hexanes, 3/7, v/v); [α]D21 -5.3 (c = 1.0, CHCl3); 1H n.m.r. (300 MHz): δ,
4.52 (dd, 1H, J5,6a = 4.4 Hz, J6a,6b = 12.1 Hz, H-6a), 4.62 (m, 1H, H-5), 4.70 (dd, 1H, J5,6b
= 2.2 Hz, H-6b), 6.02 (dd, 1H, J2,3 = 3.3 Hz, H-2), 6.07 (dd, 1H, J3,4 = 10.0 Hz, H-3),
6.24 (dd, 1H, J4,5 = 10.0 Hz, H-4), 6.64 (d, 1H, J1,2 = 1.7 Hz, H-1), 7.16-8.09 (m, 24H,
aromatic) ppm;

13

C n.m.r. (75 MHz): δ, 62.5, 66.2, 69.0, 69.6, 71.5, 96.0, 121.0, 123.5,

125.5, 126.4, 126.8, 128.4, 128.5 (x 2), 128.6 (x 2), 128.7 (x 2), 128.8, 128.9 (x 2), 128.9,
129.0, 129.2, 129.8, 129.9 (x 2), 130.0 (x 2), 130.1 (x 4), 133.2, 133.6, 133.8, 134.0,
138.1, 165.2, 165.5, 165.6, 166.1 ppm; 19F n.m.r.: δ, -121.8 (s, 1F, CF2a), -121.5 (s, 1F,
CF2b); HR-FAB MS [M+Na]+ calculated for C42H31F2NO10Na+ 770.1813, found
770.1814.
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3,4,6-Tri-O-acetyl-2-azido-2-deoxy-α-D-glucopyranosyl bromide (3.15).
compound

was

obtained

from

The title

1,3,4,6-tetra-O-acetyl-2-azido-2-deoxy-D-

glucopyranose58,59 in 90% yield as a white foam as previously described.{Paulsen, 1988
#2816{Rowan, 2009 #3894} Analytical data for 3.15: Rf = 0.46 (ethyl acetate/hexanes,
2/3, v/v); [α]D19 +146.9 (c= 1.0, CHCl3); 1H n.m.r. (300 MHz): δ, 2.06, 2.09, 2.11 (3s, 9H,
3 x COCH3), 3.81 (dd, 1H, J2,3 = 10.2 Hz, H-2), 4.12 (m, 1H, J5,6a = 1.9 Hz, J6a,6b = 8.5
Hz, H-6a), 4.33 (m, 2H, J5,6b = 4.1 Hz, H-5, 6b), 5.14 (dd, 1H, J4,5 = 9.8 Hz, H-4), 5.5
(dd, 1H, J3,4 = 10.0 Hz, H-3), 6.42 (d, 1H, J1,2 = 3.8 Hz, H-1) ppm; 13C n.m.r. (75 MHz):
δ, 20.5, 20.6 (x 2), 61.0, 62.3, 67.3, 71.7, 72.4, 87.4, 169.6, 169.7, 170.4 ppm; HR-FAB
MS [M+Na]+ calculated for C12H16BrN3O7Na+ 416.0069, found 416.0065.

3,3-Difluoro-3H-indol-2-yl

3,4,6-tri-O-acetyl-2-azido-2-deoxy-β-D-glucopyranoside

(3.16). The title compound was obtained from 3,4,6-tri-O-acetyl-2-azido-2-deoxy-α-Dglucopyranosyl bromide 3.15 by Method B in 70% yield as a white foam. Analytical data
for 3.16: Rf = 0.43 (ethyl acetate/hexanes, 2/3, v/v); [α]D24 +8.4 (c= 1.0, CHCl3); 1H n.m.r.
(300 MHz): δ, 2.05, 2.08, 2.12 (3s, 9H, 3 x COCH3), 3.88 (dd, 1H, J2,3 = 9.2 Hz, H-2),
3.93 (m, 1H, H-5), 4.16 (dd, 1H, J5,6a = 2.3 Hz, H-6a), 4.35 (dd, 1H, J5,6b = 4.3 Hz, J6a,6b
= 12.6 Hz, H-6b), 5.13 (dd, 1H, J4,5 = 8.9 Hz, H-4), 5.17 (dd, 1H, J3,4 = 9.2 Hz, H-3),
5.82 (d, 1H, J1,2 = 8.3 Hz, H-1), 7.19-7.43 (m, 4H, aromatic) ppm; 13C n.m.r. (75 MHz):
δ, 20.7, 20.8, 20.9, 60.6, 63.1, 67.8, 72.7, 73.0, 97.6, 120.7, 123.5, 126.5, 126.7, 127.0,
127.3, 133.8, 150.1, 169.8, 170.0, 170.7 ppm; 19F n.m.r.: δ, -122.2 (s, 2F, CF2). HR-FAB
MS [M+Na]+ calculated for C20H20F2N4O8Na+ 505.1147, found 505.1142.

152

2,3,4,6-Tetra-O-benzyl-α/β-D-glucopyranosyl trichloroacetimidate (3.17). The title
compound was obtained from 2,3,4,6-tetra-O-benzyl-D-glucopyranose 3.150 in 62% yield
as a white foam as previously described.60 Analytical data for is this for α-3.17: Rf = 0.43
(ethyl acetate/hexanes, 1/4 v/v); 1H n.m.r. (300 MHz): δ, 3.67 (dd, 1H, J5,6a = 1.9 Hz,
J6a,6b = 10.9 Hz, H-6a), 3.74-3.80 (m, 3H, H-2, 4, 6b), 3.99 (m, 1H, H-5), 4.05 (dd, 1H,
J3,4 = 9.4 Hz, H-3), 4.53 (dd, 2H, 2J = 12.0 Hz, CH2Ph), 4.71 (dd, 2H, 2J = 11.7 Hz,
CH2Ph), 4.73 (dd, 2H, 2J = 10.7 Hz, CH2Ph), 4.84 (dd, 2H, 2J = 7.6 Hz, CH2Ph) , 6.50 (d,
1H, J1,2 = 3.4 Hz, H-1), 7.12-7.33 (m, 24H, aromatic), 8.57 (s, 1H, NH) ppm; 13C n.m.r.
(75 MHz): δ, 68.1, 73.0, 73.2, 73.6, 75.5, 75.8, 79.5, 81.5, 91.4, 94.5, 127.8 (x 3), 127.9
(x 2), 128.0, 128.1 (x 2), 128.2 (x 4), 128.5 (x 4), 128.6 (x 4), 137.9, 138.1, 138.2, 138.7,
161.4 ppm; HR-ESI MS [M+Na]+ calculated for C36H36Cl3NO6Na+ 706.1506, found
706.1500.

2,3,4-Tri-O-benzyl-α,β-D-glucopyranosyl N-phenyltrifluoroacetimidate (3.18). The
title compound was obtained from 2,3,4,6-tetra-O-benzyl-D-glucopyranose 3.150 by
adapting previously published procedure.23 To a mixture of 2,3,4,6-tetra-O-benzyl-α/β-Dglucopyranose 3.150 (150 mg, 0.28 mmol) and 2,2,2,-Trifluoro-N-phenylethanimidoyl
chloride (89.4 μL, 0.55 mmol), was added K2CO3 (55 mg, 0.55 mmol) in acetone (1.5
mL) and the resulting mixture was stirred for 3 h at rt. The solids were filtered off
through a pad of Celite and the solvent was concentrated in vacuo. The residue was
purified by column chromatography on silica gel (ethyl acetate-hexanes gradient elution)
to afford the corresponding N-phenyltrifluoroacetimidate in 72 % yield as a white
amorphous solid. Analytical data for β-3.18: Rf = 0.5 (ethyl acetate/hexanes, 1/4, v/v); 1H
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n.m.r. (500 MHz): δ, 3.56-3.95 (m, 6H, H-2, 3, 4, 5, 6a, 6b), 4.58 (dd, 2H, 2J = 9.5 Hz,
CH2Ph), 4.69 (dd, 2H, 2J = 12.2 Hz, CH2Ph), 4.88 (s, 2H, CH2Ph), 5.00 (dd, 2H, 2J =
10.2 Hz, CH2Ph) , 5.74 (d, 1H, J1,2 = 8.0 Hz, H-1), 6.78-7.5 (m, 25H, aromatic);

13

C

n.m.r. (75 MHz): δ, 73.6, 75.3, 75.4, 75.8 (x 2), 75.9 (x 2), 75.8, 81.1, 84.7, 119.5, 124.5,
127.9, 128.0 (x 2), 128.1 (x 3), 128.2 (x 3), 128.4 (x 2), 128.6 (x 6), 128.7 (x 7), 128.9 (x
2), 137.9, 138.1 (x 2), 138.5, 143.6 ppm; HR-FAB MS [M+Na]+ calculated for
C42H40F3NO6Na+ 734.2705, found 734.2720.

2,3,4,6-Tetra-O-benzoyl-α-D-glucopyranosyl trichloroacetimidate (3.21). The title
compound was obtained from 2,3,4,6-tetra-O-benzoyl-D-glucopyranose in 83% yield as a
white foam as previously described.61 Analytical data for 3.21 was in accordance with
that reported previously.19

2,3,4,6-Tetra-O-benzoyl-α-D-glucopyranosyl N-phenyltrifluoroacetimidate (3.22).
The title compound was obtained from 2,3,4,6-tetra-O-benzoyl-D-glucopyranose by
adapting previously published procedure.23 To a mixture of 2,3,4,6-tetra-O-benzoyl-α/βD-glucopyranose (2.17 g, 3.64 mmol) and 2,2,2,-trifluoro-N-phenylethanimidoyl chloride
(0.7 mL, 4.37 mmol), was added K2CO3 (0.54 g, 5.46 mmol) in acetone (20 mL) and the
resulting mixture was stirred for 5 h at rt. The solids were filtered off through a pad of
Celite and the solvent was concentrated in vacuo. The residue was purified by column
chromatography on silica gel (ethyl acetate-hexanes gradient elution) to afford the
corresponding N-phenyltrifluoroacetimidate in 86 % yield as a white foam. Analytical
data for α-3.22: Rf = 0.5 (ethyl acetate/hexanes, 3/7, v/v); [α]D27 +49.4 (c= 1.0, CHCl3);
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1

H n.m.r. (500 MHz): δ, 4.51 (dd, 1H, J5,6a = 4.4 Hz, J6a,6b = 12.5 Hz, H-6a), 4.69 (m, 1H,

H-5), 4.77 (dd, 1H, J5,6b = 1.8 Hz, H-6b), 5.67 (dd, 1H, J2,3 = 10.3 Hz, H-2), 5.93 (dd, 1H,
J4,5 = 10.1 Hz, H-4), 6.30 (m, 3H, H-3, 2’, 6’), 6.92 (d, 1H, J1,2 = 3.6 Hz, H-1), 7.00-8.15
(m, 25H, aromatic) ppm;

13

C n.m.r. (125 MHz): δ, 62.4, 68.6, 70.0, 70.5, 70.8, 92.3,

119.1, 124.4, 128.6 (x 2), 128.7 (x 5), 128.8 (x 5), 128.9, 129.7, 129.9 (x 2), 130.0 (x 8),
133.3, 133.4, 133.7, 133.8, 142.8, 143.0, 165.2, 165.4, 165.7, 166.1; 19F n.m.r.: δ, -65.51
(s, 3F, CF3) ppm; HR-FAB MS [M+Na]+ calculated for C42H31F2NO10Na+ 790.1876,
found 790.1886.

3.5.4. General glycosylation procedures and the synthesis of glycosides
Method A. A typical TMSOTf-promoted glycosylation procedure. A mixture of glycosyl
donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular
sieves (4Å, 90 mg) in CH2Cl2 (0.5 mL) or other solvent as indicated in Tables was stirred
under argon for 1 h at rt. The mixture was cooled to -78 oC or other temperature as
indicated in Tables, TMSOTf (0.0055-0.011 mmol) was added, and the resulting mixture
was stirred for 10-15 min as indicated in Tables. The solids were filtered off through a
pad of Celite and rinsed successively with CH2Cl2. The combined filtrate (~40 mL) was
washed with 1% aq. NaOH (2 x 10 mL) and water (2 x 10 mL). The organic phase was
separated, dried with MgSO4, and concentrated in vacuo. The residue was purified by
column chromatography on silica gel (ethyl acetate - hexane gradient elution) to afford a
glycoside derivative in yields listed in Tables.
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Method B. A typical BF3-OEt2-promoted glycosylation procedure. A mixture of 3,3difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-benzyl-α-D-glucopyranoside 3.2 (32.7 mg, 0.047
mmol), methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside 3.19 (18.3 mg, 0.043 mmol), and
freshly activated molecular sieves (4Å, 95 mg) in CH2Cl2 (0.6 mL) was stirred under
argon for 1 h at rt. The mixture was cooled to -78 oC, BF3-OEt2 (0.3 μL, 0.002 mmol)
was added, and the resulting mixture was stirred for 5 min. The solids were filtered off
through a pad of Celite and rinsed successively with CH2Cl2. The combined filtrate (~40
mL) was washed with 1% aq. NaOH (2 x 10 mL) and water (2 x 10 mL). The organic
phase was separated, dried with MgSO4, and concentrated in vacuo. The residue was
purified by column chromatography on silica gel (ethyl acetate - hexane gradient elution)
to afford disaccharide 3.20 in 93% yield (α/β = 1/20, Table 3.5).

Method C. A typical Cu(OTf)2-promoted glycosylation procedure. A mixture of donor
3.2 (38.3 mg, 0.055 mmol), methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside 3.19 (23.4
mg, 0.05 mmol), and freshly activated molecular sieves (3 Å, 110 mg) in CH2Cl2 (0.64
mL) was stirred under argon for 1 h at rt. Cu(OTf)2 (2.0 mg, 0.003 mmol) was added and
the resulting mixture was stirred for 5 min. The solids were filtered off through a pad of
Celite and rinsed successively with CH2Cl2. The combined filtrate (~40 mL) was washed
with 1% aq. NaOH (2 x 10 mL) and water (2 x 10 mL). The organic phase was separated,
dried with MgSO4, and concentrated in vacuo. The residue was purified by column
chromatography on silica gel (ethyl acetate - hexane gradient elution) to afford
disaccharide 3.20 in 97% yield (β only, Table 3.5).
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Method D. A typical MeOTf-promoted glycosylation procedure. A mixture of donor 3.2
(30.6 mg, 0.044 mmol), acceptor 3.19 (18.7 mg, 0.040 mmol), and freshly activated
molecular sieves (4Å, 90 mg) in CH2Cl2 (0.5 mL) was stirred under argon for 1 h at rt.
MeOTf (0.55 μL, 0.0044 mmol) was added and the resulting mixture was stirred for 10
min. The solids were filtered off through a pad of Celite and rinsed successively with
CH2Cl2. The combined filtrate (~40 mL) was washed with 1% aq. NaOH (2 x 10 mL) and
water (2 x 10 mL). The organic phase was separated, dried with MgSO4, and
concentrated in vacuo. The residue was purified by column chromatography on silica gel
(ethyl acetate - hexane gradient elution) to afford disaccharide 3.20 in 91% yield (α/β =
1/>25, Table3.5).

Method E. A typical AgOTf-promoted glycosylation procedure. A mixture of donor 3.2
(43.5 mg, 0.062 mmol), acceptor 3.19 (26.7 mg, 0.057 mmol), and freshly activated
molecular sieves (4Å, 120 mg) in CH2Cl2 (0.73 mL) was stirred under argon for 1 h at rt.
AgOTf (7.3 mg, 0.028 mmol) was added and the resulting mixture was stirred for 24 h.
The solids were filtered off through a pad of Celite and rinsed successively with CH2Cl2.
The combined filtrate (~40 mL) was washed with 1% aq. NaOH (2 x 10 mL) and water
(2 x 10 mL). The organic phase was separated, dried with MgSO4, and concentrated in
vacuo. The residue was purified by column chromatography on silica gel (ethyl acetate hexane gradient elution) to afford disaccharide 3.20 in 71% yield (α/β = 1/1.6, Table 3.5).

Method F. A typical PdCl2-promoted glycosylation procedure. A mixture of donor 3.2
(33.2 mg, 0.048 mmol), acceptor 3.19 (20.3 mg, 0.044 mmol), and freshly activated

157

molecular sieves (4Å, 90 mg) in CH2Cl2 (0.55 mL) was stirred under argon for 1 h at rt.
PdCl2 (2.55 mg, 0.014 mmol) was added and the resulting mixture was stirred for 36 h.
The solids were filtered off through a pad of Celite and rinsed successively with CH2Cl2.
The combined filtrate (~40 mL) was washed with 1% aq. NaOH (2 x 10 mL) and water
(2 x 10 mL). The organic phase was separated, dried with MgSO4, and concentrated in
vacuo. The residue was purified by column chromatography on silica gel (ethyl acetate hexane gradient elution) to afford disaccharide 3.20 in 57% yield (α/β = 1/1.7, Table 3.5).

Method G. A typical TMSClO4-promoted glycosylation procedure. A mixture of donor
3.2 (0.11 mmol), acceptor 3.19 (0.10 mmol), and freshly activated molecular sieves (3 Å,
90 mg) in Et2O (0.5 mL) or Et2O/1.4-dioxane (0.5 mL, 1/1, v/v) was stirred under argon
for 1 h at rt. TMSClO462 (0.011 mmol) was added and the resulting mixture was stirred
for 5 min. The solids were filtered off through a pad of Celite and rinsed successively
with CH2Cl2. The combined filtrate (~40 mL) was washed with 1% aq. NaOH (2 x 10
mL) and water (2 x 10 mL). The organic phase was separated, dried with MgSO4, and
concentrated in vacuo. The residue was purified by column chromatography on silica gel
(ethyl acetate - hexane gradient elution) to afford disaccharide 3.20 in 75% (α/β = 5/1,
Table 3.5) or 54% yield (α/β = 6.2/1), respectively.

Method H. A typical Bi(OTf)3-promoted glycosylation procedure. A mixture of donor 3.2
(41.3 mg, 0.059 mmol), acceptor 3.19 (25.2 mg, 0.054 mmol), and freshly activated
molecular sieves (4Å, 120 mg) in CH2Cl2 (0.7 mL) was stirred under argon for 1 h at rt.
The reaction was cooled to -60 oC followed by the addition of Bi(OTf)3 (3.9 mg, 0.006
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mmol) and the resulting mixture was stirred for 20 min. The solids were filtered off
through a pad of Celite and rinsed successively with CH2Cl2. The combined filtrate (~40
mL) was washed with 1% aq. NaOH (2 x 10 mL) and water (2 x 10 mL). The organic
phase was separated, dried with MgSO4, and concentrated in vacuo. The residue was
purified by column chromatography on silica gel (ethyl acetate - hexane gradient elution)
to afford disaccharide 3.20 in 85% yield, (α/β = 1/7.0, Table 3.5).

Method I. A typical SnCl4-promoted glycosylation procedure. A mixture of 3,3-difluoro3H-indol-2-yl 2,3,4,6-tetra-O-acetyl-α-D-glucopyranoside 3.8 (25.8 mg, 0.051 mmol),
acceptor 3.19 (21.8 mg, 0.046 mmol), and freshly activated molecular sieves (4Å, 90 mg)
in CH2Cl2 (0.5 mL) was stirred under argon for 1 h at rt. SnCl4 (0.6 μL, 0.005 mmol) was
added and the resulting mixture was stirred for 10 min (Table 4). The solids were filtered
off through a pad of Celite and rinsed successively with CH2Cl2. The combined filtrate
(~40 mL) was washed with 1% aq. NaOH (2 x 10 mL) and water (2 x 10 mL). The
organic phase was separated, dried with MgSO4, and concentrated in vacuo. The residue
was purified by column chromatography on silica gel (ethyl acetate - hexane gradient
elution) to afford disaccharide 3.38 in 80% yield (Table 3.5).

Methyl

2,3,4-tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)-α-D-

glucopyranoside (3.20). The title compound was obtained by Methods A-H from donor
3.2 and acceptor 3.1963 in 54-97% yield (α/β ranging from 6.2/1 to β-only, see Tables).
Analytical data for 3.20 was in accordance with that reported previously.64,65
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2-Propyl 2,3,4,6-tetra-O-benzyl-β-D-glucopyranoside (3.27). The title compound was
obtained by Method A from donor 3.2 and isopropanol 3.26 as a white amorphous solid
in 77% yield (β only). Analytical data for 3.27 was in accordance with that reported
previously.66

Methyl

2,3,4-tri-O-benzoyl-6-O-(2,3,4,6-tetra-O-benzyl-D-glucopyranosyl)-α-D-

glucopyranoside (3.29). The title compound was obtained by Method A from donor 3.2
and methyl 2,3,4-tri-O-benzoyl-α-D-glucopyranoside 3.2867 in CH2Cl2 or EtCN in 89%
(α/β = 1/11) or 87% yield (α/β = 1/18), respectively. Analytical data for 3.29 was in
accordance with that reported previously.68

6-O-(2,3,4,6-Tetra-O-benzyl-β-D-glucopyranosyl)-1,2:3,4-di-O-isopropylidene-α-Dgalactopyranose (3.31). The title compound was obtained by Method A from donor 3.2
and 1,2:3,4-di-O-isopropylidene-α-D-galactopyranose 3.30 in CH2Cl2 or EtCN in 85%
(α/β = 1/12) or 89% yield (β only), respectively. Analytical data for 3.31 was in
accordance with that reported previously.

Methyl

2,3,6-tri-O-benzyl-4-O-(2,3,4,6-tetra-O-benzyl-D-glucopyranosyl)-α-D-

glucopyranoside (3.33). The title compound was obtained by Method A from donor 3.2
and methyl 2,3,6-tri-O-benzyl-α-D-glucopyranoside 3.3263 in CH2Cl2 or EtCN in 94%
(α/β = 1/4) or 92% yield (α/β = 1/12), respectively. Analytical data for 3.33 was in
accordance with that reported previously.68
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Methyl

2-O-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)-3,4,6-tri-O-benzyl-α-D-

glucopyranoside (3.25). The title compound was obtained by Method A from donor 3.2
and methyl 3,4,6-tri-O-benzyl-α-D-glucopyranoside 3.2463 in CH2Cl2 or EtCN in 90%
(α/β = 1/6.0) or 88% yield (α/β = 1/15), respectively. Analytical data for 3.25 was in
accordance with that reported previously.29

(3β)-Cholest-5-en-3-yl 2,3,4,6-tetra-O-benzyl-β-D-glucopyranoside (3.35). The title
compound was obtained by Method A from donor 3.2 and (3β)-cholest-5-en-3-ol 3.34 as
a white amorphous solid in 86% yield (β-only). Analytical data for 3.35 was in
accordance with that reported previously.69

1-Adamantyl 2,3,4,6-tetra-O-benzyl-D-glucopyranoside (3.37). The title compound
was obtained by Method A from donor 3.2 and 1-adamantol 3.36 as a white amorphous
solid in 88% yield (α/β = 1/23). Analytical data for 3.37 was in accordance with that
reported previously.69

Methyl

2-O-(3,4,6-tri-O-acetyl-2-O-benzyl-α-D-glucopyranosyl)-3,4,6-tri-O-benzyl-

α-D-glucopyranoside (40). The title compound was obtained by Method A from donor
α-12 or donor β-12 and acceptor 3463 as a clear film in 89% or 88% yield (α only),
respectively. Analytical data for 40 was in accordance with that reported previously.29

Methyl

6-O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-

glucopyranoside (3.38). The title compound was obtained by Method I from donor 3.8
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and acceptor 3.1963 as a clear film in 80% yield. Analytical data for 3.38 were essentially
the same as reported previously.70

Methyl

6-O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-

glucopyranoside (3.39). The title compound was obtained by Method A from donor
3.10 and acceptor 3.1963 as a clear film in 94% yield. Analytical data for 3.39 were
essentially the same as reported previously.63

6-O-(2,3,4,6-Tetra-O-benzoyl-β-D-glucopyranosyl)-1,2:3,4-di-O-isopropylidene-α-Dgalactopyranose (3.40). The title compound was obtained by Method A from donor
3.10 and acceptor 3.30 in 86% yield. Analytical data for 3.40 were essentially similar as
reported previously.29

Methyl

4-O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-2,3,6-tri-O-benzyl-α-D-

glucopyranoside (3.41). The title compound was obtained by Method A from donor
3.10 and acceptor 3.3263 as a clear film in 90% yield. Analytical data for 3.41 were
essentially the same as reported previously.63

Methyl

2-O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-3,4,6-tri-O-benzyl-α-D-

glucopyranoside (3.42). The title compound was obtained by Method A from donor
3.10 and acceptor 3.2463 as a clear film in 93% yield. Analytical data for 3.42 were
essentially the same as reported previously.63

162

Methyl 6-O-(2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-2,3,4-tri-O-benzyl-α-Dglucopyranoside (3.43). The title compound was obtained by Method A from donor
3.12 and acceptor 3.1963 as a clear film in 98% yield. Analytical data for 3.43 were
essentially the same as reported previously.71

Methyl 4-O-(2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-2,3,6-tri-O-benzyl-α-Dglucopyranoside (3.44). The title compound was obtained by Method A from donor
3.12 and acceptor 3.3263 as a clear film in 98% yield. Analytical data for 3.44 were
essentially the same as reported previously.29

Methyl 6-O-(2,3,4,6-tetra-O-benzoyl-α-D-mannopyranosyl)-2,3,4-tri-O-benzyl-α-Dglucopyranoside (3.45). The title compound was obtained by Method A from donor
3.14 and acceptor 3.1963 as a clear film in 93% yield. Analytical data for 3.45 were
essentially the same as reported previously.29

Methyl 4-O-(2,3,4,6-tetra-O-benzoyl-α-D-mannopyranosyl)-2,3,6-tri-O-benzyl-α-Dglucopyranoside (3.46). The title compound was obtained by Method A from donor
3.14 and acceptor 3.3263 as a clear film in 90% yield. Analytical data for 3.46 were
essentially the same as reported previously.72

3.5.5. A typical procedure for regenerative glycosylation
A mixture of ethyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside 3.4773 (30 mg,
0.051 mmol) and activated molecular sieves (3 Å, 90 mg) in CH2Cl2 (0.5 mL) was stirred
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under argon for 1 h at rt. The mixture was cooled to 0 oC, bromine (0.27 μL, 0.01 mmol)
was added, and the resulting mixture was kept for 15 min at 0 oC. After that, 3,3difluorooxindole (0.9 mg - 8.9 mg, 0.0051-0.051 mmol, see Table 2 of the manuscript),
and Ag2O (35.5 mg, 0.16 mmol) were added to the reaction mixture and the resulting
mixture was stirred for 1h. Methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside 3.19 (18.3
mg, 0.039 mmol) and BF3-OEt2 (0.33 μL, 0.0025 mmol) were added and the reaction was
stirred for 10 min - 5 h (see Table 2 of the manuscript). The solids were filtered off
through a pad of Celite and rinsed successively with CH2Cl2. The combined filtrate (~20
mL) was washed with 1% aq. NaOH (2 x 10 mL) and water (2 x 10 mL). The organic
phase was separated, dried with MgSO4, and concentrated in vacuo. The residue was
purified by column chromatography on silica gel (ethyl acetate-hexanes gradient elution)
to afford disaccharide 3.20 in 9-90% yield (see Table 2 of the manuscript).
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Chapter 4

Refinement of the Key Chemical
Aspects of the HPLC–Assisted
Automated Oligosaccharide Synthesis

4.1. Introduction
Whether in the form of simple monosaccharides or as a part of complex natural
products, conjugates or biomarkers, carbohydrates are involved in a wide variety of
fundamental or disease-related processes. As a result, carbohydrates and their conjugates
show tremendous diagnostic and therapeutic potential. With the advent of modern
technology, the need for elucidating the exact mechanism by which these carbohydrates
interact with other biomolecules, and features that are responsible for these interactions,
has been particularly stimulating in the field. While scientists have been able to
successfully isolate certain classes of natural carbohydrates, the availability of pure
natural isolates is still inadequate to address challenges offered by modern glycosciences.
As a consequence, chemical synthesis has become a viable means to obtain both natural
complex carbohydrates and unnatural analogues thereof. With the immense task of
conducting efficient drug design and the search for new pharmaceuticals, the chemical
synthesis of complex carbohydrate structures and/or mimetics thereof falls short.

4.1.1. Chemical Synthesis of Oligosaccharides
Practically all complex carbohydrates bear an oligomeric sequence wherein
monosaccharide residues are linked via O-glycosidic linkages. This linkage is obtained
by a glycosylation reaction that typically involves a nucleophilic displacement of a
leaving group (LG, Scheme 4.1.) on the glycosyl donor by a hydroxyl group of the
acceptor.1 The remaining functional groups of both components are temporarily masked
with protecting groups (Ps).2-25 Despite significant progress, chemical glycosylation
remains challenging due to the requirements of achieving complete stereocontrol and
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suppressing side reactions.1 Further elongation of the saccharide chain for the synthesis
of oligomeric structures requires additional protecting/leaving group modifications
between each glycosylation step. Fraser-Reid,26,27 Nicolaou,28 Danishefsky,29 Kahne,30
Wong,31 Boons,32 Crich,19 Huang,33 and others34 developed advanced strategies that allow
for streamlining the oligosaccharide synthesis. Nevertheless, chemical synthesis of
oligosaccharides of even moderate complexity still remains a considerable challenge. As
such, the development of efficient methods for chemical glycosylation1 and expeditious
oligosaccharide34 and glycoconjugate synthesis remains a demanding area of research.
Scheme 4.1. Conventional solution-phase synthesis

4.1.2. Solid phase oligosaccharide synthesis
Solid-phase synthesis using insoluble polymer supports35,36 has been widely used in
the

preparation

of

many

organic

molecules35-38

including

peptides39

and

oligonucleotides.40 The early example of solid phase peptide synthesis by Merrifield41
was followed by oligosaccharide synthesis by Fréchet and Schuerch that emerged shortly
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thereafter.42 Since early attempts, the polymer-supported oligosaccharide synthesis has
become a viable means for the synthesis of oligosaccharide sequences without the
necessity of purifying, and characterizing, and even isolating the intermediates.43-46
Another important advantage of oligosaccharide synthesis on a solid support is the ease
of excess reagent removal (usually can be achieved by filtration and rinsing).
There are two main strategies for solid phase saccharide synthesis that differ in the
type of the attachment (Scheme 4.2). In strategy A, the glycosyl acceptor unit is bound to
the solid support either at the anomeric position or at another suitable hydroxyl. In this
case, an excess of the glycosyl donor and promoter are in the solution. The periodic
monitoring of the solution phase by TLC can provide information on whether the
glycosyl donor is still remaining in the solution. The completeness of the coupling can be
determined experimentally by performing the Kaiser test,47 or by cleaving the product off
the polymer support followed by characterization.

Routinely, the coupling step is

repeated multiple times using fresh reagents to ensure that all glycosyl acceptor is
consumed.
Scheme 4.2. General strategies for glycosylation on polymer support
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In approach B, the glycosyl donor unit, linked to the solid support via a suitable
hydroxyl group, is reacted with the excess of the solution phase acceptor. Two-directional
techniques, combining approaches A and B are also known.48,49 To improve the
operational simplicity of the oligosaccharide assembly Seeberger developed an
automated approach, which is based on strategy A: using a solid phase acceptor and a
liquid phase donor (vide infra).50

4.1.3. Key aspects of the solid phase synthesis
The solid support, a functionalized polymer used in a majority of applications, is an
insoluble material that is usually used in the form of a bead, a gel-like spherical
microparticle. The beads have good swelling properties in organic solvents that allows
for diffusion and hence facilitates the reagent delivery to the reactive sites.51 The
polymeric bead is then covalently linked to (or loaded with) a sugar moiety, typically via
a linker (or a spacer). It is known that the efficiency of the synthesis using solid supports
depends on the following factors:
1) The loading efficiency of the resin to the first anchoring unit.
2) The amount of cross-linking: It’s believed that lesser the amount of cross-linking,
the better is the stability and swelling capacity of the resin; resins wherein 1-2%
of monomers are cross-linked are considered ideal.
3) The material from which the support is constructed.
4) Chemical stability. The functional groups present on the resin might also react
with (or trap) the reagents, thereby poisoning (contaminating) the resin.

179

5) Physical stability. Resin beads can disintegrate or collapse if out-of-range
(excessive) temperature or pressure is applied.
Among various resins studied, the three dominant resins currently used for
oligosaccharide synthesis are chloromethyl-, hydroxymethyl- and aminomethylpolystyrene resins. Amongst these, use of chloromethylpolystyrene cross-linked with
divinyl benzene (Merrifield resin), has been widely used for a variety of applications.51
The low cost and its compatibility with a variety of reagents and solvents makes the
Merrifield resin a popular choice for oligosaccharide synthesis. Nevertheless, the search
of other suitable polymer supports is ongoing and other polystyrene based supports, such
as JandaGel, Tentagel, ArgoGel, etc. have also shown wide applicability. Though most of
the polymer supported oligosaccharide synthesis has been performed on insoluble
supports, for oligosaccharides synthesis using soluble polymer supports, fluorous tag or
ionic liquid supports have been introduced.
The linker, or a linker/spacer combination, is used to connect (covalently bind) the
solid support and the first sugar building block. The chemical composition and the size
(length) of the linker are known to have an effect on the outcome of reactions. But it is
the type of the bond between the linker and the sugar as well between the linker and the
resin that are of the key importance. The linker has to withstand all reaction conditions
required for glycosylation and protecting group manipulations, yet it should be easily
removable using mild reagents at the end of the synthesis.52 Many different linkers have
been developed and classified based on the reaction conditions required, acidic or basic,
reductive or oxidative, for linker cleavage. In the recent years, photo-cleavable or
metathesis cleavable linkers have also been developed. Among other linkers, silyl ether,
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1,2-di(hydroxymethyl)-benzene,53 alkene,54 and acylsulfonamide have been successfully
employed in polymer supported oligosaccharide syntheses.51,55-57

4.1.4. Automation of oligosaccharide synthesis
In spite of remarkable progress, the solid phase technique still suffers from significant
limitations: the need for large reagent excess, limited use of molecular sieves, large
volume of waste solvent, cumbersome analysis of intermediates, lower anomeric
stereoselectivity, loss and poisoning of resin, reagent trapping, etc. To expedite solidphase oligosaccharide synthesis further, Seeberger and co-workers developed an
automated approach in 2001.50,58,59 The automation was initially accomplished by using a
peptide synthesizer that has evolved into “the first fully automated solid-phase
oligosaccharide synthesizer” (2012),60 which was recently commercialized (Glyconeer
2.1, sold by GlycoUniverse). Although the automated platform developed by Seeberger
introduces an idea of operational simplicity, the technology remains over-engineered and
underdeveloped. It offers very little promise to become universally available,
operationally simple or inexpensive.
To overcome these limitations, recently our group has expanded technologies
available for the synthesis of oligosaccharides using polymer supports. The new
experimental set-up was based on modified HPLC61 equipment that is broadly available
in most of synthetic or analytical laboratories and requires practically no investment for
the basic setup. The modular character of HPLC allows for opportunities to implement
attachments, vary reagent delivery modes, modify detection systems, accessories, and
vary software packages. HPLC-based automation allows for real-time reaction
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monitoring, which, in turn, helps reduce the reaction time and the amount of reagents
needed. In brief, a chromatography column (Omnifit glass column) was loosely packed
with the pre-swelled polymer resin loaded with the glycosyl acceptor. The column was
then connected to the HPLC system containing a three-headed pump, a detector, and a
computer equipped with the standard HPLC-operating software (Scheme 4.3). The
column was then purged with solvent and the glycosyl donor and promoter delivered
using a multi-headed HPLC pump. After a relatively short reaction time, typically 60
min, the system was purged with the solvent to rinse off any excess reagents. At this
time, the resin was loaded with the disaccharide derivative that can be either cleaved off
from the polymer support or the oligosaccharide elongation can be continued via
alternating deprotection/glycosylation steps.
Scheme 4.3. HPLC-based automation of oligosaccharide synthesis

4.2. Results and Discussion
Preliminary work in our laboratory has clearly shown the advantages of the new
technology in comparison to that of the state-of-the-art polymer-supported synthesis. This
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method has shown a promise in reducing the amount of reagents and solvents via
recirculation, achieving faster reaction times, and performing real-time reaction
monitoring using a UV detector. With success in developing this new technology to
perform automated oligosaccharide synthesis, herein we aimed at optimizing all the
aspects of the HPLC-based automated synthesis. For this purpose, we will investigate
different types and classes of polymeric supports, linkers, glycosyl donors, and activation
conditions to identify the best conditions for reaction set-up, monitoring, and quenching –
all performed in the automated manner using standard HPLC-operating software.

4.2.1. Synthesis of the polymer-bound acceptor
In the preliminary study of the HLPC automation, the monosaccharide glycosyl
acceptor was first attached to the linker and spacer and then tethered to the resin at the
end (Procedure A, Scheme 4.4a). Precursor A bearing a trityl group as the temporary
protecting group at the primary C-6 position (P1) was first glycosidated with linker B.
The resulting conjugate C was then attached to the spacer by first carrying out
deprotection of the temporary protecting group on the linker (P3) and then coupling with
the spacer to yield compound D. The latter was then tethered to Tentagel MB-NH2 resin
using EDC (3.0 equiv.) and DMAP (1.0 equiv.) mediated coupling to give precursor E.
The temporary protecting group (trityl) was then cleaved off to afford the polymer bound
acceptor F.
Inspired by recent work by Seeberger,60 we have begun loading the spacer/linker first
(Procedure B, Scheme 4.4b). Our modified approach begins with the coupling of linker
B to the spacer unit followed by treatment with EDC (3.0 equiv.) and DMAP (1.0 equiv.)
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on Tentagel MB-NH2 resin to form precursor H. The temporary protecting group of
precursor H is then removed to afford acceptor molecule I. The latter is then glycosylated
with donor A and the elongation is performed by simple reiteration of deprotection and
glycosylation steps until the oligosaccharide of the desired length is generated.
Scheme 4.4. Strategic adjustment to the loading sequence

We believe that Procedure B is much more convenient for the HPLC-based
automation platform. During the preliminary study the monosaccharide glycosyl acceptor
was manually loaded on the resin and only afterwards was it subjected to the automation
sequence. In our present study, all the steps starting from loading of compound G to the
resin are automated. The modified OH resin precursor I can also be stored and used for
multiple automated oligosaccharide syntheses as needed via the operationally simple
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iterative glycosylations and deprotection steps. This strategic adjustment is expected to
enhance the reliability of the HPLC-based automation.
Herein, we illustrate the synthesis of the polymer-bound glycosyl acceptor using a C4
(butyl), C8 (octyl) and C16 (hexadecyl) spacer, succinoyl linker and Tentagel MB-NH2
resin as the solid support. The synthesis began with monotritylation of (1,4-butanediol,
1,8-octanediol, and 1,16-hexadecanediol) to give spacer precursors 4.1, 4.2, and 4.3
respectively (Scheme 4.5). The latter was then reacted with succinic anhydride in the
presence of DMAP to give conjugate 4.4, 4.5, and 4.6 respectively. The carboxyl on 4.4,
4.5, and 4.6 was then manually coupled with the free amine group of the Tentagel resin
using a flask on a shaker in the presence of EDC (3.0 equiv.) and DMAP (1.0 equiv.) to
give 4.7, 4.8, and 4.9 respectively, with a loading capacity of 0.23/ 0.29/ 0.30 mmol/g,
respectively, in 72 h.
Scheme 4.5. Synthesis of the polymer-bound acceptor 4.4

Alternatively, the same coupling was performed using the HPLC-based set up as
follows. Tentagel resin was packed into the glass Omnifit column and swelled for 1 h in
CH2Cl2. Linker-spacer conjugate 4.4, 4.5, and 4.6 along with the coupling reagents, EDC
(1 equiv.) and DMAP, were then passed through the column at a flow rate of 1.0 mL/min
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for 3 h. After that, the column was washed with CH2Cl2 (1 x 10 mL), acetone (1 x 10 mL)
and CH2Cl2 (2 x 10 mL) to ensure complete removal of the remaining reactants. The resin
was then dried and the loading capacity (0.23 mmol/g) was calculated based on the
increase in weight of the resin. Detritylation was then performed using 90%
trifluoroacetic acid in water to yield the polymer bound acceptor 4.10, 4.11, and 4.12,
respectively.
During our exploratory study with JandaGel and Tentagel resins, it was observed that
the desired loading capacities could be achieved much faster using HPLC-based reagent
delivery rather than the manual loading in a flask. Thus, loading capacities of 0.4 and
0.23 mmol/g for JandaGel (entry 1, Table 4.1) and Tentagel (entry 2) respectively, were
obtained. Based on the periodic monitoring using Kaiser test, both manual loading
procedures required a minimum reaction time of 72 h. However, when the same
couplings were performed using the HPLC-assisted experimental set-up, similar loading
capacities were obtained within 2-3 h (entries 3 and 4). We also noticed that HPLC-based
automation allowed us to reduce the amount of the coupling reagent (EDC) to a very
minimal 1.0 equiv. whereas manual experiments required at least 3.0 equiv. of EDC.
Table 4.1. Comparison of the loading efficiency between manual and HPLCbased automated experiments

Entry
1
2
3
4

Experimental EDC
Loading
set-up
(equiv.)
Time
JandaGel
Manual
3
72 h
Tentagel
Manual
3
72 h
JandaGel HPLC-based
1
2h
Tentagel HPLC-based
1
3h
Resin
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Loading
capacity, mmol/g
0.40
0.23
0.38
0.24

4.2.2. Screening of different glycosyl donors
The original development of the HPLC-based synthesis was solely based on utilizing
glycosyl trichloroacetimidates (TCAI) as glycosyl donors. In order to expand the utility
of this technology, we wanted to investigate whether other classes of glycosyl donors
would be suitable. Our laboratory has been developing new methods for chemical
glycosylation with the central focus on glycosyl thioimidates and thioglycosides.62 The
use of thioglycosides as donors in glycosylations of solid-supported acceptors has been
reported, but the relatively low reactivity profile of thioglycosides and the requirement
for stoichiometric promoters limits their application. Also under HPLC-assisted synthesis
ethyl, phenyl or tolyl thioglycosides were quite inefficient as glycosyl donors, which
resulted in very low yields (~5%) of the coupling products. In this context, we had no
success in using glycosyl bromides and fluorides as glycosyl donors.
Based on the previous studies with S-benzoxazolyl (SBox) imidates,63 we already
knew that these glycosyl donors offer superior properties for reactions in solution.64,65
The SBox donors were also found suitable for the solid phase synthesis using polymer66
and nanoporous gold supports.67 In these applications, SBox donors were activated with
TMSOTf. When essentially the same activations conditions were applied to glycosylation
of glycosyl acceptor 4.10 with SBox donor 4.13 using the HPLC-based experimental set
up, compound 4.18 was obtained in a good yield of 67% (entry 1, Table 4.2.). This
reaction was performed by passing solutions of the glycosyl donor 4.13 in CH2Cl2 and
TMSOTf in CH2Cl2 through the column packed with acceptor 4.10 using a multi-headed
HPLC pump. The reaction mixture that eluted from the column was then recirculated for
4 h to ensure completion of the reaction. It should be noted that all yields reported here
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are isolated yields after HPLC-based coupling and cleavage from the solid support with
recirculating solution of MeONa in MeOH, followed by manual acetylation with Ac2O
and pyridine.
Table 4.2. Comparative study of different S/O-imidoyl donors using HPLC-assisted
experimental set-up
BzO
BzO

OBz
O
LG
BzO

Donor
4.13-4.17
O
O

N
H

O

OH
4.10

1) TMSOTf (0.5-4 equiv.),
OAc
CH2Cl2
O
AcO
O
AcO
2) NaOMe,
MeOH
OAc
4.18
3) Ac2O, py

OAc

Acceptor

Entry

Donor, 10 equiv.

Time for recirculation Yield

1

4h

67%

1h

83%

3

1h

85%

4

2h

90%

5

2h

87

2

OBz
O
BzO
O
CCl3
BzO
4.14 BzO
NH

Although acceptable yield were obtained in SBox-mediated couplings, it has also
become apparent that highly reactive TCAI donors easily outperform SBox imidates.
Thus, a high yield of 83% was obtained in the TMSOTf-promoted synthesis of 4.18 from
donor 4.14 and the solid phase-bound acceptor 4.10 (entry 2). As shown in Chapter 2, Obenzoxazolyl (OBox) imidates, which represent a hybrid structure between SBox and
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TCAI, are more reactive than either leaving group. Hence, we were curious to investigate
whether the higher reactivity of OBox imidates would be beneficial for HPLC-based
applications. Indeed, a similar reactivity profile and yields to those obtained with TCAI
were achieved with OBox imidates. Thus, on reacting OBox donor 4.15 with acceptor
4.10, compound 4.18 was obtained in 85% yields (entry 3).
Inspired by promising results obtained with TCAI and OBox leaving groups, we
continued the search of suitable glycosyl donors by studying other O-imidates in the
HPLC-based applications. Over the course of this study we noticed that although Nphenyl trifluoroacetimidates (PTFAI)68,69 are more stable than their TCAI or OBox
counterparts, they often outperform TCAI in glycosylations. Thus, when glycosylation of
glycosyl donor 4.16 with acceptor 4.10 was carried out in the presence of TMSOTf
compound 4.18 was obtained in an excellent yield of 90%. However, since PTFAI
imidates are less reactive than their TCAI or OBox counterparts, higher amounts of
TMSOTf (2.5 equiv.) was used for their activation versus 0.5 equiv. required for the
activation of other O-imidates.
This stimulated our interest in investigating structurally similar OFox imidates (see
Chapter 3) as glycosyl donors for HPLC-assisted glycosylations. As expected, results
similar to those obtained with PTFAI donors were achieved (87% yield, entry 5, Table
4.2.). Under solid-supported synthesis, the OFox glycosides showed similar reactivity to
PTFAI glycosides and still required 2 equiv. of TMSOTf. This represents a significantly
larger amount of the activator in comparison to that required for the activation of OFox
imidates in solution (0.03-0.10 equiv.). As an outcome of this comparison study, we
conclude that reactive, but comparatively stable PTFAI and OFox imidates, achieve the
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best yields with HPLC-assisted glycosylations. Nevertheless, a relatively high amount of
TMSOTf required for their activation represents a drawback. This stimulated our further
search of suitable reaction conditions and we decided to apply the regenerative concept
for glycosylation to the HPLC-based automated set-up.

4.2.3. Application of the regenerative concept to HPLC-assisted automated synthesis
It is widely acknowledged that glycosylations on a solid phase offer different
challenges than those in solution. Additional hurdles relate to the mismatch between
highly reactive solution-based vs. unreactive solid-phase-immobilized reactants.45,70 Yet,
little has been done to develop dedicated methods, and all solid-phase glycosylations use
donors that have been developed for couplings in solution. Low efficiency of solid-phase
reactions has been addressed by a “cavalier approach”: applying a large excess of the
glycosyl donor (5-10 equiv.) and repeating the glycosylation step 2-3 times. In our
opinion, this approach is destined to fail, from an efficiency perspective, because 80-90%
of the donor goes to waste.46 Automation offers some operational simplicity, but the
entire concept suffers from the inherited drawbacks of conventional methods.
To overcome these limitations, we wanted to investigate whether the conditions
established for the OFox leaving group-based regenerative concept (see Chapter 3) would
be beneficial to HPLC-assisted synthesis. Since the 3,3-difluoroxindole (HOFox)71,72
aglycone has the same structure before and after glycosylation, the synthesis and
glycosidation of OFox imidates can be conducted using catalytic reagents: HOFox
aglycone will first react with a stable precursor to form highly reactive OFox imidate.
The latter will then react with the polymer-bound glycosyl acceptor while regenerating
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HOFox aglycone, which will be available for the next catalytic cycle to generate
additional quantities of the OFox donor, etc. As a result, only a small amount of the
reactive OFox donor is present in the reaction medium (which depends on the amount of
HOFox added), and the donor gets regenerated only upon its consumption.
In our opinion, the implementation of the OFox-based regenerative concept into the
HPLC-based automated set-up would have a conservatively estimated three-fold benefit.
First, the reactive donor would be generated in small amounts, which will help to
minimize side reactions. Second, the donor would be constantly regenerated ensuring
continuous feeding of the system with the “fresh” donor. Third, a stable precursor can be
used, and careful monitoring of glycosylation will ensure that only a minimal amount is
delivered.
Scheme 4.6. Outline of the OFox-mediated regenerative glycosylation
on solid support

As illustrated in Scheme 4.6, a stable thioglycoside (SEt) donor is first converted to
glycosyl bromide. 3,3-Difluoroxindole and Ag2O are then added to the same reaction
flask. This solution is then passed through a column containing the polymer-bound
acceptor. After 1 hour, TMSOTf is added to the same reaction flask to activate the OFox
formed. The reaction is continued until all glycosyl bromide has been consumed
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(glycosidated or hydrolyzed). Over the course of the reaction, the consumption of HOFox
to form the OFox imidate can be monitored using the HPLC-detector. The resin is then
washed several times to remove excess reagents. The sugar moiety is then cleaved off
from the solid support using NaOMe in MeOH and then purified to get the desired
monosaccharide.
Table 4.3. Manual solid-phase synthesis using regenerative glycosylation

Entry

Donor,
equiv.

1

10

2

10

3

10

4

10

5

10

6

10

Linker
C-4
(4.10)
C-8
(4.11)
C-16
(4.13)
C-16
(4.13)
C-16
(4.13)
C-16
(4.13)

Amount of OFox
added, equiv.

Promoter
(equiv.)

Time

Yield of
4.20-4.22

0.2

Ag2O (5)

48 h

No reaction

0.2

Ag2O (5)

48 h

No reaction

0.2

Ag2O (5)

48 h

20%

0.2

AgOTf (4)

48 h

21%

0.4

AgOTf (4)

48 h

23%

0.2

AgOTf (4)/
TMSOTf (2)

48 h

10%

With these considerations in mind, we began a dedicated study of regenerative
glycosylations on a solid phase support using both a manual and HPLC-based
experimental set-up. Alongside with this study, we also wanted to investigate the effect
of the linker. Starting with the four-carbon alkyl chain linker, we also obtained C8 and
C16 linkers using essentially the same method as that described for the synthesis of the
C4 linker (see Scheme 4.5). Manual solid-supported synthesis was carried our as follows.
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The resin-bound acceptor (4.10-4.12) was swelled in dry CH2Cl2 for 1 h. To the same
flask, S-ethyl glycoside 4.19 and bromine were added to form the desired glycosyl
bromide. The latter is stable in the presence of TMSOTf, but can be readily converted to
the corresponding OFox imidate in the presence of HOFox and Ag2O. The OFox imidate
is then reacted with the solid support bound acceptor (4.10-4.12) in the presence of
TMSOTf. During our initial experimentation, regenerative glycosylations performed
using C4 or C8 linker, did not proceed. At this instant, we realized that the longer the
linker, the better will be the availability of the free hydroxyl of the glycosyl acceptor
since it creates more reaction space by extending the acceptor away from the bulky solid
support.The assumption was in accordance to the results obtained from our previous
study where we showed that higher reaction yield and improved selectivities were
obtained using C8-O-C8 spacer. Inded, when glycosylations were performed using C16
linker, some conversion (~20%, Table 4.3, entry 3) was observed.
While performing solid-phase regenerative glycosylations, we encountered some
difficulties with respect to filtering of the resin and further steps associated with the
synthesis. The reason behind that was the insolubility of silver oxide in the solvent used
for glycosylation. As a result, we decided to use silver triflate instead of silver oxide.
Because of its solubility in acetone, AgOTf can be easily washed off during filtration.
Also when present in stiochiometric amounts, it activates both bromides and OFox
imidates. Thus, regenerative glycosylation using stiochiometric amounts (4.0 equiv.) of
silver triflate provided 4.22 in 21% yield. When the same reaction was performed in the
presence of AgOTf/TfOH (4.0 equiv./1.0 equiv.) only 10% conversion was observed.
When the amount of HOFox was increased from 0.2 equiv. to 0.4 equiv. there was no
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significant change in the yields obtained. Further investigation of this regenerative
glycosylation approach to solid supported synthesis and HPLC-assisted automated
oligosaccharide synthesis are currently underway in our laboratory.

4.3. Conclusions
Our laboratory had shown a new automation platform based on HPLC (highperformance liquid chromatography) equipment to be a very promising new technology
for the synthesis of oligosaccharides. Refinement of chemical aspects of HPLC-based
experimental set-up was performed in terms of studying various linkers, resins, and
glycosyl donors. We also implemented the regenerative glycosylation concept to the
HPLC-assisted automated synthesis. With the application of the regenerative concept, we
have observed faster reaction times and achieved lower reagent excesses in comparison to
that of all other known approaches for solid-phase synthesis. With the ultimate goal of
developing universal conditions for HPLC-assisted synthesis, we expect that the
regenerative concept will significantly enhance our ability to conduct solid-supported
glycosylations.

4.4. Experimental Section
4.4.1. General Remarks
All reactions were performed under argon with dry, freshly distilled solvents unless
otherwise noted. CH2Cl2, EtCN were distilled from CaH2 directly prior to application.
TMSOTf, BF3-OEt2 and TMSClO4 were used as is. Molecular sieves (3Å) used for the
reactions were activated at 390 °C and then for 2-3 h at 390 °C under reduced pressure
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prior to application. Reactions were monitored by TLC on Kieselgel 60 F254 and the
compounds were detected by examination under UV light and by charring with 10%
sulfuric acid in methanol. Solvents were removed under reduced pressure at < 40 oC.
Column chromatography was performed on silica gel 60 (70-230 mesh). Optical rotations
were measured at ‘Jasco P-1020’ polarimeter. 1H n.m.r. spectra were recorded at 300
MHz, 500 MHz, or 600 MHz. 13C n.m.r. spectra were recorded at 75 MHz or 150 MHz.
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F spectra were recorded at 282.2 MHz. The 1H chemical shifts are referenced to the

signal of the residual CHCl3 (δH = 7.27 ppm) for solutions in CDCl3. The

13

C chemical

shifts are referenced to the central signal of CDCl3 (δC = 77.23 ppm) for solutions in
CDCl3. HRMS determinations were made with the use of JEOL MStation (JMS-700)
Mass Spectrometer.

4.4.2. Synthesis of linkers and glycosyl acceptors
4-Trityloxybutan-1-ol (4.1). The title compound was obtained from 1,4-butanediol
according to the procedure reported previously73 in 85% yield as a white amorphous
powder. Analytical data for 4.1: Rf = 0.44 (ethyl acetate/hexanes, 3/7, v/v); 1H-n.m.r.
(300 MHz): δ, 1.67 (m, 4H, -CH2), 3.08 (t, 2H, 2J = 5.9 Hz, -CH2), 4.08 (t, 2H, 2J = 5.9
Hz, -CH2), 7.20-7.42 (m, 15H, aromatic); 13C-n.m.r. (75 MHz): δ, 26.8, 30.2, 63.1, 63.7,
86.8, 127.1 (x 3), 128.0 (x 6), 128.8 (x 6), 144.4 (x 3) ppm; HR-FAB MS [M+Na]+
calculated for C23H24O2Na+ 355.1674, found 355.1676.

4-(4-Trityloxy)butoxy-4-oxobutanoic acid (4.4).

The title compound was obtained

from 4.1 and succinic anhydride as described previously61 in 93 % yield as a colorless
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syrup. Analytical data for 4.4: Rf = 0.42 (methanol/dichloromethane, 1/9, v/v); 1H-n.m.r.
(300 MHz): δ, 1.71 (m, 4H, CH2), 2.61 (m, 4H, CH2), 3.08 (t, 2H, 2J = 6.2 Hz, CH2), 4.08
(t, 2H, 2J = 6.2 Hz, CH2), 7.19-7.48 (m, 15H, aromatic);
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C-n.m.r. (75 MHz): δ, 25.8,

26.7, 29.1, 63.2, 65.1, 86.6, 127.1 (x 4), 127.9 (x 7), 128.8 (x 7), 144.5 (x 3), 172.4, 177.3
ppm; HR-FAB MS [M+Na]+ calculated for C27H28O5Na+ 455.1834, found 455.1824.

8-Trityloxyoctan-1-ol (4.2). The title compound was obtained from 1,8-octanediol as
described previously74 in 73 % yield as an amorphous powder. Analytical data for 4.2: Rf
= 0.5 (ethyl acetate/hexanes, 2/3 v/v); 1H-n.m.r. (300 MHz): δ, 1.32 (m, 6H, 3 x CH2),
1.58 (m, 6H, 3 x CH2), 3.04 (t, 2H, 2J = 6.6 Hz, CH2), 3.63 (t, 2H, 2J = 6.6 Hz, CH2),
7.20-7.49 (m, 15H, aromatic); 13C-n.m.r. (75 MHz): δ, 26.8, 30.2, 63.1, 63.7, 86.8, 127.0
(x 3), 127.9 (x 6), 128.9 (x 6), 144.7 (x 3) ppm; HR-FAB MS [M+Na]+ calculated for
C27H32O2Na+ 411.2300, found 411.2296.

4-(8-Trityloxy)octyloxy-4-oxobutanoic acid (4.5). The title compound was obtained
from 4.2 and succinic anhydride as described previously61 in 76% yield as a colorless
syrup. Analytical data for 4.5: Rf = 0.38 (ethyl acetate/hexanes, 2/3 v/v); 1H-n.m.r. (300
MHz): δ, 1.20-1.40 (m, 9H, -OH, CH2), 1.61 (m, 4H, CH2), 2.64 (t, 4H, CH2), 3.03 (t, 2H,
2

J = 6.6 Hz, CH2), 4.08 (t, 2H, 2J = 6.7 Hz, CH2), 7.19-7.49 (m, 15H, aromatic);
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C-

n.m.r. (75 MHz): δ, 26.0, 26.4, 28.7, 29.1, 29.3, 29.5, 30.2, 63.8, 65.2, 86.5, 127.0, 127.9,
128.1, 144.7, 172.4, 178.0 ppm; HR-FAB MS [M+Na]+ calculated for C31H36O5Na+
511.2460, found 511.2459.
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16-Trityloxyhexadecane-1-ol (4.3).

The title compound was obtained from 1,16-

hexadecanediol as described previously74 in 52% yield as a colorless syrup. Analytical
data for 4.3: Rf = 0.33 (ethyl acetate/hexanes, 1/4 v/v); 1H- n.m.r. (500 MHz): δ, 1.191.34 (m, 28H, 16 x CH2), 1.46-1.58 (m, 4H, 2 x CH2), 2.98 (t, 2H, 2J = 6.6 Hz, CH2),
3.57 (t, 2H, 2J = 6.6 Hz, CH2), 7.16-7.45 (m, 15H, aromatic);

13

C- n.m.r. (75 MHz): δ,

26.0, 26.5, 29.7 (x 2), 29.8 (x 7), 29.9, 30.3, 33.1, 63.3, 64.0, 86.6, 127.0, 127.5, 127.9 (x
4), 128.1 ( x3), 128.2 (x 3), 129.0 (x 4), 144.9, 147.2 ppm.

4-(16-Trityloxy)hexadecyloxy-4-oxobutanoic acid (4.6).

The title compound was

obtained from 4.3 and succinic anhydride as described previously61 in 72% yield as a
colorless syrup. Analytical data for 4.6: Rf = 0.44 (ethyl acetate/hexanes, 1/1 v/v); 1Hn.m.r. (300 MHz): δ, 1.12-1.42 (m, 27H, CH2), 1.52-1.68 (m, 4H, CH2), 2.58-2.70 (m ,
4H, CH2), 3.04 (t, 2H, 2J = 6.6 Hz, CH2), 4.09 (t, 2H, 2J = 6.7 Hz, CH2), 7.19-7.48 (m,
15H, aromatic);
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C- n.m.r. (75 MHz): δ, 28.8, 29.2 (x 2), 29.4, 29.7 (x 2), 29.8 (x 6),

29.9 (x 3), 30.3, 63.9, 65.2, 86.6, 127.0 (x 2), 127.4, 127.8 (x 4), 128.1 (x 2) 128.2 (x 2),
128.9 (x 4), 144.8 (x 2), 147.2, 172.4, 177.3 ppm.

4.4.3. Synthesis of glycosyl donors
S-Benzoxazolyl 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranoside (4.13).

The title

compound was obtained in 75% yield as a pale yellow foam as previously described.75
Analytical data for 4.13 was in accordance with that reported previously.75
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2,3,4,6-Tetra-O-benzoyl-α-D-glucopyranosyl trichloroacetimidate (4.14). The title
compound was obtained in 83% yield as a white foam as previously described.76
Analytical data for 4.14 was in accordance with that reported previously.77

Benzoxazolyl

2,3,4,6-tetra-O-benzoyl-β-D-glucopyranoside

(4.15).

The

title

compound was obtained in 75% yield as a pale yellow foam as previously described.77
Analytical data for 4.15 was in accordance with that reported previously.77

2,3,4,6-Tetra-O-benzoyl-α-D-glucopyranosyl N-phenyltrifluoroacetimidate (4.16).
The title compound was obtained in 86% yield as a white foam as previously described.68
Analytical data for 4.16 was in accordance with that reported previously.78

3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-benzoyl-α-D-glucopyranoside (4.17). The
title compound was obtained in 75% yield as a pale yellow foam as previously
described.78 Analytical data for 4.17 was in accordance with that reported previously.78

Ethyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (4.19). The title compound
was obtained as previously described.79

4.4.4. Manual and HPLC-mediated polymer supported synthesis
General glycosylation procedure using HPLC-assisted automated set-up. A solution of
glycosyl donor 4.13-4.17 (39 mM in CH2Cl2, Pump A, percentage flow: 80%), and a
solution of TMSOTf (0.28 mM in CH2Cl2, Pump B, percentage flow: 20%) were passed
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concomitantly through a column containing resin-bound glycosyl acceptor 4.10-4.12 at
the combined flow rate of 0.3 mL/min for 20 min. The pump A was then switched to
pump C (recirculating chamber, percentage flow: 80%) while pump B remained the same
(TMSOTf soln., percentage flow: 20%) and the resulting solutions were passed
concomitantly through a column with the combined flow rate of 0.3 mL/min for 10 min.
After that, the system was switched to pump C (recirculating chamber, percentage flow
100%) and the solution was recirculated at a flow rate of 0.3 mL/min for 1-4 h. Pump C
was stopped and the column was purged with CH2Cl2 (pump A, 10.0 mL/min), acetone
(pump A, 10.0 mL/min), and again with CH2Cl2 (pump A, 20.0 mL/min).

Procedure for manual cleavage of the products from the resin. A 1 M solution of sodium
methoxide in methanol (0.3 mL) was added to a suspension or a mixture of resin in
methanol (2.0 mL) and the resulting mixture was kept for 24 h at rt. After that, the
reaction mixture was neutralized with Dowex H+ resin. The resin was filtered off and
rinsed successively with MeOH (10 × 5 mL). The combined filtrate (∼50 mL) was
separated, dried with MgSO4, concentrated in vacuo, and dried. The crude product
obtained from this step was then acetylated according to the procedure described below.

Acetylation of the crude product. To a stirred solution of crude monosaccharide (0.0482
mmol) in pyridine (2 mL) Ac2O (73 mL, 0.771 mmol) was added dropwise in the
presence of catalytic DMAP. The reaction mixture was stirred under argon for 6 h at
room temperature. The reaction mixture was quenched with CH3OH (1 mL) and the
resulting mixture was concentrated under reduced pressure. The residue was purified by
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column chromatography on silica gel (ethyl acetate – toluene gradient elution) to afford
corresponding monosaccharide 4.18 in 67-90% yield.

Procedure for the manual regenerative glycosylation on solid phase. A mixture of resinbound acceptor 4.10-4.12 (0.028 mmol) and ethyl 2,3,4,6-tetra-O-benzyl-1-thio-β-Dglucopyranoside 4.1979 (0.28 mmol) in dry dichloromethane (2 mL) was agitated for 2 h
at room temperature. After that, bromine (0.01 mmol) was added, and the resulting
mixture was kept for 30 min at rt. After that, 3,3-difluorooxindole (0.056-0.14 mmol),
and Ag2O/AgOTf (1.4/1.12 mmol) were added to the reaction mixture and the resulting
mixture was stirred for 1 h at rt. After 1h, TMSOTf (0.56 mmol) was added and the
mixture was agitated for 24-36 h at room temperature under argon. The resin was
separated by sintered filter, washed successively with dichloromethane (5 x 5 mL),
acetone (5 x 5 mL) and again dichloromethane (5 x 5 mL) followed by drying in vacuo.
The residual resin was suspended in dry dichloromethane (1 mL) before adding 1 N
sodium methoxide solution in methanol (2 mL). The reaction mixture was agitated at
room temperature for 5 h; the pH was monitored and adjusted within pH ̴ 8-9 range with
1 N sodium methoxide solution, if needed. The resin was separated by sintered filter,
washed successively with methanol (3 x 5 mL) and dichloromethane (3 x 5 mL), and
dried in vacuo. The combined filtrate was neutralized with Dowex (H+), the resin was
filtered off, and the solvent was removed under reduced pressure. The residue was
purified by column chromatography on silica gel (ethyl acetate – hexanes gradient
elution) to afford corresponding monosaccharide.
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Procedure for HPLC-mediated regenerative glycosylation. A mixture of ethyl 2,3,4,6tetra-O-benzyl-1-thio-β-D-glucopyranoside 4.1979 (0.028-0.28 mmol) and activated
molecular sieves beads (3 Å, 90 mg) in CH2Cl2 (0.5 mL) was stirred under argon for 1 h
at rt. The mixture was cooled to 0 oC, bromine (0.01 mmol) was added, and the resulting
mixture was kept for 15 min at 0 oC. After that, 3,3-difluorooxindole (0.0056-0.mmol,
and Ag2O (36 mg, 0.16 mmol) were added to the reaction mixture and the resulting
mixture connected to HPLC (Pump A, percentage flow: 100%), and recirculated through
the column containing the resin bound acceptor 4.10-4.12 for 1h. Following that,
TMSOTf (4.5 µL) was added to the chamber containing the bromide, HOFox and Ag2O
and passed concomitantly through the column at a flow rate of 0.5 mL/min for 5 h. Pump
A was stopped and the column was purged with CH2Cl2 (pump A, 10.0 mL/min), acetone
(pump A, 10.0 mL/min), and again with CH2Cl2 (pump A, 20.0 mL/min).

Procedure for manual cleavage of the products from the resin. A 1 M solution of sodium
methoxide in methanol (0.3 mL) was added to a suspension or a mixture of resin in
methanol (1.0 mL) and the resulting mixture was kept for 24 h at rt. After that, the
reaction mixture was neutralized with Dowex H+ resin. The resin was filtered off and
rinsed successively with MeOH (10 × 5 mL). The combined filtrate (∼50 mL) was
separated, dried with MgSO4, concentrated in vacuo, and dried. The crude product
obtained from this step was then acetylated according to the procedure described below.
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4-Acetoxybutyl

2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside

(4.18).

The

title

compound was obtained in yields shown in Tables as a white solid. Analytical data for
4.18 was in accordance with that reported previously.80
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Figure A-1: 1H NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-acetyl-α-Dglucopyranoside (2.2)
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Figure A-2: 13C NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-acetyl-α-Dglucopyranoside (2.2)
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Figure A-3: 2D NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-acetyl-α-Dglucopyranoside (2.2)
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Figure A-4: 1H NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-benzyl-α/β-Dglucopyranoside (2.4)
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Figure A-5: 13C NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-benzyl-α/β-Dglucopyranoside (2.4)
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Figure A-6: 2D NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-benzyl-α/β-Dglucopyranoside (2.4)
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Figure A-7: 1H NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-benzyl-α-Dmannopyranoside (2.6)

160

155

150

Figure A-8:

145

13

140

135

130

125

120

115

110

105

100

95

90

85

80

75

70 ppm

C NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-benzyl-α-D-

mannopyranoside (2.6)
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Figure A-9: 2D NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-benzyl-α-Dmannopyranoside (2.6)

219

7.0

6.5

6.0

5.5

5.0

4.5

13.1287

1.0623

3.1394

1.0176

1.0761

1.0000

5.2655

1.1107
7.5

4.0

3.5

3.0

2.5

ppm

Figure A-10: 1H NMR spectrum of Benzoxazolyl 3,4,6-Tri-O-acetyl-1,2-O-(1benzoxazolyloxyethylidene)-α-D-glucopyranose (2.8)
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C NMR spectrum of Benzoxazolyl 3,4,6-Tri-O-acetyl-1,2-O-(1-

benzoxazolyloxyethylidene)-α-D-glucopyranose (2.8)
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Figure A-12: 2D NMR spectrum of Benzoxazolyl 3,4,6-Tri-O-acetyl-1,2-O-(1benzoxazolyloxyethylidene)-α-D-glucopyranose (2.8)
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Figure A-13: 1H NMR spectrum of Benzoxazolyl Benzoxazolyl 2,3,4,6-tetra-Obenzoyl-β-D-glucopyranoside (2.10)
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C NMR spectrum of Benzoxazolyl Benzoxazolyl 2,3,4,6-tetra-O-

benzoyl-β-D-glucopyranoside (2.10)
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Figure A-15: 2D NMR spectrum of Benzoxazolyl Benzoxazolyl 2,3,4,6-tetra-Obenzoyl-β-D-glucopyranoside (2.10)
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Figure A-16: 1H NMR spectrum of Benzoxazolyl-2,3,4,6-tetra-O-benzoyl-α-Dgalactopyranoside (2.12)
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C NMR spectrum of Benzoxazolyl-2,3,4,6-tetra-O-benzoyl-α-D-

galactopyranoside (2.12)
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Figure A-18: 2D NMR spectrum of Benzoxazolyl-2,3,4,6-tetra-O-benzoyl-α-Dgalactopyranoside (2.12)
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Figure A-19: 1H NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-benzoyl-α-Dmannopyranoside (2.14)

165

160

155

Figure A-20:

150

13

145

140

135

130

125

120

115

110

105

100

95

90

85

80

75

70

65

C NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-benzoyl-α-D-

mannopyranoside (2.14)
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Figure A-21: 2D NMR spectrum of Benzoxazolyl 2,3,4,6-tetra-O-benzoyl-α-Dmannopyranoside (2.14)
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Figure A-22: 1H NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-Obenzyl-α-D-glucopyranoside (3.2)
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Figure A-23: 13C NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-Obenzyl-α-D-glucopyranoside (3.2)
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Figure A-24: 2D NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-Obenzyl-α-D-glucopyranoside (3.2)
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Figure A-25: 1H NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-Obenzyl-α-D-mannopyranoside (3.4)
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Figure A-26: 13C NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-Obenzyl-α-D-mannopyranoside (3.4)
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Figure A-27: 2D NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-Obenzyl-α-D-mannopyranoside (3.4)
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Figure A-28: 1H NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 3,4,6-tri-O-acetyl2-O-benzyl-β-D-glucopyranoside (β-3.6)
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Figure A-29: 13C NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 3,4,6-tri-O-acetyl2-O-benzyl-β-D-glucopyranoside (β-3.6)
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Figure A-30: 2D NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 3,4,6-tri-O-acetyl2-O-benzyl-β-D-glucopyranoside (β-3.6)
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Figure A-31: 1H NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 3,4,6-tri-O-acetyl2-O-benzyl-α-D-glucopyranoside (α-3.6)
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Figure A-32: 13C NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 3,4,6-tri-O-acetyl2-O-benzyl-α-D-glucopyranoside (α-3.6)
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Figure A-33: 2D NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 3,4,6-tri-O-acetyl2-O-benzyl-α-D-glucopyranoside (α-3.6)
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Figure A-34: 1H NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-Oacetyl-α-D-glucopyranoside (3.8)
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Figure A-35: 13C NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-Oacetyl-α-D-glucopyranoside (3.8)
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Figure A-36: 2D NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-Oacetyl-α-D-glucopyranoside (3.8)
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Figure A-37: 1H NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-Obenzoyl-α-D-glucopyranoside (3.10)

165

160

155

150

145

140

135

130

125

120

115

110

105

100

95

90

85

80

75

70

65

ppm

Figure A-38: 13C NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-Obenzoyl-α-D-glucopyranoside (3.10)
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Figure A-39: 2D NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-Obenzoyl-α-D-glucopyranoside (3.10)
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Figure A-40: 1H NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-Obenzoyl-β-D-galactopyranoside (3.12)
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Figure A-41: 13C NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-Obenzoyl-β-D-galactopyranoside (3.12)
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Figure A-42: 2D NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-Obenzoyl-β-D-galactopyranoside (3.12)

241

7.5

7.0

6.5

1.0115
1.0575
1.0146

2.0350

1.0142

1.0000

1.6841

7.4206

5.9943

3.5660

1.0743

2.0487

6.2153
8.0

6.0

5.5

5.0

4.5

ppm

Figure A-43: 1H NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-Obenzoyl-α-D-mannopyranoside (3.14)
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Figure A-44: 13C NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-Obenzoyl-α-D-mannopyranoside (3.14)

242

ppm
4.5

5.0

5.5

6.0

6.5

7.0

7.5

8.0
8.0

7.5

7.0

6.5

6.0

5.5

5.0

4.5 ppm

Figure A-45: 2D NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-Obenzoyl-α-D-mannopyranoside (3.14)
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Figure A-46: 1H NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 3,4,6-tri-O-acetyl2-azido-2-deoxy-β-D-glucopyranoside (3.16)
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Figure A-47: 13C NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 3,4,6-tri-O-acetyl2-azido-2-deoxy-β-D-glucopyranoside (3.16)
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Figure A-48: 2D NMR spectrum of 3,3-Difluoro-3H-indol-2-yl 3,4,6-tri-O-acetyl2-azido-2-deoxy-β-D-glucopyranoside (3.16)
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Figure A-49: 1H NMR spectrum of 4-Trityloxybutan-1-ol (4.1)
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Figure A-50: 13C NMR spectrum of 4-Trityloxybutan-1-ol (4.1)
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Figure A-51: 1H NMR spectrum of 4-(4-Trityloxy)butoxy-4-oxobutanoic acid (4.4)
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Figure A-52: 13C NMR spectrum of 4-(4-Trityloxy)butoxy-4-oxobutanoic acid (4.4)
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Figure A-53: 1H NMR spectrum of 8-Trityloxyoctan-1-ol (4.2)
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Figure A-54: 13C NMR spectrum of 8-Trityloxyoctan-1-ol (4.2)

248

35

30

25

20

15

10

5

ppm

7.0

6.5

6.0

5.5

5.0

4.5

4.0

3.5

3.0

2.5

2.0

1.5

8.9137

4.2891

4.2478

1.9179

2.0000

10.4086

6.1122
7.5

1.0

0.5

ppm

Figure A-55: 1H NMR spectrum of 4-(8-Trityloxy)octyloxy-4-oxobutanoic acid (4.5)
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Figure A-56: 13C NMR spectrum of 4-(8-Trityloxy)octyloxy-4-oxobutanoic acid (4.5)
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Figure A-57: 1H NMR spectrum of 16-Trityloxyhexadecane-1-ol (4.3)
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Figure A-58: 13C NMR spectrum of 16-Trityloxyhexadecane-1-ol (4.3)
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Figure A-59: 1H NMR spectrum of 4-(16-Trityloxy)hexadecyloxy-4-oxobutanoic
acid (4.6)
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Figure A-60: 13C NMR spectrum of 4-(16-Trityloxy)hexadecyloxy-4-oxobutanoic
acid (4.6)
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